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The aim of this thesis is to have a deeper insight and more comprehensive 
understanding of  mite allergy, focusing on Group 5 and its homologue Group 21 
allergens. The study started with characterization of Blo t 21 allergen as B. tropicalis is a 
predominant mite species in Singapore as well as in many other regions of the world. 
Group 5 and Group 21 allergens in other mite species were also characterized, and finally 
IgE-binding areas of Blo t 5, a representative Group 5 allergen, were mapped.  
Blo t 21 sensitization is strongly associated with allergic rhinitis. It is a product of 
a single-copy gene mainly with α-helical secondary structure, sharing 39% identity to Blo 
t 5 protein. When it was evaluated in 43 adult patients, 93% positive response was 
obtained by ELISA and 95% by skin prick test. Blo t 21 was found to be the third most 
prevalent allergen among 19 B. tropicalis allergens through studies in 97 B. tropicalis 
positive individuals. In addition, the majority (>75%) of the Blo t 21 sensitized 
individuals were co-sensitized to Blo t 5. Blo t 21 and Blo t 5 were identically distributed 
in house dusts, implying co-exposure of these allergens in the population that leads to co-
sensitization of both allergens. Low to moderate degrees of cross-reactivity among Blo t 
21 and other Group 5 allergens observed from inhibition studies indicates that Blo t 21 
can induce specific hypersensitive responses. Hence, Blo t 21 is a novel clinically 
important allergen of B. tropicalis. 
The IgE-binding activities of both Blo t 5 and Blo t 21 are stable. Blo t 21 and Blo 
t 5 are resistant to heat treatment (up to 90 °C), extreme pH conditions (pH 2 and pH 12) 
and chemical denaturation with 6 M urea. The high stability of IgE-binding activites of 
Blo t 21 and Blo t 5 explains why these two molecules are so allergenic in B. tropicalis.  
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Parallel studies on Der f 21, Sui m 5.01, Sui m 5.02 and Sui m 5.03 consistently 
show that Group 5 and Group 21 allergens are important in both predominant mite D. 
farinae and less commonly occurring mite S. medanensis. When eleven Group 5 and 
Group 21 allergens from seven mite species were evaluated in 118 local mite positive 
atopic subjects, Blo t 5 was found the most important allergen. Cross-inhibition studies 
revealed the predominant sensitization of Group 5 and Group 21 allergens of B. tropicalis 
and D. farinae species and partial cross-reaction to Der p 5, Lep d 5 and Ale o 5 in atopic 
individuals. 
IgE-binding epitopes of Blo t 5 mapped by both site-directed mutagenesis and 
systematic overlapping peptide mapping approaches demonstrate that multiple IgE-
binding epitopes exist throughout Blo t 5 molecule, including N-terminal, Center and C-
terminal of the protein. Majority of the patients respond to multiple epitopes of Blo t 5, 
but different individuals react to different epitopes. DLNILERF (98-105) is found to be a 
common IgE-binding epitope of Blo t 5. 
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Chapter 1: Literature Review  
 
 
The immune system is a host defense system protecting our body against 
potentially life threatening infectious microorganisms, foreign harmful substances and 
abnormal cells like cancerous cells in our body.  The response of the immune system to 
the introduction of harmful or foreign substances is called immune response. This process 
is a carefully coordinated and controlled interaction between immune cells with the 
ultimate goal to eliminate the invader by pathogen-specific mechanisms. 
The immune responses fall into two broad categories, the innate and adaptive 
immune responses. Innate immunity is mediated by the phagocytic cells and it prevents 
organisms' entry in a non-specific recognition manner. Adaptive immunity has two main 
features: specificity and memory. The specificity enables the adaptive immune system to 
recognize ‘self’ and ‘non-self’, and one particular antigen and other different antigens 
from invaded microorganisms using major histocompatibility complex (MHC) molecules 
as markers and subsequently remove harmful substances from our bodies.  The memory 
of adaptive immunity enables host to recognize the antigens that it had encountered 
before. Therefore, the bodies can rapidly respond to the repeated challenge with similar 
foreign substances. Disorder of immune system can be either from lack of immune 
response or over reaction.  
 
1.1  Hypersensitivity 
Hypersensitivity refers to the excessive immune response produced by the normal 
immune system. Hypersensitivity reactions require a pre-sensitization of the host and re-
exposure of the similar antigens. According to Gell and Coombs’s study (1963), 
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hypersensitivity was classified into four types, Type I to Type IV hypersensitivity based 
on the mechanisms involved and time taken for the reaction. Usually, a particular clinical 
disease may involve more than one type of reactions. Type I hypersensitivity is the 
immediate or anaphylactic hypersensitivity. The reaction is mediated by IgE antibodies.  
Type II hypersensitivity is the cytotoxic hypersensitivity and may affect a variety of 
organs and tissues. The reaction is primarily mediated by IgM or IgG antibodies and 
complement. Type III hypersensitivity is known as the immune complex hypersensitivity. 
The reaction may be general or may involve individual organs. Type IV hypersensitivity 
is often called the delayed type hypersensitivity. This reaction is a type of cell-mediated 
response. Recently, Type V hypersensitivity driven by the innate immunity was added to 
modify the Gell-Coombs classification (Rajan, 2003).  
 
1.2  Allergy-type I hypersensitivity 
The word “allergy” originated from Greek, meaning “altered reactivity” 
(Arshad, 2002). The concept of allergy was coined by Clemens von Pirquet in 1906 who 
observed the symptoms caused by harmful immune reactions to dust, pollen and certain 
foods (Roecken et al., 2004). Allergy refers to an acquired potential to develop 
immunologically medicated adverse reactions to normally innocuous substances which 
may induce tolerance in normal people (2000, the American Academy of Allergy, 
Asthma and Immunology). The substances provoking the allergic response are named 
allergens. Most of so called “Allergy” is type I hypersensitivity and mediated by IgE 
antibody. The reaction may be either local or systemic. Symptoms vary from allergic 
rhinitis, allergic asthma, atopic dermatitis, etc., to sudden death from anaphylactic shock. 
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Death in anaphylaxis is due to systemic release of vasoactive mediators leading to 
general vasodilation and smooth muscle contraction resulting in sudden loss of blood 
pressure, angio-oedema and severe bronchiole constriction (systemic anaphylaxis). 
1.3 Mechanism of allergy  
 
Foreign antigens/allergens enter the body through respiratory mucosa, 
gastrointestinal mucosa and skin. Figure 1.1 illustrates that the first step of allergic 
immune response is the uptake and presentation of allergen by professional antigen 
presenting cells (APCs) like dendritic cells, macrophages and B lymphocytes. One of the 
most potent types of APC is the dendritic cell (DC). Dendritic cells digest antigen into 
short peptides associated with the major histocompatibility complex (MHC) molecules 
and present them on the cell surface (Clancy, 2000). In the mean time, dendritic cells 
migrate to the draining lymphoid organ to interact with naïve CD4+ T-cells. 
After interacting with the antigen-MHC complex through specific T-cell receptors 
(TCR), Naïve CD4+ T-cells (TH0) are then activated, with the help of other co-
stimulatory molecules such as CD80 and CD86, to secrete regulatory cytokines that 
determine the polarization of T helper responses (Lambrecht, 2001). Table 1.1 lists the 
factors that affect the polarization of T helper cells by dendritic cells.  
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Figure 1.1   Allergy mechanism: (a) sensitization; (b) immediate reaction; and (c) late 
reaction (Adapted from Valenta, 1999). 
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Table 1.1     Factors influencing T helper cell polarization by dendritic cells (Adapted 
from Lambrecht, 2001). 
 
 
ICAM, intercellular adhesion molecule; ICOSL, inducible costimulator ligand; MHC, major histocompatibility complex; 
PGE, prostaglandin; TCR, T cell receptor. 
      
 
When treated with allergen (Der p 1 and 2, Bet v 1) and cultured with autologous 
naive or memory T cells in vitro, dendritic cells induce both Th1 and Th2 cytokines - but 
predominantly Th2 when dendritic cells from atopic donors are used (Bellinghausen  et 
al., 2000; De et al., 2000). Th2 cells then secrete cytokines IL-4 and IL-13. These 
cytokines promote antibody class switching to produce antigen specific IgE antibody in B 
cells (Pène et al., 1988; Finkelman et al., 1988; Punnonen et al., 1993; Emson et al., 
1998). The IgE antibodies are circulated throughout the body and able to bind high-
affinity receptors (FcεR1) and low-affinity receptors (FcεR2) on mast cells, eosinophils, 
macrophages and platelets (Roitt et al., 1998).  
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Upon re-exposure to allergen, cross-linking of allergen to specific IgE on mast 
cell FcεR1 receptor triggers mast cell degranulation and the secretion of mediators such 
as histamine, tryptase, heparin, prostaglandins, leukotrienes and bradykinin (Kinet, 
1999). These mediators cause smooth muscle contraction and vasodilatation, increase 
capillary permeability and attract cells into the tissues, thus leading to inflammation. The 
symptoms of immediate hypersensitivity reactions include runny nose, watery eyes, 
sneezing, coughing, sinus congestion and constricted airways in the respiratory tract, 
cramping, diarrhea and vomiting in the gastrointestinal tract, erythema and urticaria on 
the skin. The reaction takes place within minutes.  
Mast cells stimulated by antigen cross-linked to IgE-FcεRI complexes induce 
synthesis of another group of mediators leading to prolonged symptoms (late-phase 
response).  Upon activation, eosinophils release pre-formed and newly synthesized 
mediators such as eosinophilic cationic protein (ECP), major basic protein (MBP), 
leukotrienes and prostaglandins to enhance inflammation and prolong epithelial damage 
(Dombrowicz and Capron, 2001; The Allergy Report, 2000). The late response takes 
place a few hours after the allergen exposure. 
 
1.3.1 Dendritic cell 
 
In the allergy response network, dendritic cells (DCs) play an important role in 
the orientation of immune response to inhaled allergens. Some clinically important 
allergens, such as Der p 1, a proteolytic enzyme of house dust mite, can directly activate 
dendritic cells or epithelial cells. However, other allergens, such as ovalbumin (OVA), do 
not have activating ability (de Wit et al., 2000). How dendritic cells recognize natural 
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allergens as a danger signal and how they are activated by this signal are still under 
investigation.  
Plasmacytoid dendritic cells play an essential role in preventing airway 
inflammation by inducing T cell unresponsiveness and the differentiation of regulatory T 
cells (T reg). Pulmonary dendritic cells from mice exposed to respiratory antigen 
transiently produce interleukin-10 (IL-10) and stimulate the development of CD4 (+) T 
regulatory 1-like cells, which subsequently suppress the inflammation reaction.  In 
addition, after adoptive transfer of pulmonary DCs from IL-10(+/+) mice, the recipient 
mice can induce antigen-specific unresponsiveness upon exposure to respiratory antigen 
(Akbari et al., 2001). Hence, dendritic cell mediated T cell tolerance requires interleukin- 
10.  
Dendritic cells are also crucial for the maintenance of allergic airway 
inflammation. Depletion of the dendritic cells at the time of allergen challenge abolishes 
the characteristic features of asthma, including eosinophilic inflammation, goblet cell 
hyperplasia and bronchial hyperreactivity in the mouse model. The airway 
hypersensitivity can be restored by intratracheal injection of dendritic cells (van Rijt et 
al., 2005). Another study from America also showed that myeloid dendritic cells are 
important for airway inflammation and airway hyperresponsiveness (Koya et al., 2006). 
Upon 11 challenges of ovalbumin in sensitized mice, the number of dendritic cells in the 
lung decreased. It was also observed that intratracheal instillation of bone marrow–
derived dendritic cells restored airway hyperresponsiveness and airway eosinophilia. 
Thus, dendritic cells have many functions in airway hyperresponsiveness pathway—
antigen uptake, tolerance induction and maintenance of airway hyperresponsiveness. 
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 1.3.2    Regulatory T cell 
There are two major categories of regulatory T cells: "naturally-occurring" CD4+, 
CD25+ regulatory T cells and antigen-specific regulatory T cells. "Naturally-occurring” 
regulatory T cells express the forkhead family transcription factor FOXP3 (forkhead box 
p3) that is required for the regulatory T cell development and function (Hori et al., 2003; 
Shevach, 2004; Ramsdell, 2003). Antigen-specific regulatory T cells produce IL-10  
and/or TGFβ and regulate immune reaction (Hawrylowicz et al., 2005; Maloy et al., 
2001). Activation of regulatory T cells results in suppression of Th2 cells, Th1 cells, mast 
cells, eosinophils and basophils, and subsequent prevention of allergic airway 
hyperresponsiveness. Figure 1.2 illustrates the suppression of allergic response by the 
regulatory T cell. Application of recent knowledge of the peripheral T-cell tolerance 
mechanism will help us develop more rational and safer protocols to control allergic 
diseases.  
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Figure 1.2    Control of allergic airway disease by regulatory T cells. Allergic airway 
disease is caused by inappropriate Th2-driven immune responses to 
allergens in the environment. CD4+ CD25+ and IL-10–producing Treg 
cells can regulate allergic sensitization in vivo through inhibitory effects 
on Th2 cells or on dendritic cells (DCs) in the lung. (Adapted from 
Hawrylowicz et al., 2005) 
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1.3.3    IgE antibody 
IgE antibody plays a very important role in the type I hypersensitivity reaction. It 
is the least abundant antibody class in serum. Sera IgEs from normal ("non-atopic") 
individuals are about 150ng/ml, much lower than IgGs (about 10mg/ml). IgE levels in 
sera from atopic individuals can increase up to 10-fold of the normal level. As mentioned 
previously, cross-linking of allergen to IgE-FcεR1 complex leads to degranulation of 
mast cells, release of inflammation mediators and induction of inflammation reaction. In 
addition, allergen cross-linking increases the expression of CD40-ligand (CD40-L), IL-4, 
and IL-13.  CD40-L interacts with B cells and dendritic cells that express CD40 and then 
activate B cells. B cells induce IgE synthesis under stimulation of IL-4 and IL-13 
(Gauchat et al. 1993; Pawankar et al. 1997). This positive feedback mechanism of IgE 
synthesis maintains high levels of the local IgE, which enhance the inflammation 
reactions.  
1.4    Allergen 
To solve the allergy problem, it is essential to understand allergens, the triggering 
factors of allergy. Allergens are substances that cause allergic reactions including type I 
hypersensitivity reaction. Allergens are mostly proteins, but not all proteins are allergens. 
What makes a protein an allergen in type I hypersensitivity? An allergen exhibits two 
properties: the induction of IgE response and clinical response upon re-exposure to the 
same allergen (Akdis, 2006). Allergen should contain B cell epitopes that interact with 
IgE antibody and form a complex. However, there is no unified theory to explain why 
some proteins are allergenic while others not. Allergens are commonly derived from 
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pollen, fungi, mites, endothelial tissues and dander from pets, venom from insects and 
foods such as egg, milk, fruits, nuts and fish (Kerkhof et al., 2003; Burge and Rogers, 
2000; Boulet et al., 1997; Sporik et al., 1996). Among these sources, mites, endothelial 
tissues and dander of pets, and fungi are known as indoor allergen sources, while pollen 
and fungal spore can be found outdoors. Today, more than 2000 allergens including 
variants and isoforms have been reported from house dust mites, cockroach, weeds, 
grasses, trees, animal dander, molds, insect venoms, shrimp, soybean, etc.  
1.5     House dust mites - important indoor source of allergens 
The association between sensitization to dust mite allergens and asthma has 
been extensively studied since Voorhorst and colleagues (1964) first reported that dust 
mite D. pteronyssinus was a major source of indoor dust that caused allergic reaction. 
Many studies revealed that dust mite allergy was strongly associated with the allergy 
asthma in different places of the world such as the United States (Eggleston et al., 1998 
and Huss et al., 2001), New Zealand (Sears et al., 1989 and Burrows et al., 1995), 
Ecuador (Valdivieso et al., 1999), Puerto Rico (Montealegre et al., 1997a) and Brazil 
(Arruda et al., 1991). Exposure to more than 2 µg Der p 1 and/or Der f 1 per gram of dust 
(corresponding to 100 mites per gram of dust) during infancy has been considered to be a 
risk factor for sensitization to mites and bronchial hyper-reactivity (Lau et al., 1989 and 
Arruda et al., 1991). Exposure to more than 10 µg Der p 1 per gram of dust 
(corresponding 500 mites per gram of dust) has been considered a risk factor for both 
sensitization and asthma development in atopic individuals (Sporik et al., 1990). There is 
a strong association between increasing exposure to house dust mite and the frequency of 
sensitization to house dust mite (Warner et al., 1996). It was worthwile noting that mite 
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exposures lower than "threshold" level were also found to be associated with sensitization 
in some atopic individuals (Warner et al., 1996; Huss et al., 2001). Huss et al. reported 
that exposure to 0.020-2.0 µg/g Group 1 allergen is a risk for sensitization in the subjects 
with positive family histories of allergy. 
 
1.5.1    Biology of dust mite 
Understanding of the biology of dust mite is essential for monitoring and 
management of dust mite. Mites are very diverse organisms, and their morphological 
characteristics were described by Colloff et al. (1998). Mites belong to the phylum 
Arthropoda, subphylum Cheliceriformes, class Arachnida and order Acari.   Three orders, 
Opilioacarida, Parasitiformes and Acariformes are usually recognized by acarologists 
(Arlian et al., 2003). Mites that cause sensitization and allergic reaction belong to order 
Acariformes including suborder Prostigmata and Astigmata (Table 1.2). Spider mites in 
Prostigmata were known as allergenic source to induce allergy in orchard workers. 
Suborder Astigmata contains about 5000 species. Among them, thirteen species have 
been found in house dust and three of them have been reported to be very common in 
homes worldwide and are major sources of mite allergens (Arlian et al., 2001). These 
common species are Pyroglyphidae mites: Dermatophagoides farinae (D. farinae), 
Dermatophagoides pteronyssinus (D. pteronyssinus) and Euroglyphus maynei (E. 
maynei) which are found mostly in temperate climates (Arlian et al., 1992). Blomia 
tropicalis from Glycyphagidae family is prevalent in tropical and subtropical areas 
worldwide and co-inhabits with Dermatophagoides spp. Table 1.3 shows the families and 
genera of these mite species in the Astigmata.   
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1. Subphylum Uniramia 
2. Subphylum Crustacea 
3. Subphylum Chelicerata (Cheliceriformes) 
Class Arachnida 
Order Acari 
Suborder Mesostigmata (free-living, predaceous and parasitic mites) 
Suborder Prostigmata (chiggers, follicle mites) 
Suborder Metastigmata (ticks) 
Suborder Astigmata (house dust, storage & scabies mites) 
Suborder Oribatids (soil mites) 
 
 
Table 1.3     Family and genera of allergy-causing mites that belong to the Astigmata 
(Adapted from Arlian et al., 2003 ) 
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There are five stages in the life cycle of a dust mite; from the egg, the larvae 
stage, then two nymphal stages, and the adult. Laboratory studies showed that the length 
of life cycle of D. pteronyssinus is 122.8 ± 14.5 days at 16°C, 34.0 ± 5.9 days at 23°C, 
19.3 ± 2.5 days at 30°C and 15.0 ± 2.0 days at 35°C and 75% relative humidity (Arlian et 
al. 1990). In comparison, few D. farinae mites can complete the life cycle at extreme 
temperatures of 16°C and 35°C, but at 23°C and 30°C, lengths of the life cycle are about 
the same as D. pteronyssinus (Arlian et al., 1996).  Relative humidity of the environment 
also influences the population densities of mites. The densities of D. farinae and D. 
pteronyssinus declined when mite cultures were maintained at 21-22 °C and relative 
humidity of less than or equal to 50% in the laboratory. However, if mite culture was 
constantly kept at relative humidity over 85%, the densities of these two species in 
culture also decreased (Arlian et al., 1999). The critical relative humidity (RH) for 
Dermatophagoides spp. growth ranges from 55% to 75% over the temperature from 15°C 
to 35°C (Arlian et al., 1981a, Arlian et al., 1981b). Hence, mite growth is influenced by 
both ambient relative humidity and temperature. 
 
The life cycle of mites is strongly associated with its allergenicity. The 
allergenicity of Dermatophagoides mite culture is low at the initial latency period, then 
reaches the maximum at an exponential growth period, and finally enters a decline stage 
with a rapid decreasing of living mites (Eraso et al., 1997). The extracts produced from 
the exponential growth phase of the cultures have six times more allergenic activity than 
those extracts prepared from latency and death phases when tested by skin prick assay. 
The specific IgE-binding activities of extracts produced from the exponential growth 
phase of the cultures are approximately three times higher than those extracts produced 
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from latency and death phases when tested using RAST method (Eraso et al., 1998). 
Extracts obtained from Blomia kulagini cultures with the highest concentration of live 
mites (maximum growth phase) also have higher allergenicity (Cardona et al., 2004). 
Thus, extracts produced from maximum growth phase of dust mite provide the best 
diagnostic results in vivo and in vitro. 
 
1.5.2   Distribution of dust mite 
The occurrence of different mites varies in different geographical regions. 
Surveys of mite fauna have been conducted in many countries and the results showed that 
D. pteronyssinus and D. farinae are most common species found in homes in humid 
regions worldwide (Table 1.4). Initially it was believed that D. farinae was the most 
prevalent mite in the United States, and this species was given the official common name 
American house dust mite by the Entomological Society of America. D. pteronyssinus 
was given the common name European house dust mite because it was believed to be 
more prevalent in Europe. However, it is now known that both species are distributed 
widely in North America and Europe as well as other countries where surveys have been 
conducted. Interestingly, D. pteronyssinus and D. farinae normally co-inhabit in most 
homes worldwide, although one species could be more prevalent in certain homes of a 
specific geographic area than the other. D. pteronyssinus and B. tropicalis are found to be 
the predominant mites in homes of tropical and subtropical regions such as Puerto Rico, 
Brazil, Taiwan and Singapore. In addition, a study of house dusts from 8 different 
geographic areas of the United States revealed that the predominant species present 
varied between homes even within the same geographic area (Arlian et al. 1992). These 
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findings illustrate that a patient may be exposed to more than one species of mites. Hence 
for clinical diagnosis and immunotherapy, it is necessary to test both D. pteronyssinus 
and D. farinae in temperate regions and D. pteronyssinus and B. tropicalis in tropical and 
subtropical regions.  
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Table 1.4.    Representative dust mite fauna reported in homes worldwide (Adapted from 
Arlian et al., 2002) 
 
Location DF DP EM BT SM Study 
North America       
United States X X ? ? ? Arlian et al., (1992); Arlian et al., (1982); Chew et al.,(1999); 
Fernandez-Caldas et al., (1990); Hannaway and Roundy (1997); 
 Nadchatram et al., (1981); Nelson et al.,  (1995);  
Peterson et al., (1999); Squillace et al., (1997) 
Puerto Rico ? X ? X ? Montealegre et al., (1997b) 
Barbados ? X    Barnes et al., (1997) 
Central and South America       
Costa Rica ? X    Soto-Quiros et al., (1998)  
Venezuela (Caracas) ? X ? ? ? Hurtado et al., (1987) 
Columbia ? X ?  ? Charlet et al., (1977) 
Bogota  X ? ? ? Charlet et al., (1978) 
Peru  ?  ?  Croce et al., (2000) 
Brazil ? X ? X ? Binotti et al., (2001) 
Chile     ? Franjola et al., (1999) 
Europe       
Scotland (Glasgow)  X ? ? ? Colloff (1987) 
England (Birmingham)  X ?  ? Blythe et al., (1974) 
Norway ? X ?  ? Mehl (1998) 
Sweden X X ?  ? Warner et al., (1999); Munir et al., (1993) 
Finland ? X ?   Stenius et al., (1972) 
Estonia ? X    Julge et al.,  (1998) 
Poland X ? ? ? ? Solarz (1998);  Racewicz (2001) 
Silesia X X ?   Solarz (1998) 
Denmark X X ?  ? Mehl (1998); Stenius et al., (1972) 
Germany X X    Hirsch et al., (1998) 
Switzerland (Basel) ? X X  ? Mumcuoglu (1976);  Mumcuoglu (1977) 
Pavia X ?    Moscato et al.,  (2000) 
Rome X ? ?  ? Bigliocchi et al., (1996) 
Spain ? X    Alvarez et al., (1997) 
Middle East, Western Asia       
Turkey (Anatolia) X X   ? Kalpaklioglu (1997) 
Israel X X ?  ? Feldman-Muhsam et al., (1985); Mumcoglu et al., (1999) 
Uzbekistan  ?   ? Nazrullaeva et al., (1999) 
Africa       
Egypt X X    Morsy et al., (1995); Yassin et al., (1997) 
Nigeria (Lagos) ? X  ? ? Somorin et al.,  (1978) 
Eastern Asia       
Japan (Nagoya) X X ?  ? Suto et al. [117]; Suto et al. [118] 
Tokyo ? X   ? Miyamoto and Ouchi [119] 
China  ? X ?  ? Chien et al., (1987) 
Taiwan ? X  X  Sun et al., (2000); Chang et al., (1989) 
Hong Kong  X    Leung et al., (1998) 
Malaysia  X  X  Ho [125]; Mariana et al., (2000) 
Singapore ? X  X ? Chew et al., (1999a); Zhang et al., (1997) 
Brunei ? ?  ? ? Woodcock et al., (1980) 
Indonesia (Jakarta) X ?  ? ? Baratawidjaja et al., (1998) 
Oceana       
New Zealand  X    Wickens et al., (1997) 
DF-Dermatophagoldes farinae; DP-Dermatophagoides pteronyssinus; EM-Euroglyphus maynei; BT-Blomia 
tropicalis; SM-storage mites. X- prevalent or dominant species. ?-species reported to be present.  
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1.5.3    Mite allergens 
 
 
Mite allergens are found in mite bodies, secreta and excreta (Tovey et al., 1981). 
Natural mite allergens can be prepared from aqueous extracts. Since the first allergen was 
successfully isolated from dust mite D. pteronyssinus and named as Der p 1 (Chua et al. 
1988) using molecular biology technique, more and more mite allergens have been 
identified from many mite species such as D. pteronyssinus, D. farinae, B. tropicalis, 
Lepidoglyphus destructor, etc.  As shown in Table 1.5, more than twenty allergens have 
been identified from dust mites. Some allergens have already been deposited in 
International Union of Immunologic Societies Subcommittee/ World Health Organization 
(IUIS/WHO) (http://www.allergen.org/) and Genbank.  An allergen should have specific 
IgE-binding activity in a minimum of 5 patients, or >5% of the individuals tested in 
atopic population (WHO/IUIS, 1994).  According to WHO/IUS Allergen Subcommittee 
(1994), the allergen name includes the first 3 letters of the genus, the first letter of the 
species and an Arabic numeral to indicate the chronological order of purification. 
Allergens from different species but sharing the same biochemical properties are 
considered to belong to the same group (WHO/IUS, 1994). Some allergens sharing more 
than 67% identity of amino acid sequences and having similar biological functions are 
designated as isoallergens. Isoallergen may have multiple forms of closely similar amino 
acid sequences resulting from polymorphism. These isoforms are called variants and 
designated by 4 Arabic numerals. The first two numerals 01-99 refer to a particular 
isoallergen and the two subsequent numerals 01-99 refer to a particular variant of a 
particular isoallergen.  
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25 70-90 Der f 1 (Dilworth et al., 1991),  
Der p 1 (Chua et al., 1988),  
Der m 1 (Lind et al., 1988),  
Eur m 1 (Kent et al., 1992),  
Blo t 1 (Mora et al., 2003). 
2 Unknown 14 60-90 Der f 2 (Trudinger et al., 1991),  
Der p 2 (Chua et a.,l 1990),  
Tyr p 2 (Eriksson et al., 1998),  
Eur m 2 (Smith et al., 1999a),  
Gly d 2 (Gafvelin et al., 2001),  
Lep d 2 (Varela et al., 1994). 
3 Trypsin 28, 30 51-90 Der f 3 (Nishiyama et al., 1995a),  
Der p 3 (Smith et al., 1994),  
Eur m 3 (Smith et al., 1999b)b,  
Blo t 3 (Cheong et al., 2003). 
4 Amylase 57, 60 25-46 Der p 4 (Lake et al., 1991),  
Der p 4 & Eur m 4 (Mills et al., 1999). 
5 Unknown 15 9-70 Der p 5 (Tovey et al., 1989),  
Blo t 5 (Arruda et al., 1995),  
Lep d 5 (Eriksson et al., 2001). 
6 Chymotrypsin 25 30-40 
 
Der f 6 (Kawamoto et al.,1999),  
Der p 6 (Yasueda et al., 1993). 
7 Unknown 22-31 50-62 Der p 7 (Shen et al., 1993),  
Der f 7 (Shen et al., 1995),  
Lep d 7 (Eriksson et al., 2001). 
8 Glutathione-S-
transferase 




30 >90 Der p 9 (King et al.,1996). 
10 Tropomyosin 33-37 5-80 Der p 10 (Asturias et al., 1998),  
Der f 10 (Aki et al., 1995),  
Blo t 10 (Yi et al., 2002),  
Lep d 10 (Saarne et al., 2003). 
11 Paramyosin 92, 98, 110 80 Der f 11 (Tsai et al., 1999),  
Der p11 (Tategaki et al., 2000),  
Blo t 11 (Ramos et al., 2001). 
12 Unknown 14 50 Blo t 12 (Peurta et al., 1996). 
13 Fatty acid 
binding 
protein 
14, 15 10-23 Blo t 13 (Caraballo et al., 1997), 
Lep d 13 (Eriksson et al., 2001),  
Aca s 13 (Eriksson et al., 1999). 
 
14 Apolipophorin 177 30 c  
39 d  
70 e  
Der f 14 (Fujikawa et al., 1996),  
Eur m 14 (Epton et al., 1999),  
Der p 14 (Epton et al., 2001). 
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15 98 kDa 
chitinase 
98 ? Der f 15 (McCall et al., 2001). 
Der p 15 (O'Neil et al., 2006) 
16 Gelsolin-like 
protein/ villin 






53 35 Der f 17 (Tategaki et al., 2000) 
18 60kDa 
chitinase 
60 54 Der f 18 (Weber et al., 2003) 
Der p 18 (O'Neil et al., 2006) 
19 anti-microbial 
peptide 













Unknown 14 ? Der p 21b
Mag 29f Heat shock 
protein 70 kDa 
70 10 Der f (Aki et al., 1994) 
     
 
Species name of dust mites: Der f (D. farinae), Der p (D. pteronyssinus), Eur m (E. 
maynei), Der m (D. microceras), Der s (D. siboney), Tyr p (Tyrophagus putrescentiae), 
Lep d (Lepidoglyphus destructor), Gly d (Glycyphagus domesticus), Blo t (Blomia 
tropicalis), and Aca s (Acarus siro). 
 
a Listed in the WHO/IUIS list of allergens as of December, 2006. 
http://www.allergen.org/List.htm
 
b Unpublished but sequence data available in WHO/IUIS list of allergen or GenBank.
c Data for Mag allergen 
d Data for recombinant Mag 3 allergen  
e Data for natural Mag 3 allergen  
f Not listed in WHO/IUIS list of allergen but published and sequence data available in     
GenBank. 
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Dust mite allergen isoforms have been found in Group 1 (Chua et al., 1988; Smith 
et al., 2001; Piboonpocanum et al., 2006), Group 2 (Schmidt et al., 1995; Chua et al., 
1996; Yuuki et al., 1997 Smith et al., 2001; Piboonpocanum et al., 2006) and Group 3 
(Smith and Thomas, 1996a; Smith and Thomas, 1996b). These isoforms are the result of 
the polymorphisms of allelic variations. The effects of polymorphism on the allergenicity 
(IgE-binding activities) and antigenicities (T-cell response) of dust mite allergens have 
not been widely investigated. Among the Group 2 allergen isoforms, polymorphic forms 
of Lep d 2 showed comparable in vitro IgE-binding activies to wildtype Lep d 2 (Olsson 
et al., 1998).  
IgE-binding of allergens from taxonomy distant mite species have different 
patterns. Hales and colleagues (2006) have compared a panel of nine allergens from D. 
pteronyssinus in asthmatic patients in Australia. They reported that Der p 1 and Der p 2 
bound 50-65% of the total IgE antibody, Der p 4, 5 and 7 bound about 10% of the IgE 
antibody individually, and Der p 3, 8, 10 and 20 only had a very low IgE titers. In parallel, 
IgE-binding pattern of B. tropicalis allergens was also studied in asthmatic patients in 
Taiwan. Their studies demonstrated that the IgE-binding profile of B. tropicalis was 
different from that of D. pteronyssinus (Tsai et al., 2003). Blo t 5 was the most important 
allergenic component in B. tropicalis when seven allergens (Blo t 2, Blo t 3, Blo t 5, Blo t 
10, Blo t 11, Blo t 12 and Blo t 13) were evaluated.  
Mite allergens have different biological functions. The relationship between their 
biological functions and IgE-binding activities is still not clear. Groups 1, 3, 4, 6, 8, 9, 15 
and 18 allergens have enzymatic activity. Interestingly, Groups 1, 3, 6 and 9 allergens are 
all proteolytic enzymes, but only Group 1 allergens from D. pteronyssinus and D. farinae 
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are known to be major allergens. Group 1 allergens belong to the papain-like cysteine 
protease family. They are mainly found in mite faeces. Der p 1 is the first allergen that 
was cloned from dust mite using molecular biology tool (Chua et al., 1988).  
Recombinant Der p 1 had full proteolytic activity and IgE-binding activity only when it 
was expressed in yeast Pichia pastoris and converted into mature form. Its pro-forms 
exhibited different secondary structures and less allergenicities than the mature forms 
(Takai et al., 2005). These studies indicate that maintenance of the three dimensional 
structure of mature Der p 1 is important for its IgE-binding. In addition, it has been 
demonstrated that protease activity of Der p 1 enhances systemic production of IgE and 
inflammatory cellular infiltration of the lungs in a mouse model (Gough et al., 2003). The 
increase of allergenicity may be the result of the cleavage of the low-affinity IgE Fc 
receptor (CD23) from the surface of human B lymphocytes by Der p 1. The author 
proposed that the loss of cell surface CD23 from IgE-secreting B cells might promote and 
enhance the IgE immune responses by a feedback mechanism. Since soluble CD23 can 
promote IgE production, fragments of CD23 released by Der p I may enhance IgE 
synthesis (Hewitt et al., 1995). Further studies have demonstrated that Der p 1 also 
cleaves the alpha subunit of the IL-2 receptor (IL-2R or CD25) from the surface of 
human peripheral blood T cells (Schulz et al., 1998 and Ghaemmaghami et al., 1998).  
Since IL-2R is crucial for the propagation of Th1 cells, the cleavage of IL-2R may bias 
toward Th2-mediated immune response.  Der p 1 eliciting IgE antibody responses can 
also go through protease-activated receptors (PARs) pathway. PARs can be activated by 
external protease like Der p 1. Compared with wildtype animals, airway hyperreactivity 
to inhaled methacholine was diminished by 38% in mice lacking PAR-2 and increased by 
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52% in mice over-expressing PAR-2 (Schmidlin et al., 2002). Hence, biological function 
of Der p 1 enhances its allergenicity through creating an allergic environment.  
Groups 2, 13, 14 and 16 are ligand binding proteins. Among these allergens, Der 
p 2 allergen was known as a major allergen. Crystallographic and NMR structure studies 
revealed that Der p 2 allergen contains an ML (MD-2-related lipid-recognition) domain 
which comprises two anti-parallel beta-pleated sheets and a central hydrophobic cavity. 
This domain is predicted to be involved in lipid binding. Six cysteine residues in Der p 2 
protein form three disulfide bonds which are important for stabilizing the structure 
(Nishiyama et al., 1993). Mutation of cysteine residues drastically reduces IgE-binding 
activity (Nishiyama et al., 1995b; Smith and Chapman, 1996), providing evidence that 
most IgE-binding epitopes of Der p 2 are conformational epitopes. Four studies on 
conformational IgE epitope mapping of Der p 2 (Smith and Chapman, 1997; Hakkaart et 
al., 1998; Mueller et al., 2001; Ipsen et al., 2004) further identified many other residues 
on the surface that are important for the IgE-binding.  
Groups 10 and 11 allergens, known as tropomyosin and paramyosin respectively, 
are structure proteins. Between these two allergens, tropomyosin, a highly conserved 
coiled-coil protein is important because it exists in both invertebrates and vertebrates. 
Tropomyosin has been identified as a common allergen in the extracts of crustaceans, 
mollusks, insects such as dust mites, cockroaches, and moths. Dust mite tropomyosins 
consist of 284 amino acids and share 96% protein sequence identities among Der p 10, 
Der f 10, Blo t 10 and Lep d 10.  The frequencies of Blo t 10 response was 28% in mite 
allergic patients when tested by ELISA, while Der p 10 had 29% positive response in 77 
allergic asthma patients tested by dissociation-enhanced lanthanide fluoroimmunoassay 
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(DELFIA). Cross-reactivity of tropomyosins was observed due to their high protein 
sequence homology (Martinez, et al., 1997; Asturias, et al., 1999; Ayuso et al., 1999) and 
may result in the induction of allergic reactions to both foods and inhalants in the same 
patient.  
Groups 5, 7 and 12 are allergens with unknown functions. Among these allergens, 
Group 5 allergen is the most important one since Blo t 5 has been identified as a major 
allergen in B. tropicalis. In addition to Blo t 5, Der p 5 and truncated Lep d 5 are also 
identified from D. pteronyssinus and L. destructor (Lin et al., 1994 and Eriksson et al., 
2001). Blo t 5 induces IgE in 45-69% of allergic subjects and in more than 90% of 
asthmatic patients (Arruda et al., 1995; Kuo et al., 2003; Yeoh et al., 2003).  And 
similarly, Der p 5 induces IgE antibody in 50% of allergic subjects (Lin et al., 1994).  
The cross-reactivity between Blo t 5 and Der p 5 is low in UK and Singapore population 
(Chew et al., 1999b and Simpson et al., 2003). Hence, Group 5 allergens from D. 
pteronyssinus and B. tropicalis are species specific. The truncated Lep d 5 was only 
recognized in 4 out of 45 L. destructor-sensitized subjects in Switzerland (Eriksson et al., 
2001). Further study of Lep 5 in a larger sample size of allergic patients will be needed to 
characterize its allergenicity.  
 
1.6      Strategy to identify dust mite allergen 
 
1.6.1      cDNA library screening approach 
 Classical method for cloning allergens from allergenic sources is based on the 
screening of the cDNA library using IgE antibodies from atopic individuals. cDNAs are 
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double-stranded DNA copies of messager RNAs. cDNA fragments can be inserted into 
an appropriate plasmid, phage, or cosmid vector to construct a cDNA library. A cDNA 
library represents the entire set of expressed genes in the cell or organism from which the 
RNA is isolated. By screening the cDNA products of interest using IgE antibodies from 
patient sera, Der p 1 was first successfully isolated from dust mite D. pternoyssinus 
(Chua et al., 1988). Thereafter, Der p 2, Der p 5 of D. pteronyssinus and Blo t 5 of mite 
B. tropicalis were cloned with the same strategy (Chua et al., 1988;  Chua et al., 1990; 
Caraballo et al., 1997).  The tittering of cDNA library and the efficiency of cDNA library 
expression are crucial for this strategy. However, a large proportion of cDNA inserts may 
not successfully express in this system, as cDNA library is not an ideal system for the 
expression of recombinant protein. Through screening of cDNA library with patient sera, 
usually only one allergen can be isolated from the allergenic source. In addition, this 
screening method also requires a certain amount of patients’ sera which are often difficult 
to be collected. Further more, cDNA clone isolated from cDNA library may not 
necessarily be a full length clone. For example, Blo t 5 cDNA clone isolated by above 
strategy in 1996 only contained a truncated cDNA (Caraballo et al.). Thus, cDNA library 
screening by IgE antibody can be effectively applied to isolate allergens from allergenic 
sources, but there is a need to improve the efficiency of this method. 
 
1.6.2      Phage display approach 
To enrich the expressing of the cDNA clones, phage display technology was 
developed. This technology enables the gene of interest to display on the surface of a 
phage as a fusion with one of the coat proteins of the virus. By cloning cDNAs into phage, 
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display library is produced with billions of proteins from an organism displayed on the 
surface of the viral particle. This method enables rapid isolation of phage populations 
containing multiply represented clones. The screening efficiency depends on the absolute 
number of clones displaying the same gene products among the original library and the 
amount of allergen-specific IgE antibody in serum. Hence, identification of allergens 
derived from highly abundant mRNAs of the organism is preferable by this method.  
Tove and his co-workers (2001) were able to clone three new allergens from 
Lepidoglyphus destructor by screening of phage display library. However, phage display 
based cloning still requires a certain amount of human sera that are usually difficult to be 
obtained.  
The fastest method to clone an allergen is to amplify the open reading frame by 
reverse transcribed PCR (RT-PCR) from mRNA. However, RT-PCR based cloning 
requires DNA sequence information, or at least some protein sequences. The sequences 
of new allergen genes may not be necessarily available.  
 
1.6.3      Expressed Sequence Tag - a useful tool to isolate mite allergen 
Expressed Sequence Tag (EST) approach is to obtain mass sequences of the 
transcriptomes of a particular source of organism, organ or tissue. An EST is a DNA 
sequence of a randomly picked cDNA clone corresponding to a message RNA (mRNA). 
mRNAs are transcribed from genes on chromosomes and subsequently translated into 
proteins. An EST is approximately 500 nucleotides in length with a relatively low quality 
due to the limitation of current DNA sequencing technology. However, the average 
cDNA is 2000 nucleotides in length, so an EST is only a tag of the cDNA. This tag is 
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often sufficient to identify a specific mRNA and its gene. ESTs provide the profile of the 
expressed genes in the source tissue and demonstrate the relative abundance of these 
transcripts from the source cDNA library (Adams et al., 1995). EST approach is also a 
powerful technique for genome investigations as the ESTs reflect the coding regions of 
genes in genomic sequences. ESTs contain the predicted "functional genome"-
transcriptome, which leads to prediction of their protein products, and eventually of their 
function (Yamamoto and Sasaki, 1997). With the development of DNA sequencing 
technology, it has been known to be a high throughput method to generate huge amount 
of DNA sequences from target species at present (Adams et al., 1993; Adams et al., 
1995; Ewing et al., 1999; Gross et al., 2001).  
In order to obtain the basic DNA information of dust mites, EST approach has 
been applied in our laboratory to survey the genomic components from important dust 
mites D. farinae, B. tropicalis, Suidasia medenensis, Tyrophagus putrescentiae and 
Aleuroglyphus ovatus. Together with bioinformatic analysis, many putative allergen 
sequences have been identified from these five species including some allergen genes that 
have already been deposited in WHO/ IUS, or published in international journals, and 
some putative allergens sharing homology with known allergens from other organisms or 
species but are new in D. farinae / B. tropicalis. Although EST approach is proven to be a 
useful tool for high throughput identifying potential allergen components from dust mites, 
this method can only identify homologues from known allergens.  
With accumulation of dust mite DNA sequences at hand, novel allergenic 
components which are recognized by SDS-PAGE/Western blotting using patient sera can 
be further identified by MALDI-TOF Mass Spectrometry (MS).  The integration of SDS-
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PAGE/western blotting and MS make it possible to identify new allergens from dust 
mites efficiently.  
 
 
1.7    Recombinant allergens for research, clinical diagnosis and therapy 
With the tremendous progress in molecular biology of allergens over the years, 
many allergens have been cloned with full length cDNA sequences. This enables us to 
express recombinant allergens in different expression systems, such as bacteria, yeast, 
insect cells, mammalian cells and plants with comparable IgE-binding activities to natural 
allergens. Recombinant allergens can be expressed at high level in vitro and easily 
purified using established chromatography procedures. High purity of recombinant 
allergens can be consistently produced without contamination of endotoxin which is 
crucially important for in vivo study. Hence standardization of recombinant allergen in 
terms of quantity and quality control can be established.  With recombinant allergen at 
hand, it is possible to achieve a component-resolved diagnosis of dust mite allergy and 
produce specific IgE-binding profiles for particular patients. 
Recombinant allergens also facilitate the study of those allergens which are low- 
abundant in natural sources. Natural allergen products of dust mite have variable content 
of specific allergens. Group 1 and Group 2 allergens of Dermatophagoides spp. are the 
only two allergens that may exist in a concentration of 10 µg/ml or above. The 
concentration of Der p 2 can be 5-10 folds lower than that of Der p 1, while other 
allergens exist in even much lower concentrations (Thomas et al., 2004). A proteomic 
analysis also demonstrated that not all allergens are highly expressed in D. pteronyssinus. 
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Only Groups 1, 2, 7, 10, 13 and 20 are found among the most abundant proteins of D. 
pteronyssinus extracts (Batard et al., 2006). It is difficult to prepare enough pure natural 
low-abundant allergens. Hence, studies of these allergens have to heavily depend on 
recombinant allergens.   
In order to reduce the risk of side-effect of allergen-specific immunotherapy, 
many studies have been conducted to produce hypoallergens aiming to produce modified 
recombinant allergens with reduced IgE-binding activity but retained T-cell proliferation 
activities (Takai et al., 1997; Ferreira et al., 1998; van Hage Hamsten et al., 1999; Nopp 
et al., 2000; Schramm et al., 1999; Kauppinen et al., 1999). Study on the birch pollen Bet 
v 1 hypoallergen is a good representative. The IgE-binding of Bet v 1 depends on its 
three-dimensional structure. Separating expression of this allergen into two fragments (1-
73 aa and 74-159 aa) resulted in the loss of conformation structure thus showing minimal 
allergenicity (Vrtala et al., 1997). Trimeric form of Bet v 1 was also expressed in E. coli 
and showed the reduction of IgE-binding activity and histamine release ability with its 
retained secondary structure (Vrtala et al., 2001).  
Cocktail of recombinant allergens could be another choice to be used together 
with natural allergic products, or used to replace the natural crude extract products. 
Efficacy of the therapy could be improved by using recombinant cocktail which contains 
uniform allergen level without contamination of other non-related proteins. 
In vitro expression of allergen also opens a door for studying the biological 
function and three-dimensional structure of the recombinant protein (Ferreira et al., 1993 
and Chapman et al., 2000). Der p 2 produced in E. coli has a comparable allergenicity to 
the purified natural counterpart. E. coli expressed Der p 2 was used to determine its three-
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dimensional structure through NMR and X-ray crystallography methods (Mueller et al., 
1997; Mueller et al., 1998; Derewenda et al., 2002).  In contrast, expression of 
recombinant Der p 1 precursor was established in P. pastoris (Jatquet et al., 2002). 
Additional acid treatment of Der p 1 precursor was needed to trigger the autocatalytic 
processing of mature Der p 1. The recombinant mature Der p 1 has comparable IgE-
binding, histamine release and proteolytic activity to natural Der p 1. The three-
dimensional structures of proDer p 1 and mature Der p 1 were solved by X-ray 
crystallography (Meno et al., 2005 and de Halleux et al., 2006). The structural biology is 
useful for identifying conformational epitopes of allergen and generation of 
hypoallergens by genetic engineering.  
 
1.8     Objectives of this study 
This study focuses on Group 5 and Group 21 allergens from different dust mite 
species. Group 5 and Group 21 are homologous proteins in the dust mites. 
Characterization of these allergens in terms of their IgE reactivities and cross-reactivities 
leads to a better understanding on the clinical importance of these allergens to mite 
allergy. Epitope mapping of Blo t 5, the most allergenic molecule of Group 5 and Group 
21 allergens will help to explain why this allergen is so important for B. tropicalis allergy 
and the data will provide useful information for generation of hypoallergen vaccine 
candidates in the future.  
The specific aims of this study are:  
1.    To identify Blo t 21, a Blo t 5 homologue at DNA level and protein expression 
level using Southern blotting, Western blotting and immuno-localization in B. 
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tropicalis, and to further characterize the Blo t 21 allergen in terms of the IgE -
binding activity in vitro and in vivo and cross-reactivity between Blo t 5 and 
Blo t 21.  
2.    To study the stability of IgE-binding to Blo t 5 and Blo t 21 by measuring the 
effect of temperature, pH and chemical denaturant.  
3.   To identify Der f 21 by Southern blotting and immuno-localization and to 
characterize its allergenicity by in vitro IgE-binding activity test and cross-
reactivity study. 
4.  To identify Group 5 and Group 21 allergens in Suidasia medanensis, 
Aleuroglyphus ovatus, Tyrophagus putrescentiae, Lepidoglyphus destructor and 
Glycyphagus domesticus and to further compare a panel of eleven Group 5 and 
Group 21 allergens in local atopic population.  
5.    To identify specific residues which are important for the IgE-binding of Blo t 5 





  31 
   
Chapter 2: Materials and Methods        
 
 
2.1      Dust mite samples 
Mite cultures of B. tropicalis, D.  pteronyssinus, D. farinae, S. medenesis   and L. 
destructor were purchased from the Central Science Laboratory (United Kingdom). Live 
mites were separated from the feed medium by “heat escape method”. This was 
accomplished by placing the mite cultures on a mesh filter (pore size = 125µm) with a 
light source nearby. The mites pass through the mesh, away from the medium, and fall 
onto the receiving pan below when trying to get away from the heat. They were then 
harvested, weighed, wrapped in aluminum foil before frozen in liquid nitrogen and finally 
stored at -80oC. 
 
2.2       Cloning of Group 5 and Group 21 allergens and site-directed 
mutagenesis of Blo t 5    
 
2.2.1   Bacterial strains 
 
XL1-Blue [N1]∆(mcrA) 183∆(mcrCB-hsdSMR-mrr)173 end A1 supE44 thi-1 recA1  
gyr 1A96 relA1 lac[F’proAB lacIqZ ∆M15Tn10(Tetr)] 




2.2.2 Identification of Group 5 homologous allergens 
 
ESTs generated from five dust mite species in our laboratory (Angus et al., 2004) 
were compared with sequences from protein databases available at the National Center 
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for Biotechnology Information (NCBI) using Translated Basic Local Alignment Search 
Tool algorithm (BLASTX) (http://www.ncbi.nlm.nih.gov/).  Group 5 homologues were 
identified based on the similarities of their primary protein sequences to Blo t 5, Der p 5 
and Lep d 5. Blast results with E-values <0.001 were considered significant identities. 
cDNA clones homologous to Group 5 allergens were sequenced again for further 
confirmation of DNA sequences. 
 
2.2.3 Computer-based characterization and analysis  
 
Nucleotide sequences of putative Group 5 allergens were analyzed using 
DNAMAN version 4.15 (Lynnon BioSoft, Canada), BioEdit sequence alignment editor 
v7.0.5. (Hall, 1999), ClustalW (Thompson et al., 1994), Vector NTI (InforMax) and 
BLAST (http://www.ncbi.nlm.nih.gov/BLAST/). Restriction enzyme maps of nucleotide 
sequences were generated by webcutter 2.0 
(http://www.firstmarket.com/cutter/cut2.html). Amino acid sequences were deduced from 
cDNA sequences using DNAMAN version 4.15 (Lynnon BioSoft, Canada). Signal 
peptide cleavage site was analyzed based on the deduced amino acid sequences using 
SignalP v3.0 (Bendtsen et al., 2004). Secondary structure of the protein was predicted 
using PredictProtein (http://cubic.bioc.columbia.edu/predictprotein). 
 
2.2.4 Phylogenetic tree generation 
Der p 5, Der p 21, Blo t 5 and Lep d 5 protein sequences were obtained from 
NCBI (http://www.ncbi.nlm.nih.gov). Other Group 5 and Group 21 homologous protein 
sequences from Blomia tropicalis, Dermatophagoides  pteronyssinus, Dermatophagoides 
farinae, Suidasia medanensis, Glycyphagus domesticus  were obtained from EST 
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database of our laboratory. All EST sequences used showed homology to known Group 5 
allergens in the non-redundant Database of GenBank using BLASTX algorithm (E-value 
< 0.001). Lep d 5 and Gly d 5 were two Group 5 allergens longer in length. The 
sequences were separated into two parts: N-terminal and C-terminal regions. The C-
terminal regions contain the sequence with similar size of normal Group 5 allergen, while 
the N-terminal regions contain extra repeat sequence of Group 5. The protein sequences 
were aligned using ClustalW (Thompson et al., 1994). A phylogenetic tree was drawn 
based on the multiple alignment result using DNAMAN (Lynnon BioSoft, Canada) 
/BioEdit (Hall, 1999) with neighbor-joining algorithm.  
 
2.2.5 RT-PCR method to isolate Der p 21 allergen 
Total RNA was prepared from 250 mg of mites using RNeasy® Midikit (Qiagen 
GmbH, Germany) according to manufacturer’s instructions. The quality of the RNA was 
examined by electrophoresis separation and spectrophotometer (OD260/OD280). 1µg of D. 
pteronyssinus total RNA was used to generate 5' RACE cDNA using SMARTTM RACE 
cDNA amplification kit (CLONTECH Laboratories, Inc. USA). Specific primers of Der p 
21 (listed in Table 2.1) were used to amplify cDNA of Der p 5 and Der p 21. Same sets of 
primers were used for generation of expression clones. 
 
2.2.6 Cloning of Group 5 and Group 21 allergens in expression vector and site-
directed mutagenesis of Blo t 5 
Oligonucleotide primers were designed corresponding to the cDNA fragments 
encoding proteins of Group 5 and Group 21 allergens except the signal peptide. The 
primers contained suitable restriction enzyme sites to facilitate downstream cloning 
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(Table 2.1). After the desired PCR products were amplified from cDNA clones, they 
were further inserted into either pET-15 (Novagen, Germany) or pET-M vectors 
depending on their restriction enzyme sites. pET15 (Novagen, Germany) and pETM are 
His-tag fusion vectors for over-expressing recombinant protein in E.coli. The expression 
clones were transformed into E. coli strain XL-1 Blue for DNA manipulation and BL21* 
(DE3) for protein expression (Novagen, Germany). Transformants were picked and 
employed as templates in PCR mixture to screen the correct clones. PCR was performed 
using Taq DNA polymerase (Fermentas, USA) according to manufacturer’s instruction 
with clone specific primers, i.e. M13 Forward Sequencing Primer and M13 Reverse 
Sequencing Primer. PCR products were observed using gel electrophoresis. Listed in 
Table 2.2 are universal primers used for colony screening. 
Site-directed mutations of Blo t 5 were generated using Quikchange® Site-
directed mutagenesis kit (Statagene) and PCR method with primers containing desired 
mutation. The target amino acid was mutated to alanine. Primers were listed in Table 2.3.  
All the recombinant clones were verified by DNA sequence analysis.  
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Table 2.1  Primers used for generation of expression clones 
 
Primer 
name Primer sequence 
Restriction 
enzyme Amplicon Vector 
pET15-
BT51F gggacatatgcaagagcacaagccaaagaagg NdeI Blo t 5 cDNA pET15 
pET15-
BT51R  cgggatccttattgggtttgaatatccttc BamHI Blo t 5 cDNA pET15 
pETM-
BT52F gcgggatccctaccagtctctaacgataac BamHI Blo t 21 cDNA pETM 
pETM-
BT52R cgggaattcttattcggaatcttggactcgc EcoRI Blo t 21 cDNA pETM 
pET15-
Dp5F gggacatatggaagataaaaaacatgatt NdeI Der p 5 cDNA  pET15 
pET15-
Dp5R  cgggatccttaaacttcaatctttttaacac BamHI Der p 5 cDNA pET15 
pET15-
DP52F gggacatatgtttattgttggtgacaaaaaaga NdeI Der p 21 cDNA pET15 
pET15-
DP52R gcgggatccttaataatattcatccggatttac BamHI Der p 21 cDNA pET15 
pET15-
DF51F gggacatatggaaccaaaaaaacatgattatcaa NdeI Der f 5 cDNA pET15 
pET15-
DF51R cgggatcctttcaaacttcaatctttttaacacg BamHI Der f 5 cDNA pET15 
pETM-
DF52F gcgggatccgaagataaatggcgtaatgcat BamHI Der f 21 cDNA pETM 
pETM-
DF52R gccgaattcttaatcatccgattttacagctttaac EcoRI Der f 21 cDNA pETM 
pET15-
LD5F cccacatatgaccggtgtcaagactca NdeI Lep d 5 cDNA pET15 
pET15-
LD5R cgggatccttatttggtttcgatggcct BamHI Lep d 5 cDNA pET15 
pET15-
Sm52F gggacatatggctgacaagaatgactttc NdeI Sui m 5.01 cDNA pET15 
pET15-
Sm52R cgggatccttaggcgtggacattgatag BamHI Sui m 5.01 cDNA pET15 
pET15-
Sm53F gggacatatggcggacaagaatgactt NdeI Sui m 5.02 cDNA pET15 
pET15-
Sm53R cgggatccttagactttaattgctttg BamHI Sui m 5.02 cDNA pET15 
pET15-
Sm51F  gggacatatggcaccaacccagaacgac NdeI Sui m 21 cDNA pET15 
pET15-
Sm51R cgggatccttacttgttgttggcatca BamHI Sui m 21 cDNA pET15 
Restriction enzyme sites are indicated in bold. 
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 Table 2.2  List of universal primers used for screening of desired clones 
Primer name Primer sequence 
M13 Forward Sequencing Primer GTAAAACGACGGCCAGT  
M13 Reverse Sequencing Primer AGGAAACAGCTATGACCAT 
pET upstream primer GATGCGTCCGGCGTAGA 
PETF GTATGAAAGAAACCGCTGCTGC 
PETR CTAGTTATTGCTCAGCGG 
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Table 2.3 Primers used for generation of Blo t 5 mutants 
Primer name Primer sequence 
N40F CACTTGTTGATCGAACAGGCAGCCCATGCTATCGAAAAGG 
N40R CCTTTTCGATAGCATGGGCTGCCTGTTCGATCAACAAGTG 
































  38 
   
2.2.7  DNA sequencing 
DNA sequencing reactions were performed according to the manual of ABI 
PrismTM Dye Terminator cycle sequencing ready reaction kits (Applied Biosystem) 
which involved a 20 µl mixture containing 2 µl Big Dye v3.1 , 3 µl of 2.5 X Sequencing 
Buffer (Applied Biosystem, ), 300-500 ng plasmid DNA template and 3.2 pmole primer. 
Cycle sequencing was carried out in PTC-100TM Programmable Thermal Controller (MJ 
Research, Inc., USA) with the following thermal cycling profile: denaturation at 96 °C 
for 30 sec, annealing at 50 °C for 15 sec, extension at 60 °C for 4 min and repeated for 30 
cycles. After the cycle sequencing reaction, DNA mixtures were purified by ethanol 
precipitation. 2 µl of 3M sodium acetate (pH4.6), 2 µl of 125 mM EDTA and 50 µl of 
absolute ethanol were added to the reaction mixture and incubated on ice for 10 minutes, 
followed by centrifugation for 20 min at 13,000 rpm. The pellet was then washed with 
500 µl 70% ethanol and centrifuged at 13,000 rpm for 15 min. The pellet was thoroughly 
air dried and re-suspended in 12 µl of Hi-Di formamide. The DNA mixture was subjected 
to Applied Biosystems 3100 fluorescent sequencer (USA) using default parameters.  
 
2.3     Genomic study 
 
2.3.1 Preparation of mite total genomic DNA  
Total DNA of the mites was isolated using plant DNA extraction method 
described by Dixit (1998). The total DNA was purified by repeating the chloroform 
extraction, followed by ethanol precipitation. Finally, the DNA pellet was washed with 
70% ethanol, air-dried and dissolved in 10 mM Tris-HCl buffer (pH 8.0).  
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 2.3.2 Isolation of the genomic organization  
Polymerase Chain Reaction (PCR) was used to amplify the genomic organizations 
of Blo t 5, Blo t 21, Der f 5 and Der f 21 from the total mite genomic DNA.  Gene-
specific primers were designed according to the 5’- and 3’-end sequences of the open 
reading frame (ORF). Primer sequences are listed in Table 2.4. The PCR was performed 
with BD Advantage™ 2 PCR Kits (Clontech, BD Biosciences, USA) using 100 ng of the 
genomic mite DNA as a template. The amplicons with correct size were cloned into 
pGEM®-T Easy Vector (Promega, USA) following manufacturer’s instruction. After 
preparation and purification of the plasmid DNA using Qiaprep Miniprep Kit (Qiagen, 
Germany), the plasmid DNA was sequenced from both 5’- end and the 3’- end with the 
M13 forward and reverse primers using ABI PRISM Big Dye Terminator v3.1 reagent 
(Applied Biosystems, USA) by quarter reaction. The products were processed on ABI 
Prism 3100 Genetic Analyzer/ DNA Sequencer (Applied Biosystems, USA) after cleaned 
up with ethanol precipitation. 
  40 
   
Table 2.4 List of primers used for amplification of genomic DNA fragments 
 
Primer 
name Primer sequence Amplicon 
BT5-1f ATGAAGTTCGCCATCGTTCTTATTGCC Blo t 5 genomic DNA 
BT5-1r TTTATTGGGTTTGAATATCCTTC Blo t 5 genomic DNA 
BT5-2f ATGAAATTTATCATCGCATTGGC Blo t 21 genomic DNA 
BT5-2r CTATTCGGAAGCTTGGACTCGC Blo t 21 genomic DNA 
DF5-1f ATGAAATTCATCATTGCTATTGCT  Der f 5 genomic DNA 
DF5-1r  TTTCAAACTTCAATCTTTTTAACACG Der f 5 genomic DNA 
DF5-2f AATGAAATTCATTATTTTCTGTGCC Der f 21 genomic DNA 
DF5-2r TAATCATCCGATTTTACAGCTTTAAC Der f 21 genomic DNA 
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2.3.3 Southern blotting  
The total genomic DNA of B. tropicalis was completely digested with Hind III 
and EcoR V, while total genomic DNA of D. farinae was completely digested with Cla I, 
Hind III and EcoR.  These restriction enzyme sites were not present in target genes. The 
digested genomic DNA was transferred onto a positively-charged nylon membrane 
(Roche Applied Science, Germany) and then immobilized on the membrane using CL-
1000 Utraviolet crosslinker (UVP, USA).  
DNA probes were labeled by digoxigenin with PCR probe synthesis kit (Roche 
Applied Science, Germany) using the plasmid containing Blo t 5, Blo t 21, Der f 5 and 
Der f 21 gene as a template individually.  
The membrane carrying dust mite genomic DNA was hybridized to digoxigenin-
labeled DNA probe following the protocol of non-radioactive DIG application manual 
(Roche, Germany). The detection of the hybridization signal on the DNA blot was 
performed using immunochemical techniques by testing an alkaline phosphatase 
conjugate with an anti-digoxigenin antibody. The hybrid bands were exposed to x-ray 
film after applying the chemiluminescent alkaline phosphatase subtracts CSPD to the 
membrane. 
 
2.4 Protein expression, purification and CD analysis 
 
2.4.1 Expression  and purification of wild type and mutant allergens 
 
Expression clones were transformed into E. coli strain BL21*(DE3) (Novagen, 
Germany). 100 ml cultures were grown to OD600 at approximately 0.6 and then induced 
with 0.5 mM IPTG overnight at 23 °C with continuous shaking at 200 rpm. Cells were 
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harvested by centrifugation at 2845 g for 15 min at 4 °C and re-suspended in 20 ml of 
binding buffer (5 mM imidazole, 0.5M NaCl, 20 mM Tris-HCl, pH 7.9). The cells were 
sonicated on ice for 2 min. Soluble cell lysis was separated from the supernatant by 
centrifugation at 15,000 x g for 30 min at 4 °C. The over expressed His-tag fusion 
proteins were purified by Ni-NTA affinity chromatography using the protocol provided 
by the pET system manual (Novagen, Germany). Briefly, soluble proteins of cell lysis 
were incubated with charged Ni-NTA resin (Novagen), and the bound proteins were then 
washed with wash buffer (60 mM imidazole, 0.5 M NaCl and 20 mM Tris-HCl, pH 7.9) 
and finally eluted with elution buffer (0.5 M imidazole, 0.5 M NaCl and 20 mM Tris-
HCl, pH 7.9). The purified proteins were electrophoresed on a 15% SDS-PAGE gel, and 
the protein bands were visualized with Coomassie blue staining.  
 
2.4.2 Circular Dichroism spectrum  
In order to check whether the recombinant protein was folded properly, Circular 
Dichroism (CD) spectra of recombinant proteins were measured using a Jasco J810 CD 
spectropolarimeter equipped with PFD-425S Peltier temperature controller. The 
recombinant proteins were dialyzed in 10 mM sodium phosphate buffer (pH 7.4). 200 µl 
of samples (0.1mg/ml) were applied in a 1cm quartz cuvette. The spectra were measured 
at 20 °C and collected from 190-260 nm with a data pitch of 0.1nm. A band width of 1nm 
was used with a detector response time of 8 seconds and scanning speed of 50nm/min. 
The spectrum was an average of 8 scans. For thermal denaturation study, the scanning 
was collected from 10 °C to 90 °C at 1 °C/min with intervals of 10 °C. 
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2.5 Immunoassays          
  
 
2.5.1  Patient sera    
 
Sera were obtained from 43 patients with ongoing persistent allergic rhinitis 
(PAR) and with at least two reporting symptoms (nasal obstruction, rhinorrhea, sneezing 
and itchy nose) on most days during the past year (Bousquet et al., 2001), who were 
scheduled to start sublingual immunotherapy. The characteristics of the patients are listed 
in Table 2.5. Their sensitization to both B. tropicalis and Dermatophagoides spp., the 
almost exclusive pattern of PAR in Singapore, was confirmed by a positive skin prick 
(SPT) reaction. In addition, all had a positive nasal challenge response to crude extracts 
(0.06mg/ml) of B. tropicalis. The challenge procedure was described previously by Wang 
et al. (2003). Sera from six healthy adult volunteers with no history of any allergic 
symptoms and a negative SPT to common inhalant allergens were obtained as negative 
controls.  
In addition, sera from 494 consecutive individuals attending outpatient allergy 
clinics in the hospital over one and a half years for allergic conditions were screened by 
an immuno-dot blot. A total of 262 were children below the age of 12 years (mean age 
7.2 years, 59% males, 78% Chinese, 74% had allergic rhinitis, 37% asthma, 60% atopic 
dermatitis and 14% had clinical manifestation of all three). The remaining 232 were 
adults (mean age 31.2 years, 52% males, 80% Chinese, 100% had allergic rhinitis and 
35% current or childhood asthma). The sera were collected by three batches. Approval to 
conduct these studies was obtained from the Institutional Review Boards of the National 
Healthcare Group, KK Women’s and Children’s Hospital, and Singapore General 
Hospital. 
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Measurements   
Mean (±SD) 
Sex   
 Male 21 (49%)  
 Female 22 (51%)  
    
Age  (year) 31.5 ± 9.81  
    
Ethnic representations   
 Chinese 35  
 Malay 3  
 Indian 2  
 Other 3  
    
Duration of diseases (year)   
 Persistent allergic rhinitis 43 (100%)  
 Asthma 9 (21%)  
 Childhood asthma 6 (14%)  
    
Duration of diseases (year) 14.91 ±6.92  
    
Nasal symptom score*   
 Itchy nose  2.00 ± 0.87 
 Sneezing  2.23 ± 0.72 
 Rhinorrhea  2.53 ± 0.67 
 Nasal obstruction  2.51 ± 0.70 
    
Skin Prick test† (Wheal size  mm)    
 Der p  8.22 ± 4.04 
 Der f  9.05 ± 3.40 
 Blo t  8.43 ± 2.74 
 Blo t (house made‡)  7.43 ± 1.98 
    
IgE test (CAPs) (% Positive)   
 Total IgE (>100 IU )  81% (35/43) 
                 (>50 IU)  98% (41/43) 
 Der p (>0.5 IU/ml, class 3 and above)  93% (40/43) 
 Der f (>0.5 IU/ml, class 3 and above)  98% (42/43) 
 Blo t (>0.5 IU/ml, class 3 and above)  95% (41/43) 
          
*:  Symptoms are present more than 4 days a week during the past year. These symptoms 
were recorded using a symptom severity scale: 0 = none: no symptom evident; 1 = 
mild: symptom clearly present but minimal awareness; 2 = moderate: definite 
awareness of symptom which is bothersome but tolerable; 3 = severe: symptom is 
hard to tolerate. 
†:  Standard crude allergen extracts from Stallergene. 
‡:   Crude allergen extract made by our own lab 
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2.5.2 Skin prick test 
Skin prick test with the Blo t 5 and Blo t 21 recombinant proteins (0.01µg/ml in 
PBS with 50% glycerol) was performed using a single prick technique (Solofix, B. 
Braun, Germany). Negative (PBS with 50% glycerol) and positive  controls (histamine 
10mg/ml and B. tropicalis crude extract (Stallergene))were used for comparison. A wheal 
response >3mm compared to the negative after 20 minutes was scored as positive. 
 
2.5.3 ELISA for quantification of serum specific IgE 
1µg/ml recombinant proteins were coated onto Maxisorp plates (NUNC, 
Denmark) and incubated overnight at 4°C.  The plates were blocked with PBS-0.1% 
Tween 20 at room temperature for 1 hour, washed with PBS-0.05% Tween 20 and then 
incubated with 50µl of diluted sera (1:1 ~ 1:20 (v/v) in PBS) at 4°C overnight.  Plates 
were washed, incubated with 100 µl biotinylated anti-human IgE antibodies (1:250 v/v in 
PBS) at room temperature for 2 hours, and subsequently amplified with avidin-horse 
radish peroxidase (both from BD Pharmingen, USA) for half an hour at room 
temperature. Microtitre plates were thoroughly washed with PBS-T between each step. 
Finally, 100 µl of 3,3',5,5'-tetramethylbenzidine (Sigma)  substrate was added and color 
development was stopped by adding 20 µl of 1M hydrochloric acid after 30 minutes. 
Color intensity was read using a micro-titer plate reader at 450 nm. Intensities above 2 
SD of the mean of negative sera responses were considered positive.              
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2.5.4 Immuno-dot blot analysis 
 1 µg of each recombinant protein was dotted onto nitrocellulose membranes 
together with series diluted IgE standard (National Institute for Biological Standards, 
United Kingdom) as positive control, 1 µg of BSA as negative protein control and 1 µl of 
buffer as negative control. Membranes were air dried and blocked with PBS-0.1% 
Tween-20 and incubated with sera (1:1 v/v in PBS) at 4 ºC overnight, followed by 
incubation with anti-human IgE antibodies conjugated with alkaline phosphatase (Sigma) 
(1:1000 v/v in PBS) for 2 hours. The membranes were then developed with nitroblue 
tetrazolium/5-bromo-4-chloro-3-indolyl-phosphate (Promega) for 30 minutes and spot 
intensities were measured using imaging software (MicroimageTM v.3.01, Germany). 
Spot intensities (ranging from 0-255) were normalized by subtracting the local 
background and intensities >20 (equivalent to 2 standard deviations [SD] above the mean 
negative sera responses) were considered positive. The inter- and intra-assay concordance 
was above 90% and 95% respectively, demonstrating good reproducibility of the assay. 
    
 
2.5.5 Competitive cross-inhibition ELISA 
Inhibition ELISA was carried out using the similar protocol described above 
except that sera were first absorbed with serial 10-fold dilutions of allergens (from 
1ng/ml to 100µg/ml) overnight prior to the assay. We also performed end-point inhibition 
ELISA using 10 sera. Sera were incubated with 0.1mg/ml of specific allergens overnight 
prior to the assay. The percentage of inhibition was calculated using the formula: 
     (OD450 without inhibitor-OD450 with inhibitor) 
     (OD450 without inhibitor-OD450 blank control) 
× 100 
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2.5.6 Effect of temperature, pH and urea on the IgE-binding of Blo t 5 and Blo t 21 
For thermal-denaturation study, recombinant Blo t 21 and Blo t 5 were heated at 
50°C, 70°C, and 90°C for 10 min. After cooled down to 20°C, proteins were 
subsequently coated on 96 well plate for ELISA assay as described in section 2.5.3 using 
seven sera. 
The effect of pH was assessed by diluting allergens to 0.1 mg/ml in 200 mM 
NaOAc (pH4 and pH5), PBS buffer (pH7.4), Cabornate/ biocarbonate buffer (pH9.6), 20 
mM HC1 (pH 2.0) and 20 mM NaOH (pH 12.0) individually. After 2 hours at room 
temperature, the samples were coated on 96 well plates for further ELISA assay as 
described in section 2.5.3.  
To determine the effect of protein denaturants, Blo t 5 and Blo t 21 were treated 
with 6 M urea in PBS (pH 8.5) for 2 hours and then coated on 96 well plates for ELISA 
assay as described in section 2.5.3. 
 
2.5.7 Specific IgE-binding to overlapping peptide of Blo t 5 
For overlapping peptide mapping, the ELISA procedure described above was 
slightly modified. Briefly, 100 ug/ml of peptides were coated on Streptavidin coated plate 
(Pierce).  Patient sera used in this study were diluted in 1:1(v/v) with PBS buffer. The 
secondary antibody was replaced by anti-human IgE antibodies conjugated with alkaline 
phosphatase (Sigma) (1:250 v/v in PBS). p-Nitropenyl phosphate (PNPP) (Sigma Aldrich, 
USA) was used as substrate for the assay, and colour reaction was developed for 
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approximately 30 minutes. Colour intensity was measured using a micro-titer plate reader 
at 405 nm. 
2.5.8   Specific antibody production 
Polyclonal antibodies against specific allergens were raised in New Zealand 
White Rabbits (2.5 to 3 kg). The rabbits were subcutaneously injected with 300µg of 
recombinant protein diluted in 500 µl of PBS with 500 µl of Freund’s complete djuvant 
(Sigma). Booster shots were given every 3 weeks with the same amount of recombinant 
protein with incomplete Freund’s adjuvant (Sigma) until high titers were obtained. The 
sera collected were kept at 4oC overnight for complete clotting and then centrifuged at 
3000 rpm for 20 minutes. Sera were stored at -20oC. 
 
2.5.9 Western blotting 
Whole mite extracts prepared by trichloroacetic acid-acetone method (Damerval et 
al., 1986) were separated on 15% SDS-PAGE, together with the recombinant proteins in 
parallel lanes, and transferred onto Hybond nitrocellulose membranes (Amersham 
Bioscience, USA). Western blotting was performed according to the protocol provided by 
Amersham Bioscience. Briefly, the membranes were blocked with 0.1% PBST, incubated 
with rabbit polyclonal antibody (1:2000 v/v in PBST), and then interacted with alkaline 
phosphatase conjugated goat anti-rabbit secondary antibody (1:2000 v/v in PBST). The 
specific band was detected by developing with BCIP/NBT (5-bromo-4chloro-3indolyl-
phosphate / nitro-blue tetrazolium) colour substrate (Promega, USA). 
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2.5.10  Immuno-localization 
To immuno-localize the allergens on mite sections, live mites were fixed, 
dehydrated, cleared, and embedded in paraffin and then sectioned into slides of 8µm 
thick.  The sections were de-paraffinized, hydrated, and incubated with the respective 
antibodies following the western blotting procedure. To remove the non-specific IgG 
binding, anti-Blo t 21 sera were pre-absorbed with 0.5mg/ml rBlo t 5. 
 
2.5.11 Dust sample collection and processing 
 Dust samples were collected from kitchens, sofas, carpets and bedrooms from 56 
homes in Singapore. Sampling was performed using a modified Kirby Classic III vacuum 
cleaner (Kirby Co., Cleveland, Ohio, USA) adapted with a chamber that collected dusts 
onto a filter paper. Each sample was obtained by vacuuming an area of 1 m2 for 2 mins. 
All dust samples were stored at -20 ºC until further use. The dust samples were sieved 
using a 500 µm pore size sieve. 1 ml of PBS was added to every 50 mg of dust sample. 
Samples were shaked overnight at 4ºC and then centrifuged at 2500 rpm for 20 mins at 
4ºC, and the supernatant was stored at -20ºC. 
 
2.5.12 Measurement of allergen in dust samples 
100 µl of dust samples were incubated overnight onto 96 well plates (Maxisorp, 
Nunc) at 4°C. Plates were blocked with 1% bovine serum albumin (BSA) in PBS for half 
an hour at room temperature and then washed three times with PBS-T (0.05%). The wells 
were incubated with 100 ul of rabbit sera at 1:5000 dilution in PBS for 1 hour at room 
temperature. Wells were then washed and incubated with 1:1000 dilution of horseradish 
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peroxidase conjugated anti-rabbit IgG (BD Pharmingen, USA) in PBS for 1 hour at room 
temperature. Wells were thoroughly washed before TMB (Sigma) was added. The 
reaction was stopped using 20 µL of 1M HCl and plates were read at 450 nm. Allergen 
levels were quantified and denoted as microgram of allergen per gram of fine dust (µg/g). 
 
2.6 Statistical analysis 
Statistics were analysed using SPSS 11.5 for Windows (SPSS, USA).  Two 
standard deviations (SD) above negative reactions were used as the cut off points for 
positive results.  Subsequently, 4 SD and 8 SD were used as cut off points for medium 
and high reactions respectively. All concordances were based on positive and negative 
reactions.  Spearman’s Correlation Test was used for all correlation analyses. Cluster 
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Chapter 3:  Identification and Characterization of a Novel 
Allergen from Blomia tropicalis: Blo t 21 
 
3.1     Introduction 
Blomia tropicalis is a common house dust mite in tropical regions, usually found 
together with Dermatophagoides pteronyssinus and/or D. farinae, and is predominant in 
the areas of Singapore, Malaysia, Brazil, Colombia, and Puerto Rico (Zhang et al., 1997; 
Chew et al., 1999; Mariana et al., 2000; Baqueiro et al., 2006; Fernandez-Caldas et al., 
1993; Montealegre et al., 1997b; Croce et al., 2000).  High prevalence of sensitization to 
B. tropicalis is strongly associated with the presentation of allergic diseases in these 
countries (Chew et al., 1999c; Puccio et al., 2004; Fernandez-Caldas et al., 1993b).  
Many studies have shown that allergens from B. tropicalis are species-specific 
with low to moderate cross-reactivity to other dust mite allergens (Chew et al., 1999b; 
Stanaland et al., 1994; Morgan, et al., 1996; Johansson et al., 1997).  At least 25 IgE-
binding protein bands have been identified in B. tropicalis by immunoblotting (Stanaland 
et al., 1994), of which ten allergens (Blo t 1, Blo t 3, Blo t 4, Blo t 5, Blo t 6, Blo t 10, 
Blo t 11, Blo t 12, Blo t 13 and Blo t 19) have been officially named and deposited into 
the allergen database (www.allergen.org) (Mora et al., 2003; Flores et al., 2003; Arruda 
et al., 1997; Yi  et al., 2002; Ramos et al., 2001; Puerta et al., 1996; Caraballo et al.,  
1997). Many other components still remain to be described. Most B. tropicalis allergens 
identified thus far have shown sequence homology to Dermatophagoides spp. allergens 
except Blo t 12 and Blo t 19 which have not yet been found in Dermatophagoides spp.. 
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Blo t 5 is a major allergen of B. tropicalis. A study in Taiwan showed that Blo t 5 
was the most prevalent B. tropicalis IgE-binding allergen, followed by Blo t 12, Blo t 13 
and Blo t 6. Less than 10% of patients responded to Blo t 4 and Blo t 10 (Tsai et al., 
2003).  Blo t 1 has been reported to be another major allergen (Mora et al., 2003; Cheong 
et al., 2003b). It had low cross-reactivity to Der p 1 or Der f 1 (Cheong et al., 2003b), but 
experimental results from our laboratory seem to suggest otherwise (Angus et al., 2004).   
Our laboratory recently surveyed the transcriptoms of B. tropicalis using an 
Expressed Sequence Tag (EST) strategy. ESTs were obtained from sequences of 
randomly picked B. tropicalis cDNA clones. With this database, we were able to predict 
many more allergens from B. tropicalis through bioinformatic approach.  These antigens 
shared sequence homology to allergens from mites, fungi, pollen, food sources and 
insects (Ramos et al., 2001), including a novel antigen which shared a 64% of sequence 
similarity to Blo t 5. This novel antigen could be a product of duplication gene of Blo t 5 
in B. tropicalis genome.  Duplication genes sharing a common ancestor in the genome are 
called paralog genes. In order to verify this antigen, specific IgE antibody response to this 
antigen was measured in 494 atopic individuals by immuno-dot blot screening and 43 
allergic patients with persistent rhinitis by ELISA. Skin prick test was performed in the 
same group of rhinitis patients to examine whether this antigen can cross-link specific 
IgE on mast cells and trigger the releasing of proinflammatory mediators such as 
histamine. ELISA inhibition assays was further performed to investigate the relationship 
between this antigen and its homologous allergens Blo t 5, Der p 5 and Lep d 5. 
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3.2       Results 
 
3.2.1    Identification of a novel Blo t 5 homologue (Blo t 21) from B. 
tropicalis EST database 
Using the Translated Basic Local Alignment Search Tool algorithm (BLASTX), 
Blomia tropicalis EST database generated from our laboratory (Angus et al., 2004) was 
compared with sequences from protein databases available at the National Center for 
Biotechnology Information (NCBI) (http://www.ncbi.nlm.nih.gov/). Three B. tropicalis 
ESTs were found to have approximately 40-56% amino acid similarity to the Blo t 5 
sequence in the Genbank (accession no. AAD10850). These included two full-length 
clones (accession no. CB282881 and CB283036) and one truncated cDNA which 
encoded only the C-terminal region (accession no. CB283289). These ESTs can be 
assembled into a 605-base-pair contig sequence, containing an open reading frame (ORF) 
of 390 base-pairs (Figure 3.1). Using the 5’- and 3’-end sequence of this contig, specific 
primers were designed and the full length open reading frame was amplified. The ORF 
encoding the Blo t 21 protein (accession no. AY800348) has 129 amino acids, including a 
putative 16-amino acid signal peptide predicted by SignalP (Bendtsen et al., 2004). The 
presence of a signal peptide suggests that Blo t 21 is a secreted protein. The calculated 
molecular weight of the mature protein is 13.2 kDa, with a predicted isoelectric point of 
5.21, and a predicted secondary structure of the protein made up of mainly alpha-helixes 
(PredictProtein, http://cubic.bioc.columbia.edu/predictprotein/) (Figure 3.2). The two 
full-length cDNAs were identical except at position 363 (T>C). Nevertheless, the amino 
acid coded by the affected codon remained the same (leucine). 
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1         CTAGCGGATCCCCCGGGCTGCAGGCTTTTGTAGAACCAATCTCAAACCTTCCAATTAAAC 
  
 
61        CAACAATGAAATTTATCATCGCATTGGCTGCCCTCATCGCAGTGGCATGTGCCCTACCAG 
                M  K  F  I  I  A  L  A  A  L  I  A  V  A  C  A  L  P    
 
121       TCTCTAACGATAACTTCCGTCACGAGTTTGACCATATGATCGTCAACACCGCTACTCAAC 
          V  S  N  D  N  F  R  H  E  F  D  H  M  I  V  N  T  A  T  Q    
 
181       GATTCCATGAGATTGAAAAATTCTTGTTGCATATTACTCATGAAGTTGATGATTTGGAAA 
          R  F  H  E  I  E  K  F  L  L  H  I  T  H  E  V  D  D  L  E    
 
241       AAACCGGCAACAAAGATGAGAAGGCACGACTTCTCCGAGAACTTACCGTTTCTGAGGCTT 
          K  T  G  N  K  D  E  K  A  R  L  L  R  E  L  T  V  S  E  A    
 
301       TCATCGAAGGATCAAGAGGATATTTCCAACGGGAACTCAAGCGAACTGATTTGGATTTGC 
          F  I  E  G  S  R  G  Y  F  Q  R  E  L  K  R  T  D  L  D  L    
 
361       TCGAGAAATTCAACTTTGAAGCTGCATTGGCAACCGGTGATTTGTTGTTGAAGGATCTTA 
          L  E  K  F  N  F  E  A  A  L  A  T  G  D  L  L  L  K  D  L    
 
421       AGGCTCTCCAAAAGCGAGTCCAAGATTCCGAATAGAAAGTTCGGTAAAGTCTCGTAGCAG 
          K  A  L  Q  K  R  V  Q  D  S  E         
 
481       AAACTTTTGCAAACATCCTCGTTTCTGAAAATAGTGTTCTACATGATGATTTTTTGTCAA 
  
 
541       TTGATTTGTTTTCAAAAAGATAATAAAATTATCAATTAGATTTGTTTAAAAAAAAAAAAA 
  
 
601       AAAAAAAAA 
 
 
Figure 3.1    Nucleotide and amino acid sequence of Blo t 21. The signal peptide of Blo t 
21 is underlined. Start and stop codons of open reading frame are boxed. 
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Figure 3. 2   Predicted secondary structure of Blo t 21 by PredictProtein 
(http://cubic.bioc.columbia.edu/predictprotein/).  represents α helix.  
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The Blo t 21 sequence, together with its orthologue, Der p 21 (accession no. 
ABC73706), and other Group 5 allergens from different mite species available in public 
database were aligned using ClustalW (Thompson et al., 1994). Multiple alignments 
showed that Blo t 21 shared 30%-41% amino acid sequence identity and 45%-59% 
sequence similarity to Der p 21, Blo t 5, Der p 5, and Lep d 5 throughout the entire length 
of the protein sequence (Figure 3.3). Pairwise, Blo t 21 shared 41% (52/128) amino acid 
identity (59% similarity) with Der p 21, and 39% (50/128) amino acid identity (54% 
similarity) with Blo t 5. In comparison, Der p 21 shared 31% (43/140) amino acid 
identity (45% similarity) with Der p 5, while Blo t 5 and Der p 5 shared 41% (55/134) 
amino acid identity (53% similarity). However, no clear conserved domain could be 
observed within and between the Group 21 and Group 5 protein sequences. Nevertheless, 
based on the Food and Agriculture Organization – World Health Organization 
(FAO/WHO) criteria for potential allergenicity  (Rome and Agriculture Organization of 
the United Nations (FAO); 2001), the new gene product shared more than 35% similarity 
to known allergens over a window of at least 80 amino acids and was considered as 
potentially allergenic. 
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Der f 5 19 - - - - - E P K K H D Y Q N E F D F L L M Q R I H D Q M R K G E E A L L H L H - Q I N T F E E N P T
Lep d 5 51 S D E V A I P N P D E F R N E F D R L L I H M T E E Q F A K L E Q A L A H L S H Q V T E L E K S K S
110 120 130 140 150
. . . . | . . . . | . . . . | . . . . | . . . . | . . . . | . . . . | . . . . | . . . . | . . . . |
Blo t 21 63 K D E K A R L L R - E L T V S E A F I E G S R G Y F Q R E L K R T D L D L L E K F N F E A A L A T G
Der p 21 69 K E L K E Q I L R - E L T I G E N F M K G A L K F F E M E A K R T D L N M F E R Y N Y E F A L E S I
Blo t 5 66 K E L Q E K I I R - E L D V V C A M I E G A Q G A L E R E L K R T D L N I L E R F N Y E E A Q T L S
Der p 5 65 K E M K D K I V A - E M D T I I A M I D G V R G V L D R L M Q R K D L D I F E Q Y N L E M A K K S G
Der f 5 64 K E M K E Q I L A S E M D T I I A L I D G V R G V L N R L M K R T D L D I F E R Y N V E I A L K S N








. . . . | . . . . | . . . . | . . . . | . . .
Blo t 21 112 D L L L K D L K A L Q K R V Q D S E - - - - -
Der p 21 118 K L L I K K L D E L A K K V K A V N P D E Y Y
Blo t 5 115 K I L L K D L K E T E Q K V K D I Q T Q - - -
Der p 5 114 D I L E R D L K K E E A R V K K I E G - - - -
Der f 5 114 E I L E R D L K K E E Q R V K K I E V - - - -
Lep d 5 150 A V L H K D L T A L A T K V K A I E T K - - -
 
 
Figure 3.3    Multiple alignments of Blo t 21 protein sequence with Der p 21, Blo t 5, Der 
p 5, Der f 5 and Lep d 5 protein sequences. Identical and similar sequences 
are shaded with black and grey respectively. 
 
  58 
   
3.2.2    Genomic organizations encoding Blo t 21 and Blo t 5 
Genomic components encoding Blo t 21 and Blo t 5 were isolated by PCR and 
subsequently cloned into the pGEMT vector. Sequences of ten individual Blo t 21 clones 
showed that this gene consisted of one intron that interrupted amino acid 18 of the 
protein. The intron is 56 base pairs long, starting from GT at position 47 and ending with 
AG at position 102 (Figure 3.4). Four clones (clones 1, 3, 5, 10) were found to be 
identical to each other, and the others showed nine nucleotide substitutions at eight 
positions (Table 3.1). One substitution was found in the intron while the remaining seven 
were in exon coding regions. Four of the exon substitutions affected the amino acids that 
they coded for. Protein variants occurred twice at V33 to I, once at position T35 to A, 
once at K59 to E and once at L69 to P. In addition, one nucleotide substitution was 
observed from one cDNA clone (EST Bt 1304) of Blo t 21 when cDNA and gDNA 
sequences were aligned. This substitution did not affect the primary protein sequence of 
Blo t 21. 
In contrast, the Blo t 5 genomic DNA sequence revealed a 57 base pairs intron in 
the 5’ end as well (Figure 3.5). From 10 individual clones sequenced, three clones had 
identical sequences. Eight substitutions were found in the exon region including two 
substitutions causing protein variants. The variants were at E19>G and K23>E, and both 
occurred only once in the 10 clones (Table 3.2). The genomic DNA of Blo t 5 and Blo t 
21 shared only 50% nucleotide sequence identity (Figure 3.6). 
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10 20 30 40 50
. . . . | . . . . | . . . . | . . . . | . . . . | . . . . | . . . . | . . . . | . . . . | . . . . |
gBlo t 21.0101    (1) A T G A A A T T T A T C A T C G C A T T G G C T G C C C T C A T C G C A G T G G C A T G T G G T A A
cBlo t 21 A T G A A A T T T A T C A T C G C A T T G G C T G C C C T C A T C G C A G T G G C A T G T G - - - -
60 70 80 90 100
. . . . | . . . . | . . . . | . . . . | . . . . | . . . . | . . . . | . . . . | . . . . | . . . . |
gBlo t 21.0101    (1) G T T G G T A G C T C A A T T A T T A G T T G A C C C A A A A A T T G A C C A A C T T G A T A T T T
cBlo t 21 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
110 120 130 140 150
. . . . | . . . . | . . . . | . . . . | . . . . | . . . . | . . . . | . . . . | . . . . | . . . . |
gBlo t 21.0101    (1) A G C C C T A C C A G T C T C T A A C G A T A A C T T C C G T C A C G A G T T T G A C C A T A T G A
cBlo t 21 - - C C C T A C C A G T C T C T A A C G A T A A C T T C C G T C A C G A G T T T G A C C A T A T G A
160 170 180 190 200
. . . . | . . . . | . . . . | . . . . | . . . . | . . . . | . . . . | . . . . | . . . . | . . . . |
gBlo t 21.0101    (1) T C G T C A A C A C C G C T A C T C A A C G A T T C C A T G A G A T T G A A A A A T T C T T G T T G
cBlo t 21 T C G T C A A C A C C G C T A C T C A A C G A T T C C A T G A G A T T G A A A A A T T C T T G T T G
210 220 230 240 250
. . . . | . . . . | . . . . | . . . . | . . . . | . . . . | . . . . | . . . . | . . . . | . . . . |
gBlo t 21.0101    (1) C A T A T T A C T C A T G A A G T T G A T G A T T T G G A A A A A A C C G G C A A C A A A G A T G A
cBlo t 21 C A T A T T A C T C A T G A A G T T G A T G A T T T G G A A A A A A C C G G C A A C A A A G A T G A
260 270 280 290 300
. . . . | . . . . | . . . . | . . . . | . . . . | . . . . | . . . . | . . . . | . . . . | . . . . |
gBlo t 21.0101    (1) G A A G G C A C G A C T T C T C C G A G A A C T T A C C G T T T C T G A G G C T T T C A T C G A A G
cBlo t 21 G A A G G C A C G A C T T C T C C G A G A A C T T A C C G T T T C T G A G G C T T T C A T C G A A G
310 320 330 340 350
. . . . | . . . . | . . . . | . . . . | . . . . | . . . . | . . . . | . . . . | . . . . | . . . . |
gBlo t 21.0101    (1) G A T C A A G A G G A T A T T T C C A A C G G G A A C T C A A G C G A A C T G A T T T G G A T T T G
cBlo t 21 G A T C A A G A G G A T A T T T C C A A C G G G A A C T C A A G C G A A C T G A T T T G G A T T T G
360 370 380 390 400
. . . . | . . . . | . . . . | . . . . | . . . . | . . . . | . . . . | . . . . | . . . . | . . . . |
gBlo t 21.0101    (1) C T C G A G A A A T T C A A C T T T G A A G C T G C A T T G G C A A C C G G T G A T T T G T T G T T
cBlo t 21 C T C G A G A A A T T C A A C T T T G A A G C T G C A T T G G C A A C C G G T G A T T T G T T G T T
410 420 430 440
. . . . | . . . . | . . . . | . . . . | . . . . | . . . . | . . . . | . . . . | . . . . | .
gBlo t 21.0101    (1) G A A G G A T C T T A A G G C T C T T C A A A A G C G A G T C C A A G A T T C C G A A T A G
cBlo t 21 G A A G G A T C T T A A G G C T C T T C A A A A G C G A G T C C A A G A T T C C G A A T A G
 
 
Figure 3.4    Alignment of Blo t 21 cDNA and genomic DNA (gBlo t 21.0101) revealed 
an intron of 56 base pairs.  
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 10 20 30 40 50
. . . . | . . . . | . . . . | . . . . | . . . . | . . . . | . . . . | . . . . | . . . . | . . . . |
 gBlo t 5.0101 A T G A A G T T C G C C A T C G T T C T T A T T G C C T G C T T T G C C G C T T C G G T T T T G G C
cBlo t 5 A T G A A G T T C G C C A T C G T T C T T A T T G C C T G C T T T G C C G C T T C G G T T T T G G C
60 70 80 90 100
. . . . | . . . . | . . . . | . . . . | . . . . | . . . . | . . . . | . . . . | . . . . | . . . . |
 gBlo t 5.0101 T C A A G A G C A C A A G C C A A A G A A G G A T G A T T T C C G A A A C G A A T T C G A T C A C T
cBlo t 5 T C A A G A G C A C A A G C C A A A G A A G G A T G A T T T C C G A A A C G A A T T C G A T C A C T
110 120 130 140 150
. . . . | . . . . | . . . . | . . . . | . . . . | . . . . | . . . . | . . . . | . . . . | . . . . |
 gBlo t 5.0101 T G T T G A T C G A A C A G G T A A A C A G T T T T T T T T G A A A G G T T A A T A A A A A A G T A
cBlo t 5 T G T T G A T C G A A C A G - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
160 170 180 190 200
. . . . | . . . . | . . . . | . . . . | . . . . | . . . . | . . . . | . . . . | . . . . | . . . . |
 gBlo t 5.0101 A T C A A A G A A A C T T T T T A G G C A A A C C A T G C T A T C G A A A A G G G A G A A C A T C A
cBlo t 5 - - - - - - - - - - - - - - - - - - G C A A A C C A T G C T A T C G A A A A G G G A G A A C A T C A
210 220 230 240 250
. . . . | . . . . | . . . . | . . . . | . . . . | . . . . | . . . . | . . . . | . . . . | . . . . |
 gBlo t 5.0101 A T T G C T T T A C T T G C A A C A C C A A C T C G A C G A A T T G A A T G A A A A C A A G A G C A
cBlo t 5 A T T G C T T T A C T T G C A A C A C C A A C T C G A C G A A T T G A A T G A A A A C A A G A G C A
260 270 280 290 300
. . . . | . . . . | . . . . | . . . . | . . . . | . . . . | . . . . | . . . . | . . . . | . . . . |
 gBlo t 5.0101 A G G A A T T G C A A G A G A A A A T C A T T C G A G A A C T T G A T G T T G T T T G C G C C A T G
cBlo t 5 A G G A A T T G C A A G A G A A A A T C A T T C G A G A A C T T G A T G T T G T T T G C G C C A T G
310 320 330 340 350
. . . . | . . . . | . . . . | . . . . | . . . . | . . . . | . . . . | . . . . | . . . . | . . . . |
 gBlo t 5.0101 A T C G A A G G A G C C C A A G G A G C T T T G G A A C G T G A A T T G A A G C G A A C T G A T C T
cBlo t 5 A T C G A A G G A G C C C A A G G A G C T T T G G A A C G T G A A T T G A A G C G A A C T G A T C T
360 370 380 390 400
. . . . | . . . . | . . . . | . . . . | . . . . | . . . . | . . . . | . . . . | . . . . | . . . . |
 gBlo t 5.0101 T A A C A T T T T G G A A C G A T T C A A C T A C G A A G A G G C T C A A A C T C T C A G C A A G A
cBlo t 5 T A A C A T T T T G G A A C G A T T C A A C T A C G A A G A G G C T C A A A C T C T C A G C A A G A
410 420 430 440 450
. . . . | . . . . | . . . . | . . . . | . . . . | . . . . | . . . . | . . . . | . . . . | . . . . |
 gBlo t 5.0101 T C T T G C T T A A G G A T T T G A A G G A A A C C G A A C A A A A A G T G A A G G A T A T T C A A
cBlo t 5 T C T T G C T T A A G G A T T T G A A G G A A A C C G A A C A A A A A G T G A A G G A T A T T C A A
. . . . | . . . .
 gBlo t 5.0101 A C C C A A T A A
cBlo t 5 A C C C A A T A A
  
  
Figure 3.5    Alignment of Blo t 5 cDNA and genomic DNA (gBlo t 5.0101) revealed an 
intron of 57 base pairs.  
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80  a g (intron) 2 10% 
154 33 gct/V atc/I 7,8 20% 
159 35 acc/V gcc/A 6 10% 
167 37 act/T acc/T 6 10% 
231 59 aaa/K gaa/E 9 10% 
262 69 ctt/L cct/P 3 10% 
284 76 tct/S tcc/S 8 10% 
389 111 ggt/G ggc/G 2 10% 
419 121 ctc/L ctt/L cDNA (EST 1304)  






















30 10 tgc/C tgt/C 10 10% 
56 19 gag/E ggg/G 2 10% 
67 23 aag/K gag/E 11 10% 
130 intron ttt tttt (i17 insertion  ) 9,10 20% 
130 intron ttt ttttt  (i17,18 insertion) 11 10% 
225 57 ctc/L ctt/L 9,10 20% 
270 72 atc/I att/I 3 10% 
288 78 gtt/V gta/V 6 10% 
321 89 gct/A gcc/A 4 10% 
345 97 act/T acc/T 7 10% 
* gBlo t 5.0101 refers to the sequence of genomic DNA clones 1, 5, 8. 
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                        10        20        30        40        50        60        70 
              ....|....|....|....|....|....|....|....|....|....|....|....|....|....| 
gBlo t 5       ATGAAGTTCGCCATCGTTCTTATTGCCTGCTTTGCCGCTTCGGTTT------------------------ 
gBlo t 21      ATGAAATTTATCATCGCATTGGCTGCCCTCATCGCAGTGGCATGTGgtaagttggtagctcaattattag 
                        80        90       100       110       120       130       140 
               ....|....|....|....|....|....|....|....|....|....|....|....|....|....| 
gBlo t 5       --------------------------------TGGCTCAAGAGCACAAGCCAAAGAAGGATGATTTCCGA 
gBlo t 21      ttgacccaaaaattgaccaacttgatatttagCCCTACCAGTCTCTAAC---------GATAACTTCCGT 
 
                       150       160       170      180       190       200       210 
               ....|....|....|....|....|....|....|....|....|....|....|....|....|....| 
gBlo t 5       AACGAATTCGATCACTTGTTGATCGAACAGgtaaacagtttttttttgaaaggttaataaaaaagtaatc 
gBlo t 21      CACGAGTTTGACCATATGATCGTCAACACC---------------------------------------- 
                       220       230       240       250       260       270       280 
               ....|....|....|....|....|....|....|....|....|....|....|....|....|....| 
gBlo t 5       aaagaaactttttagGCAAACCATGCTATCGAAAAGGGAGAACATCAATTGCTTTACTTGCAACACCAAC 
gBlo t 21      ---------------GCTACTCAACGATTCCATGAGATTGAAAAATTCTTGTTGCATATTACTCATGAAG 
 
                      290       300       310       320       330       340       350 
               ....|....|....|....|....|....|....|....|....|....|....|....|....|....| 
gBlo t 5       TTGACGAATTGAATGAAAACAAGAGCAAGGAATTGCAAGAGAAAATCATTCGAGAACTTGATGTTGTTTG 
gBlo t 21      TTGATGATTTGGAAAAAACCGGCAACAAAGATGAGAAGGCACGACTTCTCCGAGAACTTACCGTTTCTGA 
 
                       360       370       380       390       400       410       420 
               ....|....|....|....|....|....|....|....|....|....|....|....|....|....| 
gBlo t 5       CGCCATGATCGAAGGAGCCCAAGGAGCTTTGGAACGTGAATTGAAGCGAACTGATCTTAACATTTTGGAA 
gBlo t 21      GGCTTTCATCGAAGGATCAAGAGGATATTTCCAACGGGAACTCAAGCGAACTGATTTGGATTTGCTCGAG 
 
                      430       440       450       460       470       480       490 
               ....|....|....|....|....|....|....|....|....|....|....|....|....|....| 
gBlo t 5       CGATTCAACTACGAAGAGGCTCAAACTCTCAGCAAGATCTTGCTTAAGGATTTGAAGGAAACCGAACAAA 
gBlo t 21      AAATTCAACTTTGAAGCTGCATTGGCAACCGGTGATTTGTTGTTGAAGGATCTTAAGGCTCTTCAAAAGC 
 
                       500       510        
              ....|....|....|....|....|. 
gBlo t 5       AAGTGAAGGATATTCAAACCCAATAA  
gBlo t 21      GAGTCCAAGATTCCGAATAG------ 
 
Figure 3.6    Comparison between the genomic organization of Blo t 5 and Blo t 21. The 
intron borders are underlined. Identical sequences are shaded with black 
color. 
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3.2.3   Southern blotting 
The Blo t 21 and Blo t 5 genes were further examined in B. tropicalis using 
Southern blotting. Upon hybridization, a single band each for Blo t 21 and Blo t 5 was 
observed in each lane loaded with enzymes digested B. tropicalis genomic DNA ( Figure 
3.7 A and B). The hybridization patterns for both genes were however different. Hence, 
Blo t 21 and Blo t 5 were found to be single-copy genes located at different loci of the B. 
tropicalis genome. The nucleotide substitutions in the genomic sequences observed 
earlier were probably resulted from polymorphisms among different mite individuals 
rather than different copies of the gene in each mite. 
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Figure 3.7    Southern blot analysis of B. tropicalis using Blo t 5 and Blo t 21 probes. 
A. Hybridization with a Blo t 5 probe. B. Hybridization with a Blo t 21 
probe. In both, genomic DNA was digested with restriction enzymes, Hind 
III and EcoR V, respectively. 
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3.2.4    Secondary structures of Blo t 21 and Blo t 5 
Recombinant Blo t 21 and Blo t 5 were expressed in E. coli. Figure 3.8A shows 
the SDS-PAGE of the purified recombinant Blo t 5 and Blo t 21 proteins. Both bands 
were observed around 14 kDa, corresponding to their respective deduced molecular 
weights: Blo t 5 (14kDa) and Blo t 21 (13kDa). 
To evaluate whether the recombinant proteins were properly folded after 
purification, far UV circular dichroism (CD) spectra of both rBlo t 5 and rBlo t 21 were 
measured. The CD profiles of both rBlo t 5 and rBlo t 21 showed that these two proteins 
were typical α-helix proteins (Figure 3.8B) with two maximum negative peaks at 208 nm 
and 222 nm and one positive peak at 192 nm. The observed secondary structures were 
similar to those predicted from the amino acid sequence at PredictProtein server as 
mentioned in Section 3.2.1. The CD spectra profiles indicated that both recombinant Blo t 
5 and Blo t 21 were properly folded in solution, and also shared similar secondary 
structures. 
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Figure 3.8    Expression of recombinant Blo t 5 and Blo t 21 allergens and their far UV 
CD spectra.  A. Protein profile of recombinant Blo t 5 and Blo t 21 separated 
on 15% SDS-PAGE gel. B. Far UV CD spectra of rBlo t 5 and rBlo t 21 
proteins in solution. 
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3.2.5    Examination of the natural Blo t 21 and Blo t 5 
To evaluate the naturally-occurring Blo t 21 and Blo t 5 in crude mite extract, 
western blotting was performed using specific polyclonal antibodies. Whole mite proteins 
were extracted and separated on a 15% SDS gel together with recombinant Blo t 21 and 
Blo t 5 in parallel lanes (Figure 3.9A). In Figure 3.9B, Blo t 5 polyclonal antibodies 
recognized rBlo t 5, but not rBlo t 21. A natural Blo t 5 protein band recognized by Blo t 
5 antibody was similar to rBlo t 5 (approximately 15 kDa). Two other bands 
(approximately 20 kDa and 28 kDa) in the mite protein extract were also recognized by 
Blot 5 antibody. Same Western banding profile of Blo t 5 was also observed by previous 
study in our laboratory by Mr. Aaron Chen Angus (Data not shown). He had analyzed 20 
kDa and 28 kDa bands using Mass spectrometer and results indicated that these mite 
components were similar to the Group 5 allergen. A non-specific band (at 25 kDa, 
denoted with an asterisk in the Figure 3.9) was detected in all three Immuno-blotting 
membranes including the negative control (Figure 3.9D). We also observed that 
recombinant Blo t 5 existed as a homo-dimer at 30 kDa and homo-trimer at 45 kDa. 
In contrast, the Blo t 21 specific polyclonal antibody reacted strongly to rBlo t 21, 
but showed a weak cross reaction to rBlo t 5 (Figure 3.9C). Consequently, two natural 
protein bands around 15 kDa were observed in the lane loaded with the crude mite 
protein extract. The band that ran slightly higher was identified to be natural Blo t 5, 
while the lower band was identified to be nBlo t 21. The size of nBlo t 21 also matched 
its predicted molecular weight based on the amino acid sequence. A band that appeared at 
approximately 20 kDa was found to be similar to Blo t 5. Like rBlo t 5, rBlo t 21 also 
exists as a homo-dimer at 30 kDa and homo-trimer at 45 kDa. 
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Figure 3.9    Detection of native Blo t 5 and Blo t 21 allergens in the crude extract.  
(A). SDS-PAGE gel separating profile of rBlo t 5, rBlo t 21 and B. tropicalis 
extract. Immuno-blotting images with (B). anti-Blo t 5 (C). anti-Blo t 21 
polyclonal antibodies and (D). PBS buffer (negative control). A non-specific 
band (*) was detected in all three immuno-blotting membranes. 
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3.2.6    Prevalence of Blo t 21 and Blo t 5 sensitization in allergic rhinitis patients in 
Singapore 
The allergenicities of Blo t 21 and Blo t 5 were evaluated in forty-three adult 
patients with ongoing persistent allergic rhinitis who were positive to B. tropicalis, D. 
pteronyssinus, and D. farinae and five non-atopic healthy volunteers using direct ELISA 
method. The responses to these dust mites were verified by skin prick test assay in vivo 
using extracts prepared from three mites and CAP assay via measuring the IgE antibodies 
to extract of B. tropicalis, D. pteronyssinus and D. farinae. The detailed characteristics of 
these patients were described in Chapter 2 Materials and Methods. ELISA assay results 
showed that forty out of the forty-three patients (93%) had sera specific IgE response to 
Blo t 21, while forty-two patients (98%) had specific IgE to Blo t 5. Patients responding 
to Blo t 21 also specifically responded to Blo t 5 (Figure 3.10).  
In order to validate the ELISA system, UniCAP® system was used as a reference 
assay. B. tropicalis extract was applied to test both systems. The ELISA readings versus 
the UniCAP® ranking values were displayed in Figure 3.11. A good correlation between 
ELISA absorbance readings and ranking scores of UniCAP was observed. The correlated 
results obtained from two different assay systems indicated that direct ELISA assay is a 
reliable semi-quantitative tool to measure allergen specific IgE antibodies when the 
UniCAP system is used as the bench mark. 
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Figure 3.10     Bi-plot comparing the specific IgE levels against Blo t 21 and Blo t 5 
assessed by ELISA in sera of 43 allergic rhinitis patients. Grey lines 





Figure 3.11   Concordance of the ELISA versus UniCAP system. 
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3.2.7  Prevalence of Blo t 5 and Blo t 21 sensitization in consecutive individuals 
attending outpatient allergy clinics  
The allergenicities of Blo t 21 and Blo t 5 were further evaluated in 181 local 
atopic individuals attending outpatient allergy clinics over a period of one and a half 
years using semi-quantitative dot blot immunoarray assay♣. Ninty-seven out of 181 
(97/181) sera were found responding to B. tropicalis extract, and 30 sera responded to 
Blo t 21 corresponding to 31% (30/97) of B. tropicalis positive subjects.  
In order to compare Blo t 21 with other allergens of B. tropicalis, the IgE 
responses to a panel of 19 allergens were also included in the immunoarray♣♣. Figure 
3.12 shows that Blo t 21 (31%) is the third most prevalent IgE response allergen among 
19 B. tropicalis allergens following Blo t 5 (50%) and Blo t 3 (39%). Blo t 12 and Bt 
Mag 3 have a mid-range prevalence of 23%, Blo t 2, 6, 7, 11, 13 and Mag 1 have a 
prevalence of 11% ∼19%, and Blo t 1, 4, 8, 9, 10, 15, 20 and Mag 29 have a low 
prevalence (less than 8%) in this population. Sera with high IgE antibodies to B. 
tropicalis extract tended to respond to many allergens. The specific IgE levels against Blo 
t 21 and Blo t 5 were compared by intensities of dots detected on membranes (Figure 
3.13 A and B), and results revealed that except for one serum, most sera responding to 
Blo t 21 also responded to Blo t 5. 
                                                 
♣  This work was done by Ms. Tay Angeline. 
♣♣  Except Blo t 5 and Blo t 21, the rest 17 B. tropicalis allergens were cloned by Dr. Shang Huishen, 
Kuay Kuee Theng, and Wang Wen Long. 
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Figure 3.12    IgE-binding frequencies of B. tropicalis allergens in the B. tropicalis 
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Blo t 5 Blo t 21
Figure 3.13    Comparison of the specific IgE levels against Blo t 21 and Blo t 5 assessed 
by Dot blot immunoassay in sera of 97 B. tropicalis positive subjects 
attending outpatient allergy clinic in one and a half years. (A) Bi-plot 
comparison of IgE-binding of Blo t 5 and Blo t 21  (B) Venn diagram 
showing IgE-binding to Blo t 5 and Blo t 21.  
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3.2.8    Skin Prick test of Blo t 21 and Blo t 5 in allergic rhinitis patients 
To further confirm the allergenicities of Blo t 21 and Blo t 5 in vivo, skin prick 
test was performed on the same group of allergic rhinitis patients evaluated earlier. Two 
non-atopic volunteers were also evaluated as controls♣. All patients had positive 
responses to at least one of the allergens, with most of them (n=41) reacting to both 
allergens (Figure 3.14). The mean wheal diameter was 5.7 mm for Blo t 5 and 6.2 mm for 
Blo t 21. Healthy subjects did not develop significant wheal and flare reactions (data not 



















































































Figure 3.14     Cross comparison between Blo t 5 and Blo t 21 skin prick test responses 
among 43 allergic rhinitis patients. 
                                                 
♣  This experiment was done by Associate Professor Wang De Yun, Department of Otolaryngology, 
National University of Singapore. 
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3.2.9    Dose-response cross-inhibition of IgE-binding to Blo t 21 and Blo t 5 
Cross-reactivity between these allergens were evaluated via a dose-response 
ELISA inhibition study using three sera with high titers of specific IgE to both Blo t 21 
and Blo t 5, as well as Lep d 5 and Der p 5. Dose-dependent inhibition up to a maximum 
of approximately 100% was observed with all homologous antigens in all three sera 
(Figure 3.15 A and B). IgE-binding to Blo t 21 could be inhibited by the homologous 
antigen at very low concentrations (0.01 µg/ml) and achieved full inhibition at 100 µg/ml 
of protein in all three sera (Figure 3.15 A). Heterologous inhibition by Blo t 5, Der p 5 
and Lep d 5, however, only occurred after the inhibitor concentration was 10 µg/ml or 
above in two of the three sera, and could only achieve a maximum of less than 45% 
inhibition at the concentration of 100 µg/ml of inhibitor. In particular, no cross-reactive 
specific IgE between Blo t 21 and Group 5 allergens could be detected in serum from 
patient V1.   
In parallel, with Blo t 5 coated on the ELISA plates, partial cross-reactivity 
between Blo t 5 and Blo t 21, Der p 5 and Lep d 5 was also observed (Figure 3.15 B). 
When homologous antigen achieved full inhibition of specific IgE-binding to Blo t 5, Blo 
t 21 reached 55%-71% of the IgE-binding of Blo t 5. Der p 5 and Lep d 5 achieved 18%-
75% and 41%-77% inhibition respectively. 
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Figure 3.15     Dose-response competitive ELISA assay evaluating the IgE cross-
reactivity of Blo t 21 and Blo t 5. Three individual sera (V1, V2 and V3) 
were pre-absorbed with 10-fold series dilution of inhibitors, and then used 
to perform allergen specific IgE assay by ELISA. A. Blo t 21 immobilized 
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3.2.10    Quantitative end point cross-inhibition of Blo t 21 and Blo t 5 
To evaluate further, ten additional rhinitis patient sera with specific IgE to both 
allergens were tested in a quantitative end-point inhibition experiment using only 100 
µg/ml of inhibitor.  On average, specific IgE-binding to Blo t 21 was partially inhibited 
by Blo t 5, Der p 5 and Lep d 5 at a mean of 27%, 29% and 28% respectively (Blo t 21 
achieved 93% inhibition at 100 µg/ml). In parallel, specific IgE-binding to Blo t 5 was 
partially inhibited by Blo t 21, Der p 5 and Lep d 5 at a mean of 33%, 51% and 34% 
respectively (Blo t 5 achieved 85% inhibition at 100 µg/ml) (Table 3.3). 
Taken together, cross inhibition studies revealed that Blo t 21 has low cross-
reactivity to Blo t 5 and other Group 5 allergens, and vice versa.  Specific IgE reactions 
to Blo t 21 are mainly elicited by its unique IgE epitopes, rather than its shared epitopes 
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 Table 3.3     Quantitative end-point cross-inhibition of IgE-binding to Blo t 21 and Blo t 
5 in sera of ten atopic individuals. 
 
 
A. rBlo t 21 immobilized on solid phase. B. rBlo t 5 immobilized on solid phase. 
A. Inhibition of IgE-binding to Blo t 21 B. Inhibition of IgE-binding to Blo t 50.1 mg/ml 
Inhibitor Blo t 21 Blo t 5 Der p 5 Lep d 5 Blo t 5 Blo t 21 Der p 5 Lep d 5
R4 80% 17% 16% 19% 80% 29% 66% 54% 
R5 98% 11% 14% 17% 95% 28% 65% 26% 
R7 94% 44% 68% 53% 92% 32% 66% 51% 
R11 87% 50% 23% 25% 73% 61% 29% 34% 
R14 97% 53% 65% 59% 90% 57% 74% 56% 
R18 91% 5% 5% 6% 88% 19% 60% 42% 
R20 97% 10% 16% 12% 91% 19% 73% 49% 
R22 91% 2% 2% 8% 75% 0% 23% 0% 
R23 95% 48% 34% 31% 83% 78% 40% 32% 
R24 96% 8% 14% 2% 80% 3% 12% 0% 
mean 93% 25% 26% 23% 85% 33% 51% 34% 
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3.2.11    Localization of Blo t 21 and Blo t 5 on sections of mite body 
 
Blo t 21 and Blo t 5 were immuno-stained by anti-Blo t 21 and anti-Blo t 5 
polyclonal antibodies on paraffin sections of mite bodies. Anti-Blo t 21 antibody bound 
strongly to mid-gut contents and fecal pellets in the hindgut of the sections (Figure 3.16 
A). In parallel, anti-Blo t 5 antibody stained similar positions of the mite sections (Figure 
3.16 B). To ensure that the antibodies were not cross reacting, anti-Blo t 21 was pre-
absorbed with Blo t 5 prior to immuno-staining. A pre-immune sera control did not stain 
the mite sections (Figure 3.16 C). Therefore, Blo t 21 and Blo t 5 co-localize in similar 
positions and may likely pass out of the mite body with feces and exist in the 
environment as airborne particles. 
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Figure 3.16    Immuno-staining of Blo t 21 and Blo t 5 in paraffin-embedded sections of 
B. tropicalis. (A). Probed with anti-Blo t 21 polyclonal antibody in 
longitudinal and sagittal mite sections. (B). Probed with anti-Blo t 5 
polyclonal antibody. (C). Probed with pre-immune serum. Amg: anterior 
midgut, Hg: hind gut. 
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3.2.12    Concentration of Blo t 21 in the house dusts 
 
Seventy-one dust samples from four niches of 40 homes, namely bedroom floors, 
living room carpets, living room floors and kitchens floors were assayed for Blo t 21 and 
Blo t 5 levels. In order to ensure the specificity of the assay, cross-inhibition experiments 
of Blo t 5 and Blo t 21 antibodies were performed before dust assay. The inhibition study 
using competitive ELISA method indicated that both Blo t 21 and Blo t 5 antibodies were 
specific for their own proteins (Figure 3.17). 
Wilcoxon-Mann-Whitney rank test showed identical distributions of Blo t 21 and 
Blo t 5 among different niches where dust samples were collected. Blo t 21 was found in 
70 out of 71 dust samples with a geometric mean of 220 ng/g, while Blo t 5 was detected 
in 67 dust samples with a geometric mean of 163 ng/g. Figure 3.18 shows slightly higher 
Blo t 21 levels than Blo t 5 in dust samples collected from kitchen floors, bedroom floors 
and living room carpets.  The geometric means of Blo t 21 were higher on kitchen floors 
and living room carpets than those on bedroom floors and living room floors, while the 
geometric means of Blo t 5 in four niches were relatively similar. The paired t test results 
showed non-correlation between Blo t 21 and Blo t 5 levels in the dust samples of this 
study. Bi-plot analysis of the concentration of Blo t 21 and Blo t 5 in house dust samples 
also indicated the non-correlation of distributions of the two allergens (Figure 3.19). 
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Figure 3.17     Competitive ELISA assay evaluating the IgG specificity of Blo t 21 and 
Blo t 5. (A) Blo t 21 IgG antibody (B) Blo t 5 antibody. 
 
 









































Figure 3.18     Blo t 21 and Blo t 5 levels in 71 house dust samples. The solid lines 
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Figure 3.19   Correlation of Blo t 21 and Blo t 5 levels in the house dusts in Singapore. 
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3.3     Discussion 
 
 
A novel Blo t 21allergen has been identified from our in-house B. tropicalis EST 
database. It has been discovered in B. tropicalis mite at DNA level, transcription level 
and translation level. Its genomic DNA has been detected by Southern blotting, 
transcriptional products were obtained from cDNA library by EST approach, and native 
protein was observed from mite extract by Western blotting.  
Blo t 21 is a product of a single-copy gene which contains an intron with 56 base 
pairs.  The open reading frame of its cDNA encodes a protein similar to Group 5 and 
Group 21 allergens.  Additionally, multiple sequence alignment showed that Blo t 21 
shared 30-41% amino acid identity with Der p 21 and other known Group 5 allergens. 
The CD spectra of Blo t 21 and Blo t 5 indicated typical α-helical structures of both 
proteins, similar to that of Der p 5 (Liaw et al., 2001). These similarities between the 
primary and secondary structures of Group 21 and Group 5 allergens as well as their co-
localization in the dust mite seem to suggest that these two classes of allergens possibly 
have related functions.  The conservation of amino acid sequences in different proteins, 
originated from the same species is most likely due to a prior gene duplication event 
within the genome of the organism. Duplicated gene sequences may however change 
quickly before selective pressure sets in on its new function. Hence, duplicated gene 
products may have slightly modified structures and functions but show some residual 
resemblance of each other. These duplicated genes are then called paralogs. Paralogs 
resulted from gene duplication, are thought to be retained in the organism because of 
selective benefits. These genes may have overlapping functions in the initial period after 
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duplication, but this functional redundancy could diminish over the time, as these genes 
acquire more refined roles (Green et al., 2004).  
Many mite proteins with sizes around 15 kDa are allergenic, including the Groups 
2, 5, 13 and now Group 21 allergens. Due to the lack of genomic information, 
identification of new allergens using Immuno-blotting combined with standard molecular 
biology methods can be difficult and time consuming. Using EST approach (Angus et al., 
2004), our laboratory has previously identified putative allergens in the dust mite. 
Applying the similar approach, a novel Blo t 21 allergen of 13.5 kDa has been identified 
in this study. 
The concurrent IgE-binding responses to Group 21 and Group 5 allergens found 
in this study were consistently observed in other populations screened in our laboratory   
including allergic individuals from Italy and South Africa (data not shown) (Potter et al., 
2006).  We initially reasoned that this might be a result of either co-sensitization to both 
allergens, or cross-reactions through the presence of common epitopes (Sander et al., 
1997; Potter et al., 1991). However, both dose-response inhibition and quantitative 
inhibition studies showed that Blo t 21 and Blo t 5 are specific low-cross-reactive 
allergens. They also demonstrated low degree of cross-reactivity to the orthologues 
between species (Der p 5 and Lep d 5). This is in agreement with studies conducted 
elsewhere by other researchers (Chew et al., 1999b; Kuo et al., 2003). The scattered 
patches of identical amino acids across the whole length of Blo t 21, Der p 21 and other 
Group 5 allergens could be the basis for some cross-reactivities, but the inhibition data 
strongly support the idea that Group 21 is a distinct group of allergens. IgE antibody 
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responses to Blo t 21 are mainly elicited by specific epitopes, rather than cross-reactive 
epitopes on other Group 5 homologous allergens. 
The strong co-sensitization profile, not ascribed to antigen cross-reactivity, could 
then be due to at least two other reasons. Firstly, the Group 5 and Group 21 allergens 
could both cause sensitizations in susceptible individuals when present in the 
environment.  This is likely due to the wide distribution of Blo t 21 and Blo t 5 in the 
environment, although the ratio of Blo t 21: Blo t 5 can be different from one room to the 
other. Secondly, allergen-specific IgE responsiveness towards purified allergens has been 
shown in some cases to be restricted by certain HLA types and it is possible that immune 
responses to the two antigens are restricted by similar host factors.  Previous study in our 
laboratory has shown that HLA-DRB1*09 may be a marker of IgE non-responsiveness to 
Blo t 5 among patients in Singapore (Lee et al., 1998), but not to Der p 5.  Whether this is 
the case for Blo t 21 remains to be evaluated. 
Sequence diversity was found in the genomic DNA of both Blo t 21 and Blo t 5. 
Since Blo t 21 and Blo t 5 present as a single-copy in mite genome, the nucleotide 
substitutions are most likely resulted from the allele polymorphisms among different mite 
individuals, and not from multi-gene families of the mite. Using high fidelity Taq 
polymerase to amplify genomic DNA also ensured that the substitutions were resulted 
from sequence polymorphisms rather than PCR error.  Most substitutions in Blo t 5 
genomic DNA were silent changes with only two missense changes of amino acids 19 
and 23. These two amino acid substitutions are located closely in the N terminal of the 
mature protein. In contrast, half of the variations in the Blo t 21 genomic DNA were 
missense substitutions. Four amino acid substitutions were present at positions 33, 35, 59 
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and 69. Our observation of protein variants is in agreement with the finding of Blo t 5 
isoforms through Two-dimensional Western blotting (Yi et al., 2004). Whether these 
protein variants stimulate different IgE-binding in atopic patients is to be further 
investigated. Although polymorphisms of allergens in mites have been reported before, 
there were no reports for Group 5 and Group 21 polymorphisms prior to this study. It is 
well known that polymorphisms of Groups 1, 2 and 3 sequences were common in many 
mite species.  Group 1 substitutions were mostly missense changes with low frequency, 
while the polymorphisms of Group 2 allergens were conserved (Smith et al., 2001). Der p 
3 missense substitutions were found in two out of five cDNA clones. All these variants 
resulted from allele polymorphisms (Smith et al., 1996b). 
It has been noticed that charged and polar residues on the surface of protein 
molecules are important for IgE-binding, particularly for inhalant allergens (Chan et al., 
2006).  Blo t 21 and Blo t 5 both have more than 40% charged residues and 20% polar 
residues throughout the entire sequence. Such high percentage of solvent accessible 
residues could allow IgE antibodies to bind the proteins more readily.  
This study clearly showed that sensitization to Blo t 21 is important for B. 
tropicalis allergy, although most patients were co-sensitized to Blo t 5 at the same time. 
To prevent the B. tropicalis allergic diseases, effective allergen avoidance is necessary. 
Our Immuno-localization result revealed that both Blo t 21 and Blo t 5 were secreted 
from mite digestive system and mixed with feces in the hind-gut of dust mite, suggesting 
that Blo t 21 could be passed out with feces and become airborne particles in the 
environment. Although Blo t 21 and Blo t 5 levels in the environment were below the 
"threshold" concentration of Der p 1 for sensitization, low levels of exposure to mites 
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allergen is a risk for inducing sensitization, especially for individuals with positive family 
histories of allergy (Waner et al., 1996; Wahn et al., 1997; Huss, et al., 2001). 
In tropical regions like Singapore, weather conditions are suitable for mite 
proliferation. Due to relatively constant temperature and humidity, it is difficult to avoid 
dust mite completely in the environment. At this stage, allergen-specific immunotherapy 
(SIT) is the only potential specific treatment for IgE-mediated B. tropicalis allergy. In 
current clinical practice, aqueous extracts of dust mite are used for diagnosis and 
immunotherapy. However, natural allergen extracts consist of complex mixtures of 
allergenic and non-allergenic components. In addition, endotoxin has been found in the 
mite extracts from D. farinae and D. pteronyssinus (Trivedi et al., 2003; Finkelman et al., 
2006).  In order to improve the quality and consistency of vaccine, multi-component 
recombinant allergens can be used in diagnosis and treatment to enhance the clinical 
efficacy. Circular Dichroism Spectroscopy has confirmed that both rBlo t 21 and rBlo t 5 
are α-helical proteins. These two recombinant allergens also exhibited IgE-binding 
activities. Although IgE-binding activities of rBlo t 21 and rBlo t 5 were not compared 
with natural counterparts in this study, it has been reported that rBlo t 5 expressed in 
E.coli has comparable IgE-binding activity versus natural Blo t 5 (Yi et al., 2004). We 
believe that rBlo t 21 may also have comparable IgE-binding activity to its natural 
counterpart like rBlo t 5.  
Multiple recombinant allergen vaccine contains only relevant allergens for 
immunotherapy, and thus could reduce the side-effect caused by contamination of 
unrelated allergens or other reagents in conventional vaccine.  rBlo t 21 and rBlo t 5 
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produced in our laboratory may facilitate the substitution of  natural allergens in specific 
diagnosis and immunotherapy.  
In conclusion, we describe here a novel allergen from Blomia tropicalis, Blo t 21, 
that is able to elicit and bind specific IgE in more than 31% of atopic individuals and 
90% of patients with ongoing persistent allergic rhinitis. The allergencity of Blo t 21 is 
unique, although it shares some primary and secondary structure similarities to Blo t 5 
allergen. IgE-binding to this allergen does not cross react to Blo t 5. Blo t 21 is thus an 
important allergen in B. tropicalis, and should be taken into considerstion in the diagnosis 




The name Blo t 21 was accepted by the World Health Organization (WHO) / 
International Union of Immunological Societies (IUIS) Subcommittee of Allergen 
Nomenclature.  
The GenBank accession numbers for the nucleotide sequence encoding for Blo t 21 is 
AY800348. The GenBank accession numbers for seven Blo t 21 and nine Blo t 5 
genomic organizations variants are DQ788677-DQ788683 and DQ788684-DQ788692.  
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Chapter 4:    Effect of Temperature, pH and Chemical 
Denaturant on Blo t 5 and Blo t 21 IgE-binding  
 
4.1     Introduction 
Dermatophagoides pteronyssinus, Dermatophagoides farinae and Blomia 
tropicalis dust mites are the three most important allergen sources associated with 
hypersensitivity reactions in human beings. B. tropicalis and Dermatophagoides spp. are 
frequently found in house dusts in tropical and subtropical regions (Baqueiro et al., 
2006), while D. pteronyssinus and D. farinae are domestic mites in temperate regions. 
Groups 1 and 2 allergens are two most important allergens in D. pteronyssinus, as Der p 1 
and Der p 2 account for 50-65% of the total IgE antibodies in D. pteronyssinus sensitized 
asthma patients including low and high responders, and the prevalence of Der p 1 and 
Der p 2 in D. pteronyssinus positive patients are about 80% (Hales et al., 2006). Blo t 5 
and Blo t 21 are two most important allergens in B. tropicalis as mentioned in Chapter 3.  
B. tropicalis is the most frequently found dust mite in the rainy season of the 
tropical regions (Baqueiro et al., 2006; Chew et al., 1999). When dust samples from 459 
beds of Brazil residences were surveyed, the percentage of B. tropicalis and D. 
pteronyssinus were found to be 71.8% and 39.9%, respectively. When major allergens 
Der p 1 and Blo t 5 were further quantified by ELISA assay in the same samples, 10 
times lower concentration of Blo t 5 (geometric mean=2.8µg/g) was detected compared 
to that of Der p 1 (geometric mean=30.2 µg/g) (Baqueiro et al., 2006).   The lower 
concentration of Blo t 5 could be resulted from its low expression level in B. tropicalis 
/per mite or the instability of the allergen so that the protein was removed from 
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environment quickly. Nevertheless, Blo t 5 at 2.8µg/g in the environment was still above 
the sensitization threshold of dust mite and thus induced high frequency of sensitization 
in the atopic subjects. To understand the mechanism behind this, stabilities of IgE-
binding activities of Blo t 5 and Blo t 21 were investigated in this chapter. 
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4.2    Results 
4.2.1    Effect of thermal treatment on IgE-binding activities of Blo t 5 and Blo t 21 
IgE-binding activities of Blo t 5 and Blo t 21 were retained after thermal 
treatment.   Figure 4.1A showes that there is no significant difference of the IgE-binding 
activities between treated and non-treated Blo t 5 in sera of seven pre-selected subjects 
with two high reactors to Blo t 5 (OD450 >2.0), two medium reactors to Blo t 5 
(OD450=1.0 ∼2.0), two low reactors (OD450>0.4) to Blo t 5, and one healthy subject as 
negative control). Similar results were observed from the IgE-binding activity of heat 
treated Blo t 21 allergen (Figure 4.1B). Hence, both IgE-binding epitopes of Blo t 5 and 
Blo t 21 are thermal stable.  
The thermal resistance of IgE-binding to Blo t 5 and Blo t 21 could be due to their 
linear epitopes that are recognized by IgE antibodies. The recognition of IgE antibodies 
to linear epitopes depends only on their amino acid sequence rather than the tertiary 
structure of the allergen. Thermal stability of Blo t 5 and Blo t 21 structures could be 
another reason for the thermal stability of their IgE-binding, so that the conformational 
epitopes of these allergens are retained after thermal treatment.  In order to study the 
effect of heat treatment on the conformations of Blo t 5 and Blo t 21, the secondary 
structure changes in the protein were monitored by circular dichroism analysis in the next 
section.  
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Figure 4.1    IgE-binding activities of heat treated Blo t 5 (A) and Blo t 21 (B) in six sera 
of atopic subjects and one sera of non-atopic healthy subject. 
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4.2.2    Effect of thermal treatment on Blo t 5 and Blo t 21 folding 
The thermal stabilities of Blo t 5 and Blo t 21 were assessed by measuring 
changes of circular dichroism spectrum with increasing temperature from 10 °C to 90 °C. 
Firstly, the temperature dependency of the circular dichroism signals at various 
temperatures were recorded at 222 nm. This wavelength was chosen because Blo t 5 and 
Blo t 21 have negative peaks at this wavelength and the ellipticity of this wavelength is 
also important for monitoring the α-helix structure. Hence, any changes in the α-helix 
structure of Blo t 5 and Blo t 21 allergens can be detected upon thermal treatment.  It can 
be seen from Figure 4.2 that a smooth sigmoid curve of the ellipicity of Blo t 5 was 
recorded at various temperatures. From 10-40°C, the ellipicity of Blo t 5 slowly increased 
with increasing temperature. Above 40 °C, an exponential increase of the ellipicity was 
observed until a plateau was reached at 70 °C. In contrast, the ellipicity of Blo t 21 
slightly increased when temperature was changed from 10 to 60 °C, dramatically 
increased at 70 °C and stopped changing when temperature reached 80 °C.  Above 80 °C, 
Blo t 21 completely lost its α-helix content.  
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Figure 4.2   Far-UV CD spectrum of Blo t 21 and Blo t 5 at 222 nm recorded at 
temperatures from 10 °C to 90 °C.  
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The thermal stability of Blo t 5 and Blo t 21 structures was further examined by 
recording the circular dichroism spectra at 20, 50, 70 and 90 °C. After heat denatured, the 
proteins were cooled down to 20 °C, their CD spectra were recorded again and compared 
to the un-treated protein. Figure 4.3 illustrates that the alternation of the circular 
dichroism spectra occurred when Blo t 5 and Blo t 21 were denatured by thermal 
treatment. When temperature increased, the intensity of CD spectra of Blo t 5 and Blo t 
21 decreased. The temperature-induced loss of α-helical structure of Blo t 5 was 
reconfirmed at 70 °C, as the minimal peak was shifted to a shorter wavelength above this 
temperature. Once temperature was brought back to 20 °C, the CD spectrum of Blo t 5 
showed a profile similar to that of the untreated protein.  As shown in Figure 4.3, the 
reduction of the negative peak at 222 nm of the protein cooled down from thermal 
treatment indicated that Blo t 5 was partially refolded.  
The parallel experiments showed that Blo t 21 structure was also very stable as its 
CD spectrum at 50°C was almost the same as that at 20 °C. However, the intensity of CD 
spectrum was decreased at 70 °C, indicating the loss of its α-helix content at this 
temperature. The CD spectrum of Blo t 21 at 90°C lost its minimal peaks at 208 and 
222nm, which indicated that Blo t 21 had completely lost its structure at this temperature.  
However, when the protein was cooled down to 20 °C, part of its α-helix structure was 
recovered. Its CD profile after denaturing was similar to that at 70 °C. Therefore, Blo t 21 
was not completely refolded after heat denaturation.  
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Figure 4.3    CD spectrum of Blo t 5 (A) and Blo t 21
°C, 90 °C and after cooling down to 20 °
260 nm.  
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4.2.3    Resistance of IgE-binding of Blo t 5 and Blo t 21 to acid, alkaline and urea 
treatment 
The IgE-binding activities of Blo t 5 and Blo t 21 are resistant to acid, alkaline 
and chemical denaturant urea (6 M). The proteins of Blo t 5 and Blo t 21 were first 
adjusted to variant pH conditions from pH 4.0 to pH 9.5 for 2 hours before their specific 
IgE-binding activities were tested. Due to insufficient amount of sera, we were not able to 
use exactly the same batch of sera for both thermal stability and pH susceptibility studies. 
In this study, seven sera positive to both Blo t 5 and Blo t 21 were used with a serum 
from non-atopic healthy volunteer as negative control.   Results showed that IgE-binding 
activites of both Blo t 5 and Blo t 21 were not affected by pH conditions in the range 
from 4 to 9.5. The ELISA reading of OD450 of two proteins showed no significant 
difference at various pH conditions including neutral condition as shown in Figure 4.4(A) 
and (B). The extreme pH conditions were then introduced to test the pH susceptibility of 
Blo t 5 and Blo t 21 allergens.  100 mg/ml of proteins were suspended in 20 mM HCl (pH 
2), 20 mM NaOH (pH 12) and phosphorated buffer (pH7.5) for 4 hours and then coated 
on Maxisop plate with 1 mg/ml concentration in coating buffer. From Figures 4.5 A and 
B, it can be seen that even after Blo t 5 and Blo t 21 were treated under extreme pH 
conditions, the ELISA readings were still the same as those proteins under neutral 
condition. Hence, IgE-binding activities of Blo t 5 and Blo t 21 were stable under a broad 
range of pH conditions from pH 2 to pH 12.   
In addition, the susceptibilities of Blo t 5 and Blo t 21 to 6 M urea were assayed 
as well. The proteins were suspended in 6 M urea for two hours and then coated on 
ELISA plate for assay. Results were integrated in Figures 4.4 and 4.5. ELISA reading of 
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urea-treated and un-treated (in pH7.5 neutralized buffer) Blo t 5 and Blo t 21 showed no 
significant difference. Blo t 5 and Blo t 21 still retained their IgE-binding activities when 
the allergens were treated with 6 M urea.  
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Figure 4.4       IgE-binding activities of urea, acid and alkaline treated Blo t 5 (A) and 
Blo t 21 (B) at different pH ranges from pH 4 to 9.5. 
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Blo t 21-6M Urea
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Figure 4.5       IgE-binding activities of urea, acid and alkaline treated Blo t 5 (A) and 
Blo t 21 (B) at pH 2, 7.5 and 12.  
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4.3     Discussion 
 
The IgE-binding activities of both Blo t 5 and Blo t 21 are resistant to thermal 
treatment. Even after the proteins were treated at 90 °C, their IgE-binding abilities were 
not affected, despite some loss of the secondary structure contents. This study also 
showed that Blo t 21 is a thermal-stable protein. It maintains its secondary structure up to 
60 °C. After heat denaturing, its secondary structure can be partially refolded. Hence, Blo 
t 21 major epitopes would present as liner epitopes. Similar to Blo t 21, IgE-binding of 
Blo t 5 is also thermal stable. In addition, more secondary structures were regained after 
heat denaturing.  In contrast, Group 1 and Group 2 allergens are sensitive to thermal 
treatment. IgE-binding of Der p 1 and Der f 1 decreased more than 100 folds after 
proteins underwent treatment at temperatures above 75 °C, and Group 2 lost about 2-fold 
of IgE-binding activity after the thermal treatment (Lombardero, et al., 1990). Heat 
denaturation of ProDer p 1 also drastically reduced IgE-binding activity toward human 
allergic sera using direct ELISA method (Magi et al., 2004). Thus, IgE-binding activities 
of Blo t 5 and Blo t 21 are more stable against thermal denaturation than those of Der p 1 
and Der p 2.  
IgE-binding activities of Blo t 5 and Blo t 21 are also resistant to the changes of 
pH conditions. Even at pH 2 and pH 12, these two allergens still retain their full IgE-
binding activities. Group 2 from Dermatophagoides spp. is resistant to pH conditions. 
Same degree of inhibition of mAb and IgE antibody was found among Der p 2 at pH 2, 
pH 12 and pH 7.4 conditions.  In contrast, Der p 1 is sensitive to acid treatment 
(Lombardero, et al., 1990). At pH 2, the IgE and IgG binding activities to Der p 1 were 
reduced by 100-1000 folds when compared to proteins at neutral condition (pH 7.4). 
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Thus, IgE-binding activities of Blo t 5 and Blo t 21 are more resistant to pH changes than 
Der p 1. Although the secondary structures of Blo t 5 and Blo t 21 between pH 2 and pH 
12 were not measured by circular dichroism spectrum in this study, the similar α-helical 
structure of Der p 5 between pH 2 and pH 11 (Liaw et al., 2001) implies that the 
secondary structure of Blo t 5 and Blo t 21 may not significantly change as well.   
This study has also demonstrated that IgE-binding activity of Blo t 5 and Blot 21 
are resistant to 6 M urea treatment.   Urea is a strong protein denaturant. 6M urea treated 
Der p 1 and Der f 1 lost part of their IgE reactivitis. 39% and 45% of cross-inhibitions of 
urea-treated Der p 1 and Der f 1 to their native proteins were observed when full self-
inhibitions were achieved (Lombardero, et al., 1990). Thus, allergenicities of Blo t 5 and 
Blo t 21 are more resistant to urea-treatment than that of Der p 1.  
IgE-binding epitopes of Blo t 5 and Blo t 21 are more stable than Der p 1 and Der 
p 2. There seems to be no influence of thermal, pH and denaturant treatment on the IgE-
binding reactivities of Blo t 5 and Blot 21. Thus, it can be speculated that the IgE-binding 
epitopes of Blo t 5 and Blo t 21 could be mainly liner epitopes or conformational epitopes 
located in the structure of the proteins that can be refolded. The core structures of Blo t 5 
and Blo t 21 could be regained after heat, extreme pH and denaturant treatment. The 
stability of IgE-binding epitopes of Blo t 5 and Blo t 21 would be important for the 
clinical applications of these two allergens, such as dust sample monitoring for allergen 
avoidance and mite extracted preparation for diagnosis and treatment. 
The stability of IgE-binding epitopes of Blo t 5 could also be used to explain why 
relatively low concentration of Blo t 5 in the environment can induce high frequency of 
sensitization in the atopic subjects. In contrast, due to its susceptibility to denaturation, 
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Der p 1 allergen in the environment may not necessarily retain its full IgE-binding 
activity. Thus, higher amount/concentration of Der p 1 in the environment might be 
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Chapter 5:  Identification and Characterization of Der f 21: a 
Der f 5 Homologue    
 
5.1      Introduction 
House dust mite Dermatophagoides spp. was recognized as the most important 
source of house dust allergens 30 years ago (Voorhorst et al., 1964). Since then, multiple 
epidemiological studies have demonstrated dose-response relationships between exposure 
and sensitization to mite allergens. Sensitization to mite allergens is strongly associated 
with the prevalence of allergic asthma in many countries (Arlian and Platts-Mills, 2001).  
D. farinae, originally known as American house dust mite, is highly prevalent in 
the temperate regions worldwide, such as the United States (Arlian et al, 1992), Poland 
(Solarz, 1998), Italy (Bigliocchi et al., 1996), Germany (Kuher et al., 1994), France 
(Dornelas de Andrade et al., 1995), United Kingdom (Doull et al., 1997), Portugal 
(Placido et al., 1996), Denmark (Mosbech et al., 1991), Korea (Ree et al., 1997), Hong 
Kong (Leung et al., 1997) , Taiwan (Chang and Hsieh, 1989) and Thailand (Malainual et 
al., 1995). Surveys in the United States demonstrated that most homes contained both D. 
farinae and D. pteronyssinus in many locations like Florida (Fernandez-Caldas et al, 
1990), Virginia (Platts-Mills et al. 1987) and California (Mulla et al., 1975), although 
some homes had predominantly D. farina, and some had mostly D. pteronyssinus. Up to 
now, twenty-one groups of dust mite allergens have been identified, 16 groups of 
allergens have been reported in D. pteronyssinus, and 12 groups of allergen have been 
found in D. farinae. IgE responses to a panel of nine D. pteronyssinus allergens revealed 
that Der p 1 and Der p 2 were major allergens of D. pteronyssinus, Der p 4, Der p 5, and 
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Der p 7 were moderate allergens, while Der p 3, 8, 10 and 20 were minor allergens with 
low IgE prevalence and low IgE titters in allergic asthmatic patients (Hales et al. 2006). 
The quantitative comparison of the IgE-binding among allergens of D. farinae has not 
been studied yet. 
Recently, Der p 21 was released from Genbank database as a new putative 
allergen. Its allergenicity has not been characterized. In our local D. farinae EST 
database, a cDNA was found homologous to Der p 21 and its deduced protein sequence 
has 66.4% identity to Der p 21. Based on the Food and Agriculture Organization – World 
Health Organization (FAO/WHO) (2001) criteria for potential allergenicity, we proposed 
that this antigen might be allergenic. In this study, we aim to characterize Der f 21 in 
terms of its gene organization, human IgE-binding ability and cross-reactivity to Blo t 21, 
Blo t 5, Der f 5, and Der p 5. 
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5.2          Results     
5.2.1      Identification of a novel homologous Group 5 allergen-Der f 21 from D. 
farinae EST database 
Using local TBLASTN (Basic Local Alignment Search Tool) algorithm, Der f 5 
protein sequence was compared with D. farinae Expressed Sequence Tags (ESTs) 
generated from our laboratory (Angus et al., 2004). One D. farinae EST was found to 
have a deduced protein sharing approximately 36% amino acid identity and 55% 
similarity to Der f 5 sequence (accession no.BAE45865) in the genbank. This EST 
sequence contains an open reading frame (ORF) of 411 bp encoding Der f 21♣ with 136 
amino acids.   It has a putative 17-amino acid signal peptide (predicted by SignalP v3.0 
(Bendtsen et al., 2004) (Figure 5.1), suggesting that Der f 21 is a secreted protein.  The 
calculated molecular weight of the mature protein is 14.2 kDa, with a predicted 
isoelectric point of 4.64, and a predicted majority alpha-helical secondary structure 
(PredictProtein, http://cubic.bioc.columbia.edu/predictprotein/) (Figure 5.2).   
Der f 21 protein sequence, its orthologue – Der p 21 (accession no. ABC73706), 
Blo t 21 (accession No. AY800348) and their Group 5 counterparts were aligned using 
ClustalW solfware (Thompson et al., 1994) (Figure 5.3). Pairwise alignments showed 
that Der f 21 shared 66.4% amino acid sequence identity (77.9% similarity) to Der p 21, 
37.5%  identity (59.6% similarity) to Blo t 21,  but only 28.7% identity (41.2% similarity) 
to Der f 5, 29.4% identity (44.9% similarity) to Der p 5 and 41.2% identity (53.7% 
similarity) to Blo t 5. In contrast, Der p 21 shared 41% amino acid identity (59% 
similarity) to Blo t 21, 30.7% identity (45% similarity) to Der p 5, 32.6% identity 
                                                 
♣ Accession No. AY800348 
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1         GTGAAACATTAAATCAATCGAATCAAAAACAACGACAAAAAAAATTTTGAAAAATGAAAT 
                         M  K    
 
61        TCATTATTTTCTGTGCCATTGTAATGGCTGTTTCTGTTTCCGGTTTCATCGTTGATGTCG 
          F  I  I  F  C  A  I  V  M  A  V  S  V  S  G  F  I  V  D  V    
 
121       ATACAGAAGATAAATGGCGTAATGCATTCGATCATATGTTGATGGAAGAATTTGAAGAGA 
          D  T  E  D  K  W  R  N  A  F  D  H  M  L  M  E  E  F  E  E    
 
181       AAATGGATCAAATCGAACATGGCCTACTTATGCTCAGTGAACAATATAAAGAATTGGAAA 
          K  M  D  Q  I  E  H  G  L  L  M  L  S  E  Q  Y  K  E  L  E    
 
241       AAACCAAAAGCAAAGAATTAAAAGAACAAATTCTTCGTGAATTGACAATCGCAGAAAACT 
          K  T  K  S  K  E  L  K  E  Q  I  L  R  E  L  T  I  A  E  N    
 
301       ATTTGCGTGGTGCCTTGAAATTCATGCAACAGGAGGCTAAACGTACCGATTTAAATATGT 
          Y  L  R  G  A  L  K  F  M  Q  Q  E  A  K  R  T  D  L  N  M    
 
361       TCGAACGTTATAACTTTGAAACAGCAGTGTCAACTATCGAAATATTGGTTAAAGATTTGG 
          F  E  R  Y  N  F  E  T  A  V  S  T  I  E  I  L  V  K  D  L    
 
421       CTGAATTGGCCAAAAAAGTTAAAGCTGTAAAATCGGATGATTAAATACAATCCACAATTT 
          A  E  L  A  K  K  V  K  A  V  K  S  D  D     
 
481       AATATAACACAATTTTCATCATCAACATCCCGGAAATAATTATAATATAAAAGACGAAAA 
 
541       ATTTTGAAGAAATAACCG 
 
 
Figure 5.1      cDNA and deduced protein sequence of Der f 21. Start and stop codons of 
the open reading frame are boxed. The signal peptide of protein sequence 
is underlined.  
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Figure 5.2       Predicted secondary structure of Der f 21 by PredictProtein 
(http://cubic.bioc.columbia.edu/predictprotein/).  represents α helix.  
 represents the confidence of prediction.  represents random  
coil. H: helix;  C: coil.  
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10 20 30 40 50
. . . . | . . . . | . . . . | . . . . | . . . . | . . . . | . . . . | . . . . | . . . . | . . . . |
Der f 21 M K F I I - - F C A I V M A V S V S G F I V D V D T E D K W R N A F D H M L M E E F E E K M D Q I E
Der p 21 M K F I I T L F A A I V M A A A V S G F I V G D K K E D E W R M A F D R L M M E E L E T K I D Q V E
Blo t 21 M K F I I A L A A L I A V A C A L P - - - - - - V S N D N F R H E F D H M I V N T A T Q R F H E I E
Der f 5 M K F I I A I A V C T L A V V C V S G - - - - E P K K H D Y Q N E F D F L L M Q R I H D Q M R K G E
Der p 5 M K F I I A F F V A T L A V M T V S G - - - - E D K K H D Y Q N E F D F L L M E R I H E Q I K K G E
Blo t 5  M K F A I V L I A C F A A S V L A Q E H K - - - P K K D D F R N E F D H L L I E Q A N H A I E K G E
60 70 80 90 100
. . . . | . . . . | . . . . | . . . . | . . . . | . . . . | . . . . | . . . . | . . . . | . . . . |
Der f 21 H G L L M L S E Q Y K E L E K T K S K E L K E Q I L R - E L T I A E N Y L R G A L K F M Q Q E A K R
Der p 21 K G L L H L S E Q Y K E L E K T K S K E L K E Q I L R - E L T I G E N F M K G A L K F F E M E A K R
Blo t 21 K F L L H I T H E V D D L E K T G N K D E K A R L L R - E L T V S E A F I E G S R G Y F Q R E L K R
Der f 5 E A L L H L H - Q I N T F E E N P T K E M K E Q I L A S E M D T I I A L I D G V R G V L N R L M K R
Der p 5 L A L F Y L Q E Q I N H F E E K P T K E M K D K I V A - E M D T I I A M I D G V R G V L D R L M Q R
Blo t 5  H Q L L Y L Q H Q L D E L N E N K S K E L Q E K I I R - E L D V V C A M I E G A Q G A L E R E L K R
110 120 130 140
. . . . | . . . . | . . . . | . . . . | . . . . | . . . . | . . . . | . . . . | .
Der f 21 T D L N M F E R Y N F E T A V S T I E I L V K D L A E L A K K V K A V K S D D - -
Der p 21 T D L N M F E R Y N Y E F A L E S I K L L I K K L D E L A K K V K A V N P D E Y Y
Blo t 21 T D L D L L E K F N F E A A L A T G D L L L K D L K A L Q K R V Q D S E - - - - -
Der f 5 T D L D I F E R Y N V E I A L K S N E I L E R D L K K E E Q R V K K I E V - - - -
Der p 5 K D L D I F E Q Y N L E M A K K S G D I L E R D L K K E E A R V K K I E G - - - -
Blo t 5  T D L N I L E R F N Y E E A Q T L S K I L L K D L K E T E Q K V K D I Q T Q - - -
 
 
Figure 5.3    Multiple alignments of protein sequences of Der f 21, Der p 21, Blo t 21, 
Der f 5, Der p 5 and Blo t 5. Identical and similar sequences are shaded in 
black and gray respectively. 
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 (45.5% similarity) to Der f 5 and 39.3% identity (50.7% similarity) to Blo t 5. From 
studies on Der f 5, we found that Der f 5 has higher amino acid identity to Der p 5 (75.2% 
identity) than to Der f 21 (28.7% identity). 
Neighbor-Joining (NJ) phylogenetic tree built by DNAMAN (Lynnon BioSoft, 
Canada) showed that Group 21 allergens and Group 5 allergens clustered in two major 
clades (Figure 5.4).  Group 21 and Group 5 allergens are from the same Pyroglyphidae 
family cluster in the same sub-clade. The Phylogenetic tree clearly indicated that Group 
21 and Group 5 allergens of Dermatophagoides pteronyssinus, D. farinae and Blomia 
tropicalis were originated from duplicated allergen before speciation. However, no clear 
conserved domain could be observed within and between the Group 21 and Group 5 
protein sequences.  
 
5.2.2      Genomic organization of the gene encoding Der f 21 and Der f 5 
Genomic organizations of Der f 21 and Der f 5 were amplified by PCR method 
and cloned into the pGEMT vector and subsequently sequenced. Sequences of ten 
individual clones showed that Der f 21 has an intron that interrupts amino acid 17 of the 
protein. The introns of 6 individual clones were 58 base pairs long, while the other four 
had an extra T insertion at intron position of 26. Among ten individual clones, clones 2, 3 
and 4 were identical. There were 10 nucleotide variants in the entire genomic sequence, 
including two variants in the intron and the remaining eight in the exon regions. Six exon 
substitutions affected the amino acids that they were coding for. Protein variants occurred 
once at N30 to G, once at E41 to G, four times at M44 to I, once at L61 to S, once at L69 
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Figure 5.4       Phylogenetic tree of Group 5 and Group 21 allergens in three important 
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to P and once at S113 to P. In addition, protein sequences deduced from 10  genomic 
DNA clones of Der f 21 were different from that deduced from cDNA at  position 34 
(R>H)  (Table 5.1).  
In contrast, out of ten Der f 5 genomic DNA clones, seven had a 65 base pairs 
intron and three had an extra insertion of T in the intron. Intron disrupted amino acid 14 
of the protein. Among sequences obtained from 10 clones, five from clones 1, 2, 8, 9, 10 
were identical. In total, six substitutions were found in the exon region and four 
substitutions resulted in protein variants. The variants were at K22>E, R43>K, K68>E 
and T77>A, and all of them occurred only once in the 10 clones. Der f 5 protein sequence 
deduced from cDNA was also slightly different from that deduced from genomic DNA. 
There were two substitutions of E40>D and G73>A and one deletion of Q53. The 
insertion of additional three nucleotide acids in the cDNA sequence resulted in the 
replacement of G72 with A and S (Table 5.2). Figure 5.5 compares the genomic DNA 
sequences of Der f 21 and Der f 5. It can be seen that both Der f 21 and Der f 5 have one 
intron and their intron-exon splice borders are in agreement with the GT-AT rule (Mount, 
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g75 -- ttt tttt (i26) Intron 2,3,4,8 40% 
g130 24 act/T aca/T Exon 1,6,7,9 40% 
g146-147 30 aat/N ggt/G Exon 10 10% 
g164 36 ttg/L ctg/L Exon 10 10% 
g181 41 gaa/E gga/G Exon 1 10% 
g190 44 atg/M att/I Exon 1,6,7,9 40% 
g240 61 ttg/L tcg/S Exon 6 10% 
g395 113 tca/S cca/P Exon 8 10% 
c101 34 cgt/R cat/H cDNA cDNA 10% 
 
gDer f 21.0101 refers to the sequence of genomic DNA clones 2, 3, 4. g represents 
genomic DNA, and c represents cDNA. The polymophic amino acid is in red. 
 
 








(gDer f 5. 
0101) 





g49 -- ttt tttt (i9)  Intron 4, 5, 7 30% 
g54 -- cgt cgc ( i15) Intron  11 10% 
g129 22 aaa/K gaa/E Exon 3 10% 
g193 43 aga/R aaa/K Exon 5 10% 
g206 47 gag/E gaa/E Exon 4, 5 20% 
g267 68 aaa/K gaa/E Exon 6 10% 
g275 70 cag/Q caa/Q Exon 5, 7 20% 
g294 77 act/T gct/A Exon 5 10% 
c120 40 gaa/E gac/D Exon cDNA 10% 
c141 47 gag/E gaa/E Exon cDNA 10% 
c159 53 caacat/QH cat/H Exon cDNA 10% 
c215 72 ggt/G gcaagt/AS Exon cDNA 10% 
 
gDer f 5.0101 refers to the sequence of genomic DNA clones 1, 2, 8, 9, 10. g represents 
genomic DNA, and c represents cDNA. The polymophic amino acid is in red. 
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                   10        20        30        40        50        60
          ....|....|....|....|....|....|....|....|....|....|....|....| 
gDer f 21  ATGAAATTCATTATTTTCTGTGCCATTGTAATGGCTGTTT-CTGTTTCCGGTTTGTAAAT  
gDer f 5   ATGAAATTCATCATT------GCTATTG------CTGTTTGCACTTTGGC----------  
                   70        80        90       100       110       120 
          ....|....|....|....|....|....|....|....|....|....|....|....| 
gDer f 21  TTTGTAAGTTTTTTTTGGAAATAATAACCAATCTTCTGTTCATTTTAGGT----------  
gDer f 5   ------------------------------------------------CGGTAAGTTTTC  
                  130       140       150       160       170       180 
          ....|....|....|....|....|....|....|....|....|....|....|....| 
gDer f 21  -------------------------------------------------------TTCAT  
gDer f 5   CCGTAATTATTTTCTTACCCATTCTAATCTGATAAAATTTTCCAATTCTTCTCAGTTGT-  
                  190       200       210       220       230       240 
          ....|....|....|....|....|....|....|....|....|....|....|....| 
gDer f 21  CGTTGATGTCGATACAGAAGA---TAAATGGCGTAATGCATTCGATCGTATGTTGATGGA  
gDer f 5   ATGCGTTTCGGGTGAACCAAAAAAACATGATTATCAAAATGAATTTGATTTTCTTCTCAT  
                  250       260       270       280       290       300 
          ....|....|....|....|....|....|....|....|....|....|....|....| 
gDer f 21  A-GAATT-TGGAGAGAAAATTGATCAAATC-GAACATGGCCTACTTA--TGCTCAGTGAA  
gDer f 5   GCAACGTATCCATGAACAGATGAGAAAAGGAGAAGA-GGCATTGTTACATCTTCAAC-AT  
                  310       320       330       340       350       360 
          ....|....|....|....|....|....|....|....|....|....|....|....| 
gDer f 21  CAATATAAAGA-ATTGGAA-AAAACCAAAAGCAAAGAATTAAAAGAACAAATTCTTCG-T  
gDer f 5   CAA-ATTAACACATTCGAAGAAAACCCAAC-CAAAGAGATGAAAGAACAGAT-CTTAGGT  
                  370       380       390       400       410       420 
          ....|....|....|....|....|....|....|....|....|....|....|....| 
gDer f 21  GAATTG---AC-A--ATCGCA--GAAA-ACTATTTGCGTGGTGCCTTGAAATTCATGCAA  
gDer f 5   GAAATGGATACTATTATTGCACTGATCGACGGTGTTCGTGGTGTTTTGAA--TCGTCTTA  
                  430       440       450       460       470       480 
          ....|....|....|....|....|....|....|....|....|....|....|....| 
gDer f 21  CAGGAGGCTAAACGTACCGATTTAAATATGTTCGAACGTTATAACTTTGAAACAGCAGTG  
gDer f 5   T--GAAACGTACC-----GATTTGGACATATTTGAACGATATAACGTAGAAATTGCATTG  
                  490       500       510       520       530       540 
          ....|....|....|....|....|....|....|....|....|....|....|....| 
gDer f 21  TCAACTATCGAAATATTGGTTAAAGATTTGGCTGAATTGGCCAAAAAAGTTAAAGCTGTA  
gDer f 5   AAATCTAATGAAATATTGG--AACGTGAT--CTTAA-----AAAAGAAGAACAACGTGTT  
                  550       
          ....|....|....|... 
gDer f 21  AAATCGGATGATTAA     
gDer f 5   AAAAAGATTGAAGTTTGA
Figure 5.5       Pairwise alignment of genomic DNAs of Der f 21 and Der f 5. Identical 
sequences are shaded in black. The GT-AG intron borders were 
underlined.  
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5.2.3      Southern blotting of Der f 21 and Der f 5 
Der f 21 and Der f 5 genes were further examined in D. farinae using Southern 
blotting. Upon hybridization, different banding patterns for Der f 21 and Der f 5 were 
observed and a single hybrid band for both genes was detected in each lane loaded with 
different enzyme digested D. farinae genomic DNA (Figure  5.6). Hence, Der f 21 and 
Der f 5 were located at different loci of the D. farinae genome with a single-copy. The 
nucleotide substitutions in the genomic sequences observed earlier were likely due to 
polymorphisms among different mite individuals rather than different copies of the gene 
in each mite.  
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Figure 5.6       Southern blot analysis of Der f 21 and Der f 5 genes in mite genome. 
Genomic DNA was digested with restriction enzymes, Hind III and EcoR 
V, respectively. 
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5.2.4      Secondary structures of Der f 21 and Der f 5 
Recombinant Der f 21 and Der f 5 were expressed and purified from E. coli. SDS-
PAGE electrophoresis bands of the purified recombinant Der f 21 and Der f 5 proteins 
were about 14 kDa (Figure 5.7A), corresponding to their respective deduced molecular 
weights: Der f 21 (13 kDa) and Der f 5 (13.5 kDa).  
To evaluate whether the recombinant proteins were properly folded after 
purification, far UV circular dichroism (CD) spectra of both rDer f 21 and rDer f 5 were 
measured. The CD profiles of both rDer f 21 and rDer f 5 revealed a typical α-helix 
structure of protein (Figure 5.7B) with two maximum negative peaks at 208 and 222 nm 
and one positive peak at 192 nm. The observed secondary structures were similar to those 
predicted from the amino acid sequences at PredictProtein server, as well as the Der p 5 
secondary structure published previously by Liaw et al. (2001). The CD spectra profiles 
indicated that both recombinant Der f 5 and Der f 21 properly folded in solution, and also 
shared similar secondary structures. 
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Figure 5.7       Expression of recombinant Der f 21 and Der f 5 allergens and their far UV 
CD spectra.  (A)  Protein profile of recombinant Der f 5 and Der f 21 
separated on 15% SDS-PAGE gel. (B)  Far UV CD spectra of rDer f 5 and 
rDer f 21 proteins in phosphate buffer (pH7.4). 
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5.2.5       IgE-binding of Der f 21 and Der f 5 in consecutive atopic individuals in 
Singapore 
 
Specific IgE antibodies to Der f 21, Der f 5, together with a panel of 9 allergens 
from D. farinae, were measured using semi-quantitative immuno-dot blot assay♣. Among 
181 consecutive atopic individuals attending outpatient allergy clinics in a period of one 
year and a half, 74 were positive to D. farinae extract.  Fourteen individuals (19% of D. 
farinae positive individuals) responded to Der f 21, and the same number of individuals 
responded to Der f 5. Twelve out of 14 sera responding to Der f 21 also responded to Der 
f 5. In general, specific IgE antibodies toward Der f 21 were lower than those of Der f 5 
(Figure 5.8).  
In a panel of 12 recombinant allergens of D. farinae tested among 74 atopic 
individuals positive to D. farinae, Der f 21 and Der f 5 were the second most prevalent 
allergens following Der f 2 in this population (Figure 5.9), suggesting that Der f 21 is an 
important allergenic component of D. farinae. Comparison of the IgE-binding capacities 
of Der f 2 and Der f 21 revealed that 64% (9/14) of Der f 21 positive sera strongly 
responded to Der f 2 (Figure 5.10). These sera had higher Der f 2 titer than Der f 21. 
However, 34% of sera only reacted to Der f 21, but not to Der f 2.  
 
 
                                                 
♣ Semi-quantitative immuno-dot blot assay was performed by Tay Angeline, and ten D. farinae allergens 
included in this screening were cloned by Dr. Ong Siew Then and Dr. Shang Huishen. 
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Figure 5.8      Comparison of the specific IgE levels against Der f 21 and Der f 5 assessed 
by dot blot immunoassay in sera of 74 D. farinae positive subjects 
attending outpatient allergy clinics over one and a half years. Grey lines 














































Figure 5.9      Frequencies of IgE-binding to a panel of 12 recombinant allergens of D. 
farinae in 74 mite positive subjects.  
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Figure 5.10   Comparison of the specific IgE levels against Der f 21 and Der f 2 
assessed by dot blot immunoassay in sera of 74 D. farinae positive 
subjects attending outpatient allergy clinics over one and a half years. 
Grey lines indicate negative cut-off for the assay.   
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 The allergenicities of Der f 21 and Der f 5 were further evaluated using direct 
ELISA in thirty adult patients with ongoing persistent allergic rhinitis (R1-R31) who 
were positive to B. tropicalis, D. pteronyssinus and D. farinae and two non-atopic 
healthy volunteers. The characteristics of patients were described in Chapter 2 Material 
and Methods. Twenty-five out of thirty patients (83%) had specific IgE response to Der f 
21, while twenty-eight patients (93%) had specific IgE to Der f 5 (Figure 5.11). Patients 
responding to Der f 21 also specifically responded to Der f 5. Compared with the results 
obtained in previous section, allergenicities of Der f 5 and Der f 21 were found more 
prevalent in patients with severe allergic rhinitis disease than in consecutive atopic 
individuals.  
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Figure 5.11  Bi-plot comparison of specific IgE levels against Der f 21 and Der f 5 
assessed by ELISA in sera of 30 patients with ongoing persistent allergic 
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5.2.7   Dose-response cross-inhibitions of Der f 21 and Der f 5  
The dose-response inhibitions of Der f 21 and Der f 5 to each other, as well as to  
Der p 5, Blo t 5 and Blo t 21, were further evaluated using ELISA in three sera positive to 
both Der f 21 and Der f 5. These sera were selected from the immunoarray screening. It 
can be seen from Figure 5.12 that heterogeneous inhibition curves of Der f 21 were much 
lower than the self-inhibition curves in two of three patients tested individually. Der f 21 
self-inhibition occurred at a very low concentration (0.01 µg/ml) of inhibitor and 
achieved full self-inhibition at 100 µg/ml. In contrast, heterogeneous inhibition occurred 
after the inhibitor concentration reached 10 µg/ml, and could only achieve 34%-68% for 
Blo t 21, 14%-41% for Der f 5, 29%-52% for Der p 5, and 15%-38% cross-reactive with 
100 µg/ml of inhibitor. Similar observation was obtained in these two sera when Der f 5 
was immobilized on the solid surface (Figure 5.12 B).  
In addition, high degree of cross-reactions of Der f 5, Der f 21, Blo t 5, Blo t 21 
and Der p 5 were observed in one patient. As shown in the inhibition curve measured 
from the sera of patient V3, both Der f 21 and Der f 5 were completely inhibited by Blo t 
21 and Blo t 5, and partially inhibited by Der p 5. The heterogeneous inhibitions of Blo t 
5 and Blo t 21 were even stronger than self-inhibitions of Der f 21 and Der f 5. Hence this 
patient was predominantly sensitized by Blo t 21 and Blo t 5, and then cross-reactive to 
Der f 21 and Der f 5. Knowing that B. tropicalis is a local predominant mite, it is not 
surprising to see this phenomenon.  
Partial inhibitions between Der f 5 and Der p 5 were observed in all three sera, 
suggesting that even though Der f 5 is closer to Der p 5 than to Blo t 5 and Group 21 
allergens, specific epitopes still exist between these two molecules.   
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5.2.8     Localization of Der f 21 on sections of mite body 
 
To ensure that reaction to antibody was specific, cross-reaction of anti-Der f 21 
and anti-Der f 5 polyclonal antibodies was tested before anti-Der f 21 antibody was used 
for localization. Inhibition study indicated that anti-Der f 21 polyclonal antibody was 
unique to Der f 21 protein. It did not cross react to Blo t 21, Der f 5, Der p 5 and Blo t 5. 
BSA, a non-specific inhibitor, was used as negative control of the experiment.  Similarly, 
anti-Der f 5 polyclonal antibody was also found specific to its own protein, Der f 5 
(Figure 5.13).  
 Der f 21 immuno-staining was performed using anti-Der f 21 rabbit sera on 
paraffin sections of mite bodies. The Der f 21 antibody bound strongly to mid-gut 
contents of the mite sections (Figure 5.14), similar to our previous localization study of 




  127 












































































Figure 5.13     Competitive ELISA assay evaluating the IgG specificities of Der f 21 and 
Der f 5. (A) Der f 21 IgG antibody (B) Der f 5 antibody. 
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Figure 5.14     Immuno-staining of Der f 21 in paraffin-embedded sections of D. farinae 
probed with anti-Der f 21 polyclonal antibody in longitudinal (A) and 
sagittal mite sections (B). Section probed with pre-immune sera (C).  
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5.2.9      Der f 21 and Der f 5 in house dust samples 
Seventy-seven dust samples from four niches of 40 homes, namely bedroom 
floors, living room carpets, living room floors and kitchen floors were assayed for Der f 
21 and Der f 5 levels. Wilcoxon-Mann-Whitney rank test showed identical distributions 
of Der f 21 and Der f 5 among different niches where dust samples were collected. Der f 
5 was detected in 50 out of 77 dust samples with concentrations ranging from 39 to 470 
ng/g and the geometric mean was 74 ng/g. In parallel, Der p 21 was detected in 66 dust 
samples ranging from 10 to 350 ng/g with a geometric mean of 36 ng/g. Both allergens 
were present in the indoor dusts with low concentration in all four niches. Der f 21 and 
Der f 5 concentrations on living room carpets and bedroom floors were slightly higher 
than those on kitchen floors and living room floors. The overall concentrations of Der f 
21 were lower than those of Der f 5 in all four niches where dust samples were collected.  
 
  130 


































































Figure 5.15     Der f 21 and Der f 5 levels in 76 house dust samples. The solid lines 













  131 
   
5.3      Discussion 
In this study, a novel allergen, Der f 21, has been identified from our in-house D. 
farinae EST database using local TBLASTN searching against Der f 5. It is a product of 
a single-copy gene with an intron of 58 base pairs.  The cDNA of Der f 21 encodes a 
protein similar to Der p 21, Blo t 21, as well as their Group 5 counterparts. Multiple 
sequence alignment showed that Der f 21 protein sequence is more related to Der p 21 
(66.4% identity) than Der f 5 (28.7% identity).  In parallel, Der f 5 was also found to 
share higher percentage identity to Der p 5 (75.2%) than Blo t 5 and other Group 21 
allergens. According to sequences diversities of Group 21 and Group 5, phylogenetic tree 
was built using Neighbor-Joining (NJ) method (Figure 5.4). This phylogenetic tree shows 
that Group 21 and Group 5 allergens of three major dust mite species clustered in two 
major clades, indicating that Group 21 and Group 5 allergens may occur due to a prior 
event of gene duplication from the same ancestor and the duplication occurred before 
speciation. Since Der f 21 and Der f 5 had introns at different positions, it can be 
speculated that their introns may insert into genes after gene duplication. 
It is of great interest to know whether Der f 21 is allergenic. IgE response to Der f 
21 and Der f 5 was thus investigated in 181 consecutive atopic individuals attending 
outpatient allergy clinics over one year and a half and 30 severe rhinitis patients who 
were positive to D. pteronyssinus, D. farinae and B. tropicalis and needed to undergo 
further immunotherapy. Frequency of IgE-binding to Der f 21 is the same as Der f 5 
allergens in atopic individuals. Sera responding to Der f 21 mostly responded to Der f 5 
as well. Lower IgE level towards Der f 21 than Der f 5 has been observed in atopic 
individuals and rhinitis patients.  
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IgE-binding of Der f 21 could be resulted from co-sensitization or cross-reaction 
through common epitopes of Der f 21 and Der f 5. Dose-response inhibition study was 
performed to further investigate the reason for IgE-binding to Der f 21. Inhibition study 
revealed that in two out of three sera, Der f 21 was a low cross-reactive allergen against 
Der f 5, Blo t 21, Der p 5 and Blo t 5. One subject was found predominantly sensitized to 
Blo t 5 and Blo t 21 and cross-reactive to Der f 5 and Der f 21. Hence, different patients 
had different immuno-responses to Der f 21. Allergic response of Der f 21 could be either 
due to sensitization to specific epitopes of Der f 21, or cross-reactivity to Blo t 5 and Blo 
t 21 through the common epitopes existing in the conserved amino acid sequences 
between molecules of Der f 21, Der p 21, Blo t 21 and Blo t 5. 
Immuno-localization experiment in this study revealed that Der f 21 localizes in 
the digestive system of dust mite like Der p 1 and Der p 2. Similar to Der p 1 and Der p 2, 
Der f 21 may also get out of the mite body and become airborne particles in the 
environment. The environmental levels of Der f 21 and Der f 5 were examined in 77 
samples from 4 niches of 40 homes. Although Der f 21 and Der f 5 levels observed in this 
study were below the commonly suggested risk level for sensitization (2 µg/g of dust), 
they were similar to Der p 5 levels measured in houst dusts in Taipei, Taiwan (Li et al., 
1996), but much lower than the level of Der p 1 or Der f 1 in the dust samples of 
Singapore by other studies (Li et al., 1994; Sporik et al., 1990).  It is interesting to note 
that exposure to low levels of mite allergens would lead to sensitization especially for 
individuals with positive family histories of allergy (Waner et al.,; 1996 Wahn et al., 
1997; Huss, et al., 2006).  
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This study revealed that Der f 21 alone was able to elicit IgE response in many 
susceptible individuals. Hence, it is important to include this allergen for allergy 
diagnosis and allergen-specific immunotherapy (SIT). Up to now, D. farinae extract is 
used for SIT in clinical practice. However, it has been reported that mite extract is 
unstable and may vary from batch to batch. In addition, endotoxin has ever been found in 
D. farinae extract (Trivedi et al., 2003).  To overcome these problems, standardized 
formulation of mixed allergens to mimic natural mite extract could be used for better 
immunotherapy. Recombinant Der f 21 used in this study has retained its secondary 
structure and IgE-binding capacity. It can be used as a good candidate to form 
formulation allergens for immunotherapy. 
In conclusion, a novel allergen Der f 21 was identified and characterized in D. 
farinae in this study. It is possible to elicit specific IgEs and bind to these IgEs. The 
cross-linked IgEs cause allergic response in many atopic subjects who were sensitized to 
D. farinae. Although Der f 21 shares some primary and secondary structure similarities to 
Der f 5, IgE antibodies binding to this allergen do not cross-react to Der f 5 in some 
patients. Der f 21 is thus an important allergen of D. farinae and should be considered in 
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Chapter 6: Identification and Characterization of Group 5 and 
Group 21 in S. medanensis and Cross Comparison 
of a Panel of 11 Group 5 and Group 21 Allergens
 
 
6.1      Introduction 
 
 
Wide spectrums of mite species were identified from house dusts (Chew et al., 
1999a) in Singapore. B. tropicalis is a predominant mite species in this region, but high 
counts (>100 mites/g) of other less commonly occuring dust mites such as Tyrophagus 
putrescentiae, Austroglycyphagus malaysiensis were also found in dust samples. High 
temperatures (24-31 °C) and high relative humidity (64-96%) throughout the year could 
be the reason for the growth and proliferation of such a wide spectrum of dust mites.  
Exposure to more than 100 mites/g of dust mites is considered as an independent 
risk factor for sensitization. Sensitization to dust mite is associated with development of 
allergic diseases. Skin prick test and sera IgE antibodies measurement in allergic asthma 
and allergic rhinitis patients in Singapore demonstrated high prevalence of sensitization to 
B. tropicalis (96.2%), D. pteronyssinus (93.4%), D. farinae (92.3%), A. malaysiensis 
(78.2%), S. brasiliensis (71.6%) and T. putrescentiae (71.3%). High degrees of 
sensitization to less commonly occuring dust mites may be caused by exposure to high 
counts of mites in house dusts or cross-reactivity of predominant mites like B. tropicalis.  
B. tropicalis and Dermatophagoides spp.  have been extensively studied. Blo t 5 
and Der p 5 have been reported as major allergens that cause allergic diseases, because 
they can bind IgE antibodies in mite sensitized subjects with high frequencies and 
intensities (Lin et al., 1994; Arruda et al., 1997). Low cross-reactivity between Blo t 5 and 
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Der p 5 has been reported in several studies (Chew et al., 1999b; Kuo et al., 2003). Thus, 
it can be inferred that Blo t 5 and Der p 5 are able to specifically induce allergy by their 
specific epitopes.  
In 2006, a cDNA of Group 5 homologous gene, Der p 21 was deposited in the 
public database (Genbank, http://www.ncbi.nlm.nih.gov/). Its allergenicity has yet to be 
characterized. From B. tropicalis and D. farinae EST database available in our laboratory, 
Blo t 21 and Der f 21 have been identified as well. Characterization of Blo t  21 and Der p 
21 allergens in Chapter 3 and Chapter 5 demonstrated that Blo t 21 and Der f 21 are also 
specific for sensitization and development of allergic diseases. It is of interest to find out 
whether Group 5 and Group 21 in less commonly occurring mite species are also 
allergenic, since these mites are also present in the environment. The EST projects 
conducted in our laboratory provide a large amount of DNA sequences of eight mite 
species, including some storage mites existing in house dusts worldwide. Such 
information opened a door for further identification of Group 5 and Group 21 from 
storage mites such as Suidasia medanensis, Tyrophagus putrescentiae and Aleuroglyphus 
ovatus.  
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6.2      Results 
 
 
6.2.1       Group 5 and Group 21 allergens in Suidasia medanensis 
 
 
6.2.1.1    Identification of Group 5 and Group 21 in S. medanensis 
 
 
From the expressed sequence tagging database of S. medanensis prepared in the 
laboratory♣, twenty-five ESTs homologous to Group 5 dust mite allergens were identified 
by local BLASTX searching. Group 5 homologous ESTs were among the top ten most 
abundant ESTs in S. medanensis. Multiple alignments of these ESTs using DNAMAN 
(Lynnon BioSoft, Canada) and subsequent generation of an unrooted phylogenetic tree 
based on the diversities between these sequences using a bootstrap value of 1000 with the 
same software provided a clear picture of the relationship between these EST sequences 
(Figure 6.1). These 25 ESTs were clustered into three separated clades, suggesting that 
there could be three different "sub-groups" of Group 5 homologoues in S. medanensis. 
The presence of multiple copies of cDNA sequences in each clade offers additional 




                                                 
♣ S. medanensis cDNA library construction and ESTs generation were conducted in my previous studies and 
not described in this thesis. The sequencing of cDNAs was performed together with Kavita Reginald. 
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Figure 6.1     Unrooted phylogenetic tree of 25 S. medanensis cDNAs encoded Group 5 
and its homologues drawn using a bootstrap value of 1000 (DNAMAN). 
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 cDNAs from representative ESTs, the most frequently occurring polymorphism in 
each clade were given their temporary names as SM5-1, SM5-2 and SM5-3 according to 
the sequential of cloning, before officially named by the WHO/IUIS nomenclature 
committee. The open reading frames of SM5-1, SM5-2 and SM5-3 cDNAs encode 
proteins in the lengths of 134, 130 and 128 amino acids (Appendix 1-III). Each protein 
contains a 16 amino acids signal peptide in the N-terminal of the protein predicted by 
SignalP v3.0 (Bendtsen et al., 2004), suggesting that these proteins may be secreted 
proteins.  Since S. medanensis is taxonomically closer to B. tropicalis than 
Dermatophagoides spp., protein sequences of SM5-1, SM5-2, and SM5-3 were compared 
with Blo t 5 and Blo t 21 using ClustalW (Thompson et al., 1994) integrated in BioEdit 
(Hall, 1999) (Figure 6.2A). The unrooted phylogenetic tree was built subsequently using 
Neighour-Joining algorithm in BioEdit (Figure 6.2 B). These five proteins fall into 2 
major clades with Blo t 5, SM5-2 and SM5-3 clustering in one, and Sm5-1 and Blo t 21 in 
the other. In pair-wise comparison, SM5-2 has 76.9% identity to SM5-3, 48.9% to Blo t 5, 
but 39.6 % to SM5-1. According to the guideline of WHO/ IUIS nomenclature committee, 
SM5-2 and SM5-3 are renamed as Sui m 5.01 and Sui m 5.02, and SM5-1 is renamed as 
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10 20 30 40 50
. . . . | . . . . | . . . . | . . . . | . . . . | . . . . | . . . . | . . . . | . . . . | . . . . |
Sm5-1 M K F V L A L A A L L A V A Y A A P T Q - - N D K G F R N E F D H L L V I E A E H R F K E I E Q G L
Sm5-2 M K C L L V L A A C L V A - V Y A A D - - - - K N D F R H E F D Y L L M K T A E H N M E R G E A M L
Sm5-3 M K F V L I L A T C L V A - V L A A D - - - - K N D F R N E F D F L L M Q T M E H N M H R G E Q M L
Blo t 5 M K F A I V L I A C F A A S V L A Q E H K P K K D D F R N E F D H L L I E Q A N H A I E K G E H Q L
Blo t 21 M K F I I A L A A L I A V A C A L P V S - - N D N - F R H E F D H M I V N T A T Q R F H E I E K F L
60 70 80 90 100
. . . . | . . . . | . . . . | . . . . | . . . . | . . . . | . . . . | . . . . | . . . . | . . . . |
Sm5-1 M R L S L Q V E T L E K S K S K A L K A E I L R E I T I G V N F A T G A K E F F T R E A K R T D L D
Sm5-2 L A L T E Q I A H L E Q S K N K E E K E K I V R E L E T I I A L I S G S H D V L E R E L K R T D L D
Sm5-3 L A L T E Q I A H L E E S K N K E E K E H I I R E L E T I I A M I F G S H S V L E R E L K R T D L N
Blo t 5 L Y L Q H Q L D E L N E N K S K E L Q E K I I R E L D V V C A M I E G A Q G A L E R E L K R T D L N
Blo t 21 L H I T H E V D D L E K T G N K D E K A R L L R E L T V S E A F I E G S R G Y F Q R E L K R T D L D
110 120 130
. . . . | . . . . | . . . . | . . . . | . . . . | . . . . | . . . . | .
Sm5-1 L V E K F N Y D A A V V S A E I L I K D L T E L A K K V N A I D A N N K
Sm5-2 I L E R Y N F E S A L K I G A I L V R D L K A A E A K V K A I N V H A -
Sm5-3 I L E R F N F E S M L K V T Q V L A K D L K D A E A K V K A I K V - - -
Blo t 5 I L E R F N Y E E A Q T L S K I L L K D L K E T E Q K V K D I Q T Q - -
Blo t 21 L L E K F N F E A A L A T G D L L L K D L K A L Q K R V Q D S E - - - -
 
 
Figure 6.2A    Multiple alignments of SM5-1, SM5-2, SM5-3 with Blo t 5 and Blo t 21. 








Sui m 5.02 





Figure 6.2B  Phylogenetic tree of Group 5 homologues in S. medanensis, Blo t 5 and 
Blo t 21 drawn by Neighbor-Joining method. 
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6.2.1.2   Expression of Sui m 5.01, Sui m 5.02 and Sui m 21 in E.coli 
In order to study these putative allergens, cDNAs of Sui m 5.01, Sui m 5.02 and 
Sui m 21 encoding secreted part of proteins were cloned into pET15 vector to produce six 
histidine tagged N-terminal fusion proteins. Group 5 homologues proteins were over-
expressed as soluble proteins in E. coli BL21* (DE3) cells. The proteins purified by a Ni-
NTA column were about 13 kDa when analyzed on a 15% SDS-PAGE gel stained with 


































































Figure 6.3   SDS-PAGE profile of purified Blo t 5, Sui m 5.01, Sui m 5.02 and Sui m 21 
proteins.
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6.2.1.3   IgE-binding activities of Sui m 5.01, Sui m 5.02 and Sui m 21 
Specific IgE antibodies against Sui m 5.01, Sui m 5.02, Sui m 21 and other ♣eight 
allergens of S. medanensis were measured by semi-quantitative immuno-dot blot assay 
using recombinant proteins♣♣. These eight allergens are Sui m 1 to Sui m 3, Sui m 7 to 
Sui m 10 and Sui m 13.  Among total 181 consecutive atopic individuals attending 
outpatient allergy clinics over one year, 82 subjects were positive to S. medanensis 
extract, and 75 out of 82 subjects responded to both S. medanensis and B. tropicalis.  
28% (23/82) of S. medanensis positive subjects responded to Sui m 5.01, 19% (16/82) to 
Sui m 5.02 and 16% (13/82) to Sui m 21. Sui m 5.01 was thus the most common allergen 
in the total of 11 allergens, and Sui 5.02 and Sui 21 were the third and fourth most 
common allergens in the panel (Figure 6.4A).  
When IgE-binding intensities of an individual allergen in all tested sera are 
summed together, this integral value could represent the specificity of IgE to that 
particular allergen source in the population. According to the information obtained from 
B. tropicalis and D. pteronyssinus, major allergens were normally among Group 1 and 
Group 13. The sum of the IgE activities towards Groups 1, 2, 3, 5, 7, 8, 9 10, 13 and 21 
allergens in S. medanensis may contribute to the majority of total S. medanensis IgE 
activities. In this study, IgE antibodies of Sui m 5.01, Sui m 5.02 and Sui m 21 accounted 
for 20%, 16% and 10% of the total IgE levels of S. medanensis (Figure 6.4B).  IgE 
antibodies against these three allergens contributed to 46% of the total sera IgE, 
suggesting the importance of Group 5 and Group 21 in S. medanensis allergy. A strong 
                                                 
♣           Group 1 to Group 10 allergens of S. medanensis were cloned in pET32 in my previous study. This 
part of work was not included in this thesis.  Sui m 6 and Sui m 13 were constructed by Kavita 
Reginald. 
♣♣           Immuno-dot blot assay was done by Ms Tan Angeline. 
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correlation between IgE antibodies of Sui m 5.01 and Sui m 5.02 was observed, while 
low correlation between Sui m 5.01 and Sui m 21 IgE antibodies was found by scatter 































































































































Figure 6.4A    Frequencies of IgE-binding to a panel of 11 allergens of S. medanensis in 
82 sensitized subjects. 
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Figure 6.4B    Percentage of specific IgE activities of Groups 1, 2, 3, 5, 7, 8, 9 10, 13 and 
21 allergen in total IgE of S. medanensis.
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Figure 6.4 C and D   Correlation of specific IgE antibodies between Sui m 5.01 and 5.02 







  145 
   
6.2.2   Identification of Ale o 5 
 
From the expressed sequence tag (EST) database of Aleuroglyphus ovatus 
available in the laboratory (Angus et al., 2004), sequences showing homology to Blo t 5 
and Blo t 21 were identified using local BLASTX. Four cDNA sequences were fished out 
from EST database when searched against either Blo t 5 or Blo t 21. All four cDNA 
clones had similar DNA sequences. The BLAST score of Blo t 5 searching was higher 
than that of Blo t 21 searching, indicating that these sequences were closer to Group 5. 
Hence, putative allergen encoded by these cDNAs was named Ale o 5 (accession number 
AAS75832), in accordance with the allergen nomenclature guidelines (WHO/IUS 
Allergen Nomenclature Subcommittee World Health Organization, 1994). The open 
reading frame of Ale o 5 encodes 135 amino acid residues (Appendix IV). Ale o 5 
contains a signal peptide with 16 amino acids predicted by SignalP v3.0 (Bendtsen et al., 
2004).  
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6.2.3   Expression of recombinant Ale o 5, Gly d 5, Lep d 5 and Der p 5 in E. coli 
The cDNA encoding for the mature protein of Ale o 5 was amplified using PCR 
method and cloned into pET15 vector. The primers were designed according to the 
cDNA sequences of Der p 5 and Lep d 5 available in Genbank database. Der p 5 and Lep 
d 5 cDNAs were then amplified by RT-PCR and subsequently inserted into pET15 
vector. Gly d 5♣ was expressed as thioredoxin fusion protein. Thioredoxin tag helped 
increase the expression and solubility of Gly d 5.  
The recombinant Ale o 5, Der p 5, Lep d 5 and Gly d 5 were over-expressed in E. 
coli BL21* (DE3) strain and produced as His-tag fusion protein. Ale o 5, Der p 5, Lep d 
5 and Gly d 5 purified by a Ni-NTA column were about 14 kDa, 14 kDa, 20 kDa and 42 
kDa when analyzed on a 15% SDS-PAGE gel stained with Coomassie blue (Figure 6.5).  
 
                                                 
♣ Gly d 5 expression clone was provided by Mr. Aaron Chen Angus. 
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Figure 6.5     SDS-PAGE profile of a panel of Group 5 and Group 21 proteins including 
Ale o 5, Der p 5, Lep d 5 and Gly d 5. 
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6.2.4   IgE-binding profiles of 11 Group 5 and Group 21 allergens 
Specific IgE activites to 11 Group 5 and Group 21 from B. tropicalis, D. farinae, 
D. pteronyssinus, Lepidoglyphus destructor, G. domesticus and S. medanensis were 
studied in 118 local mite positive sera using semi-quantitative immunoarray assays. 
These sera were recruited from consecutive atopic subjects attending similar outpatient 
allergy clinics in one year and a half.  Dust mite crude extracts and thioredoxin-tag 
protein were dotted on membrane as positive and negative protein controls. Sera from 
atopic individuals did not bind to thioredoxin-tag protein produced by pET32a. 
In this batch of sera, 97 responded to B. tropicalis, 74 to D. farinae, 80 to D. 
pteronyssinus, 58 to Aleuroglyphus ovatus, 82 to S. medanensis, 63 to L. destructor and 
82 to G. domesticus. Majority of D. farinae (68/74) and D. pteronyssinus (73/80) positive 
sera were positive to B. tropicalis. Thus B. tropicalis allergy was the most common mite 
allergy tested in this atopic Singaporean population.  
Among mite positive subjects, 41% (48/118) had specific IgE antibodies to Blo t 
5, followed by Ale o 5 (27%, 32/118), Blo t 21 (25%, 30/118) and Sui m 5.01 (19%, 
22/118). Frequencies of IgE-binding to Der f 5, Der p 5, Gly d 5, Lep d 5, Sui m 5.02, 
Der f 21, and Sui m 21 were below 14 % (Figure 6.6). Scatter plot analysis of IgE 
antibodies to Blo t 5 and other Group 5 allergens demonstrated the predominance of IgE 
antibodies towards Blo t 5 in mite positive sera tested in this batch (Figure 6.7A). Similar 
predominance of Blo t 21 was found against Der f 21 and Sui m 21 (Figure 6.7B).   
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Figure 6.6    Frequencies of IgE-binding toward a panel of 11 Group 5 and Group 21   
allergens from seven mite species existing in local environment tested in 
118 local mite positive sera visiting outpatient clinic.  
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Figure 6.7(A)   Bi-plot assay of IgE activities of Blo t 5 to Der f 5, Lep d 5, Ale o 5, Sui 
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Figure 6.7(B)    Bi-plot assay of IgE activities of Blo t 21 to Der f 21 and Sui m 21. 
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 6.2.5   Cross-reactivity of Group 5 and Group 21 allergens 
Cross-inhibitions of Group 5 and Group 21 allergens between different species 
are very important for clinical diagnosis and immunotherapy.  With a large panel of 
Groups 5 and 21 allergens at hand, it is possible for us to study the specificities of these 
allergens. Due to limited amount of sera collected, cross-inhibition was only performed 
by ELISA end-point competition using seven Group 5 and Group 21 allergens from 
important mite species as inhibitors at the concentration of 100 µg/ml.  
 
6.2.5.1 Cross-reactivity of Blo t 5 and Blo t 21 
Three sera (V1-V3) screened by previous studies showing positive to Blo t 5, Blo 
t 21 and with sufficient amount were selected for the inhibition study of Blo t 5 and Blot 
21. When Blo t 5 was immobilized on the solid phase, complete homozygous inhibition 
of Blo t 5 was achieved in all three patients tested at the concentrations of 100 µg/ml. 
Heterozygous inhibitors were only able to partially inhibit IgE-binding activities to Blo t 
5 (49%-67% for Blo t 21; 19%-77% for Der f 5; 52%-54% for Der f 21; 18%-67% for 
Der p 5; 28%-71% for Lep d 5; and 2%-37% for Ale o 5) (Figure 6.8), indicating low to 
moderate cross-reactivity between these allergens.  
Same sera were used to conduct competition study for Blo t 21. Results showed 
that Alo e 5 was not able to inhibit the IgE-binding acticities to Blo t 21 in all three sera 
(< 2% inhibition).  Blo t 5 and Der p 5 were not able to inhibit Blo t 21 in two sera and 
only had low inhibition to Blo t 21 in one sera (16% inhibition). Lep d 5 demonstrated 
low inhibition in all three sera (17%-23% inhibition). Der f 5 and Der f 21 showed low to 
moderate inhibition to Blo t 21 (18%-69%) (Figure 6.9).  
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Figure 6.8       Inhibition of Blo t 5 by Group 5 and Group 21 inhibitors from B. 
tropicalis, D. farinae, D. pteronyssinus, L. destructor and A. ovatus using 
three sera. 
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Figure 6.9   Inhibition of Blo t 21 by Group 5 and Group 21 inhibitors from B. tropicalis, 
D. farinae, D. pteronyssinus, L. destructor and A. ovatus using three sera. 
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6.2.5.2     Cross-reactivity of Der f 5 and Der f 21 
Cross-inhibition of Der f 5 and Der f 21 was evaluated as well using three sera. In 
this study, serum V3 was replaced by serum V4 due to its low specific IgE titer to Der f 5 
and Der f 21. Sera V1, V2 and V4 showed high IgE activities to Der f 5, Der f 21, Blo t 5 
and Blo t 21. High homozygous inhibitions (>79.6%) of Der f 5 were observed in three 
sera. Ale o 5 was not able to fully inhibit Der f 5 in all three sera. Der f 21, Blo t 5, Blo t 
21 and Lep d 5 were able to partially abolish IgE-binding to Der f 5 at 100 µg/ml in sera 
V1 and V4 (41%-58% inhibition), and fully inhibit the IgE of serum V2. Der p 5 was 
able to partially inhibit Der f 5 in serum V1 (44% inhibition), and fully inhibit in sera V2 
and V4 (>80% inhibition) (Figure 6.10).   
When Der f 21 was immobilized on solid surface of ELISA plate, Ale o 5 was not 
able to completely inhibit IgE-binding to Der f 21 in all three sera. Der f 5, Der p 5, Blo t 
5, Blo t 21 and Lep d 5 partially inhibited Der f 21 at low to moderate level (11%-70%) 
in sera V1 and V4 and completely inhibited Der f 21 in serum V2 (Figure 6.11).  
In subject V2, Blo t 5 and Blo t 21 were partially cross-inhibited by Der f 5 and 
Der f 21. In contrast, Der f 5 and Der f 21 were completely inhibited by Blo t 5 and Blo t 
21, suggesting that this subject was predominantly sensitized by Blo t 5 and Blo t 21, and 
cross-reactive to Der f 5 and Der f 21.  
Thus, IgE activities to Der f 5 and Der f 21 in our local atopic population are most 
probably caused by two reasons: firstly primary sensitization to D. farinae and secondly 
cross-reaction to B. tropicalis. Der f 5 and Der f 21 IgE were partially inhibited by Ale o 
5, a Group 5 allergen isolated from non-commonly occurring mite A. ovatus.  
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Figure 6.10  Inhibition of Der f 5 by Group 5 and Group 21 inhibitors from B. tropicalis, 
D. farinae, D. pteronyssinus, L. destructor and A. ovatus using three sera. 
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Figure 6.11  Inhibition of Der f 21 by Group 5 and Group 21 inhibitors from B. 
tropicalis, D. farinae, D. pteronyssinus, L. destructor and A. ovatus using 
three sera. 
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6.2.6   Cross-reactivity of Der p 5 and Lep d 5 
Cross-inhibition of Der p 5 and Lep d 5 was evaluated in serum V1, the only 
serum that had high IgE titer to Der p 5 and Lep d 5 with enough amounts to perform 





pre-incubated with serum before they were reacted with either Der p 5 or Lep d 5 on the 
solid surface of ELISA plate.   
When complete homologous inhibition of Der p 5 was achieved at the 
concentration of 300 µg/ml, Blo t 5, Der f 21, and Ale o 5 were able to fully inhibit IgE-
binding to Der p 5.  Hence, Der p 5 showed high cross-reactivity to Der f 21, Blo t 5, Lep 
d 5 and Alo e 5. It also displayed a moderate cross-reactivity to Der f 5 and Blo t 21 (50% 
inhibition) and a high cross-reactivity to Lep d 5 (Figure 6.12A).  
When Lep d 5 was immobilized on the solid surface, full (>80% inhibition) 
inhibition was achieved by its own protein at the concentration of 100 µg/ml.  Der f 21 
was able to completely inhibit IgE-binding of Lep d 5. Both Blo t 21 and Der f 5 were 
able to inhibit IgE-binding to Lep d 5 at high levels (> 75 % inhibition). Blo t 5 and Ale o 
5 were able to inhibit IgE-binding to Lep d 5 at moderate levels, while Der p 5 was only 
able to inhibit Lep d 5 at a low level (Figure 6.12B). Hence, subject V1 was 
predominantly sensitized by Group 5 and Group 21 from both B. tropicalis and D. 
farinae and partially cross-reactive to Der p 5, Lep d 5 and Ale o 5. Since only one serum 
was used in the inhibition experiment, further studies using sera from more subjects 
would be needed to provide a better picture of cross-reactivity of Group 5 and Group 21 
isolated from different species. 
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It is noteworthy that the majority of individuals in this screening showed higher 
IgE titers to Blo t 5 than to other Group 5 and Group 21 allergens (Figure 6.6), suggesting 
that individuals in this group might develop more specific IgE antibodies to epitopes of 
Blo t 5, Blo t 21, Der f 5 and Der f 21 than those of Group 5 and Group 21 allergens in 
less commonly occurring dust mites. 
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Figure 6.12(A)   Inhibition of Der p 5 by Group 5 and Group 21 inhibitors from B. 
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Figure 6.12(B)   Inhibition of Lep d 5 by Group 5 and Group 21 inhibitors from B. 
tropicalis, D. farinae, D. pteronyssinus, L. destructor and A. ovatus. 
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6.3   Discussion 
Group 5 and Group 21 allergens are universal in dust mites. They were found in 
different mite species from different families. Together with published Group 5 and 
Group 21 allergens and those identified from Chapter 3 and Chapter 5, a total of 13 
Group 5 and Group 21 allergens were identified from seven mite species. Highly 
abundant Group 5 and Group 21 homologous ESTs have been found in S. medanensis, 
indicating high expression of Group 5 and Group 21 homologues in this species.  Two 
Group 5 isoforms were first reported from this species. It seemed that Group 5 isoforms 
were not just restricted in one species, they were also observed in T. putrescentiae when 
T. putrescentiae ESTs were surveyed.  It can be speculated that more Group 5 isoforms 
may be identified in other species of mites.  However, Group 5 and Group 21 genes are 
only found in dust mites up to the present. No homologous genes can be found in other 
organisms using homologous based searching in public database.  
Group 5 and Group 21 allergens isolated from B. tropicalis, D. pteronyssinus, D. 
farinae, A. ovatus and S. medanensis have similar protein sizes, and their proteins all 
contain a signal peptide, while Group 5 allergens isolated from Glycyphagidae family 
(Lep d 5 and Gly d 5) have extra duplication in the N-terminal of the protein. Part of 
duplicated DNA was lost in Lep d 5 and this resulted in the loss of signal peptide. 
Multiple alignments of protein sequences of Group 5 and Group 21 allergens and the 
drawing of an unrooted Neighbor-Joining phylogenetic tree based on the diversities of 
these sequences indicated two major clusters: Group 5 and Group 21 (Figure 6.13). In 
this phylogenetic tree, Group 5 and Group 21 allergens of T. putrescentiae were added, 
but an outgroup gene was not included, because Group 5 and Group 21 were only found 
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in mites so far, and it is impossible to find a homologous gene in distant species other 
than mites. This phylogenetic tree clearly demonstrated that Group 5 and Group 21 were 
evolved separately in the species. The duplication event was most likely taking place 
before speciation.  The phylogenetic tree of Group 5 and Group 21 based on sequence 
diversity was also in a good agreement with the phylogenetic tree of dust mite generated 
from the observation of morphology. It can be seen from the phylogenetic tree that Group 
5 and Group 21 from D. pteronyssinus and D. farinae always fall into the same clades. D. 
pteronyssinus and D. farinae belong to Pyroglyphidae family.  Gly d 5 and Lep d 5 
whose gene duplication occured within the gene seemed to cluster as outgroups of normal 
Group 5 and Group 21 allergens. Lep d 5 and Gly d 5 clustered into the same clades. 
Interestingly, N-terminal parts of two allergens clustered in one clade and C-terminal 
parts in another, suggesting that gene duplication most probably happened before 
speciation. Gly d 5 and Lep d 5 clustering together also reflected the taxonomy 
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Figure 6.13    Neighbor-Joining phylogenetic tree of Group 5 and Group 21 allergens 
from eight mite species.  
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Gene duplication plays an important role in evolution. In the initial period of 
duplication, the duplicated gene has overlapping function as the original one.  Later on, 
random mutations occurred in the duplicated gene during evolution. Due to the presence 
of two copies of the same gene, mutation only in one copy often has no effect on the 
organism. This leads to an accumulation of large amount of mutations in the second copy. 
The mutations could lead to either gain of a new function or loss of any function. The 
function-losing mutations (pseudogene) will be deleted in the genome later on. Group 5 
and Group 21 are most likely paralogs in mite species, which may exist after gene 
duplication. However, the biological functions of these two groups of allergens are still 
under investigation.  
Despite the sequence diversity, both Group 5 and Group 21 allergens from 
predominant mite B. tropicalis and D. farinae are able to induce species specific allergy 
in mite positive atopic individuals in Singapore. Group 5 and Group 21 from other less 
commonly occurring mites also showed some degree of IgE-binding. When 11 allergens 
(Groups 1∼3, Groups 5 ∼ 10, Group 13) of S. medanensis were studied in 82 S. 
medanensis positive subjects attending outpatient clinic,  Sui m 5.01, 5.02 and 21 were 
found contributing about half of the total IgE of 11 allergens, suggesting that Group 5 and 
Group 21 were important allergens in S. medanensis. However, when Sui m 5.01, 5.02 
and 21 were studied together with a panel of Group 5 and Group 21 in the screening, 
frequencies and intensities of Sui m 5.01 and Sui m 5.02 were lower than that of Blo t 5, 
and lower frequency and intensity of Sui m 21 were found compared to Blo t 21.  Ale o 5, 
Der f 5, Der p 5, Lep d 5 and Gly d 5 in the same screening also showed lower IgE-
binding frequencies and intensities than Blo t 5, and Der f 21 and Sui m 21 showed lower 
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IgE-binding frequencies and intensities than Blo t 21. These results reflected the 
predominant sensitization of B. tropicalis in local atopic subjects. This hypothesis was 
supported by the result of cross-inhibition studies. Cross-inhibition studies revealed that 
atopic individuals were predominantly sensitized by Group 5 and Group 21 from both B. 
tropicalis and D. farinae species and partially cross-reactive to Der p 5, Lep d 5 and Ale 
o 5. 
In addition, positive responses to Blo t 5 and Blo t 21, together with other Blomia 
tropicalis major allergens, may be indicative of more severe atopic disease or 
concomitant clinical manifestation of all three atopic diseases in the tropics (Kidon et al., 
2007).  Studies in our laboratory revealed that significant increases in the number of 
sensitizations to discrete mite allergenic groups (including the Group 21 allergens) in 
atopic children correlated well with an increasingly complex allergic phenotype 
(manifestation of all three atopic diseases) (Kidon et al., 2007).  Whether this can be used 
as a predictive risk factor for future development of asthma and allergic rhinitis in young 
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Chapter 7:  B Cell IgE-binding Epitope Mapping of Blo t 5 
 
 
7.1     Introduction 
 
 
House dust mites have been known to play an important role in the pathogenesis 
of asthma and allergic diseases. In Singapore, one in five school children has doctor 
diagnosed asthma and 140,000 individuals suffer from current asthma (Goh et al., 1996).  
More than 100 individuals die of this disease annually and the annual economic cost on 
asthma management has been estimated over US$33.93 million (Chew et al., 1999d).   A 
major risk factor for asthma in Singapore is dust mite allergy (Chew et al., 1996), and 
dust mite allergy was mainly caused by sensitization of Blomia tropicalis and 
Dermatophagoides spp. (Chew et al., 1996). Current clinical strategies for mite allergy 
management include allergen avoidance by patients, pharmacotherapy and allergen-
specific immunotherapy. Among these, only allergen-specific immunotherapy provides a 
curative treatment. It is based on the repeated administration of increasing doses of mite 
crude extracts to allergic patients to obtain allergen-specific non-responsiveness. 
However, with the administration of crude extracts, patients may develop new IgE 
activity to previously non-IgE-binding allergen components in the crude extracts after 
treatment. In addition, patients may encounter the risk of anaphylaxis that can be fatal. 
Intensive study on allergens is necessary toward a better understanding of the mechanism 
of dust mite allergy and safe immunotherapy.   
It has been demonstrated in Chapter 3 that Blot 5 and its homologous allergen Blo 
t 21 are important allergenic components of B. tropicalis. Both of them are able to induce 
specific IgE response in 34%-50% of allergic subjects and in more than 90% of allergic 
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rhinitis patients in Singapore. In the study with a panel of 11 Group 5 and Group 21 
allergens in Singaporean atopic subjects in Chapter 6, Blo t 5 was found to be the most 
important allergen in Group 5 and their homologous allergens (Group 21).  Further 
investigation of the IgE-binding area of Blo t 5 will provide useful information on the 
pathogenesis of Group 5 and Group 5 homologous allergens.  
There are many methods to identify B cell epitopes of an allergen. Phage display 
technique is able to define the mimotopes that mimic natural epitopes, but they do not 
correspond to the linear sequence of the cognate allergen. X-ray crystallography and 
Nuclear Magnetic Resonance Spectroscopy (NMR) are able to solve the structure of IgE 
antibody-allergen complexes, so as to define the antibody binding site of the allergen. 
Naturally occurring variants which have less allergenic activity reflect the IgE-binding 
site of wildtype allergen. However, not all natural occurring variants have reduced IgE 
reactivity. Site-directed mutagenesis is commonly used to determine IgE epitopes of 
allergens. It can be used to selectively modify target amino acid. The substitutes affecting 
the allergen-IgE interaction can be measured by immuno-protein array or ELISA assay. 
Such site-directed mutagenesis approaches have been successfully applied to epitopes 
mapping of Der p 2 (Mueller, 2001), Bet v 1 (Spangfort, 2003), and Der f 13 (Chan et al., 
2006). Synthetic peptides approach is another powerful method for identification of linear 
B cell epitopes. This method has been deployed to identify epitopes of tropomyosin 
(Ayuso et al., 2002), Cry j 1 (Takagi et al.,   2005) and Ole e 1 (Gonzalez et al., 2006). 
However, this method was not able to determine the IgE epitopes of Der p 1 and Der p 2 
due to lack of continuous epitopes (Chua et al., 1991; van 't Hof et al., 1991).  
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In this study, specific IgE epitopes of Blo t 5 were determined by site directed 
mutagenesis of charged and polar amino acids. These mutants were then assayed for IgE-
binding activities by immuno-dot blot method.  
 
7.2      Results 
 
7.2.1      Identification of Blo t 5 specific epitopes using site-directed mutagenesis 
 
 
7.2.1.1    Selection of residues for site-directed mutagenesis 
 
 
From previous studies in Chapter 3 and Chapter 6, it has been revealed that Blo t 
5 is the most important allergen among Group 5 and their homologous allergens (Group 
21). The allergenicity of this allergen is very specific compared to other Group 5 and 
Group 21 allergens, because low to moderate levels of cross-inhibitions of Blo t 5 were 
achieved by Der f 5, Der p 5, Lep d 5, Blo t 21 and Der f 21 inhibitors. Hence, specific 
epitopes may play important roles in Blo t 5 allergy. The residues which may affect Blo t 
5 specific epitopes were selected based on the alignment of amino acid sequences of Blo t 
5, Der f 5, Der p 5, Blo t 21 and Der f 21. The amino acid residues most different among 
Blo t 5 and other Group 5 and Group 21 were firstly selected.  To further refine this 
selection, residues with similar side chain properties (D-E, K-R, and S-T ) were excluded. 
Hydrophobic residues were not included in the selection either, because these residues 
are normally not involved in antibody interactions (Davies et al., 1996). Based on these 
considerations, a total of 16 residues were selected for site-directed mutagenesis to 
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determine the IgE-binding epitopes, including five charged residues (Glu, Lys and His) 
and ten polar residues (Gln, Asn, Ser, Thr and Tyr) (Figure 7.1). All these selected 
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    67Der p 5
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Figure 7.1  Sequence alignment of Blo t 5 with Der p 5, Der f 5, Blo t 21 and Der f 21. 
100%, 75%, 50% and 33% identical residues are shaded in black, red, 
light blue and yellow. Arrows indicate the residues that have been selected 
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7.2.1.2      Expression of Blo t 5 mutations 
 
Selected amino acid residues were mutated into alanine by PCR method using 
DNA of Blo t 5 expression clone (pET15-BT5) as a template.  The mutation clones were 
confirmed by DNA sequencing. The mutants were transformed in E. coli BL21 (DE3) 
strain for expression. E. coli strains carrying mutant DNA were cultured until OD600 0.8 
and induced by IPTG. The expressed protein was purified by Nickel-NTA resin and 
separated by SDS-PAGE electrophoresis.  Figure 7.2 shows electrophoresis bands of the 






















































































































































































































7.2.1.3      Influence of amino acid substitutions on IgE-binding 
 
 
IgE-binding capacities of Blo t 5 mutants were measured by immuno-dot blot 
assay using 10 Blo t 5 positive sera and 6 Blo t 5 negative sera from local consecutive 
patients. The IgE-binding activities of mutants in immuno-dot blot were calculated for 
each sera using wild-type Blo t 5 as a reference (100% IgE-binding activity). Negative 
serum showed no reactions towards Blo t 5 wild-type and mutants (Data not shown).  
Major IgE-binding residues were identified when more than 50% of sera tested showed 
significant reduction of IgE-binding.  
Different IgE-binding patterns of Blo t 5 mutants were obtained when different 
sera were tested (Figure 7.3). It seemed that IgE-binding residues of Blo t 5 were 
distributed throughout its whole molecule (Figure 7.4). Epitopes at the N-terminal were 
observed mainly at positions N40-E44, N61 and Q81, while C-terminal epitopes were 
observed mainly at positions E91 and T124. Sera 3576, 3578 and 3626 responded to the 
epitopes at the N-terminal of Blo t 5 molecule, while sera 3640 and 3641 mainly 
responded to the epitopes at the C-terminal. In addition, sera 3604 and 3688 responded to 
the epitopes at both N-terminal and C-terminal. 
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Figure 7.4       Percentage of subjects whose sera showed reduced IgE-binding activity to 





7.2.2     Identification of Blo t 5 IgE-binding regions using systematic 
synthetic peptide 
The IgE-binding regions on Blo t 5 were determined by peptide mapping 
approach. This method has been used to systematically identify linear epitopes of antigens 
in many studies (Shreffler et al., 2005, Ayuso et al., 2002, Takagi et al., 2005). Thirteen 
overlapping peptides were initially designed to span entire Blo t 5 molecule. Each peptide 
was 16 amino acids long with an offset of 8 residues. According to site-directed 
mutagenesis based mapping result, certain regions like N40 to N61 may contain 
predominant epitope of Blo t 5. To further increase resolution of the IgE-binding epitope 
mapping, eight extra peptides were added into the assay.   Thus, certain regions of Blo t 5 
were spanned by overlapping peptides with four residues offset. In total, 21 peptides 
covering Blo t 5 primary protein sequence were designed as Biotin-SGSG-Peptide-Amide 
and purchased from commercial company (GL Biochem(Shanghai) Ltd) (Figure 7.5) and 
20 peptides were obtained except peptide 10.  Blo t 5 molecule was still covered by the 
remained 20 peptides.  
Synthesized peptides were coated on strep-avidin-coated plate and tested with 10 
Blo t 5 positive sera and one negative serum from healthy people using ELISA assay. As 
displayed in Figure 7.6, nine out of ten Blo t 5 positive sera responded to at least two 
peptides, except that one serum did not respond to any peptides. Negative serum showed 
no response to any peptide with baseline absorbance reading observed. In general, each 
serum had its own specific IgE responding profile to peptides. Fifteen out of twenty 
peptides interacted differently with specific IgE antibodies in patient sera tested in this 
study (Figure 7.7). These peptides were distributed in the entire Blo t 5 molecule 
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including N-terminal, Center and C-terminal regions. Peptides 14 and 15 were recognized 
by eight out of ten sera, followed by Peptide 16 by six sera, Peptides 1 and 11 by three 
sera. The rest peptides were recognized by only one serum.  Interestingly, five Peptide 16 
positive sera were able to react strongly to Peptides 14 and 15 as well. This finding led to 
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Figure 7.5 Overlapping peptides covering Blo t 5 molecule. Residues substituted by 
alanine in site-directed mapping study are marked in violet.  Peptides 
showing response to IgE antibody of patients were in blue. The 
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Figure 7.7  Number of sera reacting to the overlapping peptides of Blo t 5 (total sera 
number=10). 
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7.2.3  Overlapping peptide mapping rabbit IgG binding regions of Blo t 5 
 
The immunogenicity of the overlapping peptides of Blo t 5 was investigated using 
polyclonal rabbit antiserum raised against purified Blo t 5 protein by ELISA method. The 
results were shown in Figure 7.8.  A large proportion of peptides of Blo t 5 were 
immunogenic in rabbit with 60% (12/20) peptides having strong immune response 
(ELISA reading >2.5) and 35% (7/20) peptides having low immune response. Peptide 11 
was not immunogenic in rabbit. Many epitopes were scattered in the entire Blo t 5 
molecule, since peptides responding to rabbit polyclonal IgG almost covered the 
sequences of the whole molecule.  For example, sequence between amino acids 82 and 
113 (MIEGAQGALERELKRTDLNILERFNYEEAQT) may contain many epitopes, 
because overlapping peptides (Peptide 12-Peptide 16) covering this area all showed high 



























Figure 7.8  Immuno-response of rabbit polyclonal antiserum to overlapping peptides 
of Blo t 5. 
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7.3    Discussion 
 
 
Studies of the interaction areas of Blo t 5 with its IgE and IgG specific antibodies 
can help define the molecular basis of its allergy. The ideal method to identify the 
interaction area of epitope is direct scanning of the solvent accessible amino acid on the 
molecule surface area. However, due to lack of information of the three-dimensional 
structure of Blo t 5, structure-based epitope analysis can not be applied to this molecule.  
In this study, two methods have been used to investigate the interaction of Blo t 5 with 
IgE and IgG specific antibodies, site-directed mutagenesis and overlapping peptide 
mapping methods.  
Site-directed mutagenesis is a useful strategy to identify residues critical for IgE-
binding. Epitopes on Der p 2 (Mueller, 2001), Der f 13 (Chan et al., 2006), Bet v 1 
(Spangfort, 2003) and Lol p 5 (Swoboda et al., 1995) have been identified by replacing 
target amino acid with alanine. It is also a powerful tool to disrupt the overall 
conformational structure of target protein by replacing cysteine, proline or other residues. 
Substitution of cysteine residues on Der p 2 resulted in destruction of disulfate bonds, 
which led to conformational change of the structure (Smith et al., 1996). Conformational 
change of Der p 2 indirectly disrupts the conformational epitopes and causes reduction of 
IgE-binding activity. Substitutions on Blo t 5 might either directly affect IgE epitopes of 
the molecule, or disrupt the structure of molecule which indirectly disrupted 
conformational IgE epitopes. Although detailed structure of Blo t 5 has not been released 
yet, analysis of primary amino acid sequence has revealed the three coiled-coil structure 
of the protein by computer programme Matcher (Fischetti et al., 1993). Coiled-coil 
structure contains haptad repeats (a-b-c-d-e-f-g) . Positions "a" and "d" are usually apolar n
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residues which form the hydrophobic core, while polar residues are in other positions 
forming the solvent-exposed part. Single substitution of coiled-coil protein on solvent-
exposed region may not significantly affect its coiled-coil structure. It has been reported 
that twelve substitutions on dominant epitopes of Pen a 1, a major shrimp allergen with 
coiled-coil structure, did not significantly change the secondary structure (Reese et al., 
2005). CD spectroscopy study revealed that these substitutions still maintained the α-
helical profiles (Reese et al., 2005). Residues selected for mutagenesis in this study are 
also located at the solvent-exposed region. We supposed that replacement of these 
residues with alanine may not significantly affect the coiled-coil structure. Thus, any 
changes in the allergenic potency of Blo t 5 mutants could be attributed to mutations at the 
critical amino acid positions of IgE-binding. CD spectrum assay of the mutant proteins 
needs to be further examined to monitor the conformational change in future studies.  
This study revealed that single mutation of Blo t 5 is able to reduce the IgE-
binding acticity. Different sera display different IgE-binding profiles to the mutants. Some 
sera showed reduced IgE reactivity to the substitutions located on N-terminal of the 
molecule, while some sera showed the reduction mainly on C-terminal regions and some 
sera on both N and C-terminal regions. Predominant epitopes are located most probably at 
N40-E44, N61, Q81, E91 and T124, because more than 50% sera tested had reduced IgE-
binding activities to substitutions of these residues.  
Overlapping peptides mapping is another systematic approach to study the 
antigen–antibody interactions. Identification of a number of B epitopes from different 
allergens has been achieved by this method, such as Blo t 11, Pen a 1 and Ole e 1 (Ramos 
et al., 2003, Ayuso et al., 2002, Gonzalez et al., 2006).  Pen a 1 is a typical α-helical 
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coiled-coil protein, which may have the similar structure to Blo t 5. Ayosu et al. (2002) 
reported five major linear epitopes scattered in Pen a 1. It is possible that Blo t 5 also 
contains a number of linear epitopes. In order to find all linear epitopes on Blo t 5 
molecule,   the ideal strategy is to test the overlapping peptides with an offset of one 
residue. However, this approach is not cost effective. In this study, a set of 16 amino acids 
overlapping peptide was initially designed with an overlap of 8 amino acids. To increase 
the resolution of mapping, the overlap between peptides was increased to 12 amino acids 
in the regions that may contain potential epitopes based on the study using side-directed 
mutagenesis. The peptides were biotinylated at N-terminal to avoid the non-physiological 
charge. They were also amidated at C-terminal to mimic the amide form of an internal 
peptide sequence. Ser-Gly-Ser-Gly was recommended as a spacer inserting between the 
N-terminal Biotin and Blo t 5 sequence to eliminate the steric inhibition of binding (Carter 
et al., 2004). When peptides were tested for IgE-binding activitis with ten Blo t 5 positive 
sera, it was found that most sera responded to at least two peptides, four out of ten sera 
responded to more than six peptides. These peptides were scattered along Blo t 5 molecule 
at region Q18 - N61 and V78-Q134. Peptides 7, 8, 9, 17 and 18 did not interact with any 
IgE antibodies from all sera tested. Thus, region L50-A81 and L102-L121 of the molecule 
may not contain any entire linear epitope. From reaction patterns of five Blo t 5 sera, a 
predominant IgE-binding region DLNILERF (98-105) was identified. When looking into 
this protein sequence in other Group 5 and Group 21 protein sequences at hand, we found 
that this sequence was conserved throughout all Group 5 and Group 21 proteins. This 
conserved sequence can be summarized as 
DL(N10/D6)(I8/L5/F2/M1)(L9/F3/V3/A1)E(K8/R6/Q2)(F11/Y4/I1). The subscript numbers 
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indicate the occurrence of that particular amino acid. Sui m 5.02 and Tyr p 5.01 have 
sequences identical to this epitope broader region, suggesting that this common epitope 
might cause cross-reactive response throughout all Group 5 and Group 21 allergens. Other 
IgE-binding peptides were distributed along the molecule, including those located on the 
"less-conserved areas" of the molecule, i.e. Peptides 3, 4, 11, 19, 20. Epitopes on these 
peptides may induce specific IgE response of Blo t 5.  
Rabbit IgG antibodies were able to bind almost all overlapping peptides of Blo t 5 
with different activities except for Peptide 11. It seems that most sequences of allergen are 
immunogenic for rabbit. This result was in accordance with other studies on polyclonal 
IgG epitopes mapping such as Hev b 1 (Chen et al., 1996) and Chi t 1.01 (van Kampen et 
al., 2001).  
Results of epitope mapping could be affected by the strategies applied and sera 
selected for the study. Site-directed mutagenesis method enabled us to narrow down the 
regions which were specific for Blo t 5. These regions might contain linear epitopes 
and/or conformational epitopes. Systematic overlapping peptide approach helps identify 
regions which may contain linear epitopes. Regions narrowed down by two methods may 
not be necessarily identical. That is in agreement with the studies of Chi t 1.01 epitopes 
(van Kampen et al., 2001).  Indeed, the parallel studies using two methods provided more 
information for Blo t 5 and sera antibody interaction. It appears that there are many 
epitopes on Blo t 5 molecule, including linear epitopes and conformational epitopes. 
These epitopes seem to be scattered throughout most of the Blo t 5 protein sequence. We 
found that different subjects recognized different epitopes of Blo t 5. That could be the 
reason why Blo t 5 is a major allergen of dust mite and why it is so specific for mite 
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allergy. Further investigations, particularly on the generation of hypoallergen with 
preserved T cell activity but abolished IgE-binding activity may help produce a better 





Chapter 8:   Conclusions and Future Direction              
 
 
8.1  Conclusions 
 
Sensitization to dust mites is one of the major causes of airway allergic diseases 
worldwide. D. pteronyssinus and D. farinae are predominant mites in the temperate 
regions, while Blomia tropicalis is predominant in the tropics. Up to now, more than 
twenty groups of mite allergens have been characterized, but only Group 1 and Group 2 
allergens have been extensively studied. This study focused on Group 5 and their 
homologous allergens, Group 21 allergens, aiming toward a more comprehensive 
understanding of mite allergy. 
cDNA sequences homologous to Group 5 allergens have been identified from EST 
database for seven dust mite species using local Translated Basic Local Alignment Search 
Tool algorithm. These seven dust mite species included B. tropicalis, D. farinae, S. 
medanensis, A. ovatus, L. destructor, G. domesticus and T. putrescentiae. At least two 
clusters of Group 5 homologous sequences have been found in six species out of the 
above seven. Sequences clustering together with Blo t 5 and Der p 5 were named as 
Group 5, and the others were named as Group 21, according to the World Health 
Organization (WHO)/ International Union of Immunological Societies (IUIS) 
Subcommittee of Allergen Nomenclature. 
In order to understand Group 5 and their homologous allergens, Group 21 
allergens, we initially focused on two new Group 21 allergens in B. tropicalis and D. 
farinae, and then S. medanensis, a less commonly occurring dust mite.  Eleven Group 5 
and Group 21 allergens from six mite species were compared in local atopic population 
when all these allergens were expressed in E.coli system.  
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 A cDNA showing homology to Blo t 5 from the B. tropicalis cDNA library was 
isolated and characterized. Amino acid sequence deduced from this cDNA had 39% 
identity to Blo t 5. However, this cDNA was transcripted from a single-copy gene, which 
was different from Blo t 5. Genomic organization studies revealed that both Blo t 21 and 
Blo t 5 had an intron insertion in different positions, implying the separation evolution of 
these genes within species. Allergen encoded by this cDNA was named Blo t 21 by the 
World Health Organization (WHO) / International Union of Immunological Societies 
(IUIS) Subcommittee of Allergen Nomenclature.  
Blo t 21 is a clinically important major allergen of B. tropicalis. Ninety-three 
percent (40/43) of positive responses to Blo t 21 were obtained by ELISA assay and 95% 
(41/43) by skin prick test (SPT) from 43 adult patients with ongoing persistent allergic 
rhinitis. In addition, Blo t 21, following Blo t 5 and Blo t 3,  was found to be the third 
most prevalent IgE response allergen (31%) after studies in a panel of 19 B. tropicalis 
allergens with 97 B. tropicalis positive individuals who attended outpatient allergy clinics 
over a period of one and a half years. The majority (>75%) of sensitized individuals were 
co-sensitized to both Blo t 5 and Blo t 21, as low to moderate degrees of cross-reactivity 
to these two allergens were observed in above two populations. Co-sensitization of Blo t 5 
and Blo t 21 in the same population could be resulted from the low protein sequence 
identity between these two allergens due to lack of conserved domains, or co-exposure to 
both allergens in the environment.  
Immuno-staining studies indicated that both Blo t 21 and Blo t 5 localize to mid- 
and hind-gut contents of B. tropicalis as well as fecal particles, suggesting that Blo t 21 
and Blo t 5 could pass out with feces and become airborne particles in the environment. 
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The distributions of Blo t 21 and Blo t 5 were then examined in 77 house dust samples. 
Results showed identical distributions of Blo t 21 and Blo t 5 with low concentrations 
(<2.0 µg/g). Identical distributions in the environment lead to co-exposure of these 
allergens in the population.   
IgE-binding of Blo t 21 and Blo t 5 are stable. Thermal treatment does not affect 
their IgE-binding even at 90 °C. In this study, Blo t 5 and Blo t 21 lost their secondary 
structures at 90 °C. However, their secondary structures could be partially refolded back 
after they were cooled down to 20 °C.  When treated under extreme alkalic and acidic 
conditions, the IgE-binding of Blo t 5 and Blo t 21 were not affected either. Their IgE-
binding activities were even retained after treatment with 6 M urea, a strong protein 
denaturant. IgE-binding of Blo t 21 and Blo t 5 seem more stable than those of Der p 1 
and Der p 2, in terms of thermal stability, pH and chemical denaturation resistance. 
Hence, the IgE-binding epitopes of these molecules could be linear epitopes whose 
primary amino acid sequences are recognized by the specific IgE antibodies regardless of 
their structures. The epitopes might be located at core structures of these proteins and 
these core structures could be regained after denaturation. The high stability of IgE-
binding of Blo t 5 and Blo t 21 explains why these two allergens are so important for B. 
tropicalis allergy.  
Der f 21 is another Group 5 homologous allergen studied in this thesis. It is also a 
product of a single-copy gene with its amino acid sequence sharing 66.4% identity to Der 
p 21 and 28.7% to Der f 5. The allergenicity of Der f 21 was evaluated in thirty adult 
patients with ongoing persistent allergic rhinitis, and 83% (25/30) of them had specific 
IgE response. Patients responding to Der f 21 also had specific response to Der f 5. When 
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Der f 21 was compared in a panel of 12 recombinant allergens of D. farinae in 74 atopic 
individuals positive to D. farinae, Der f 21 and Der f 5 were the second most prevalent 
allergens following Der f 2 in this population, suggesting the importance of Der f 21 in D. 
farinae.  
Der f 21 also localizes to mid- and hind-gut contents of D. farinae as well as fecal 
particles like Blo t 5 and Blo t 21. Consistent immuno-staining results confirmed that 
Group 21 and Group 5 were overlappingly expressed at the same positions. Both Der f 5 
and Der f 21 can be detected by ELISA assay in the environment at low concentrations.  
Group 5 and Group 21 allergens of S. medanensis were studied as examples 
representing non-common dust mites. Two Group 5 isoforms and one Group 21 allergen 
have been identified from this species. They were highly transcribed in S. medanensis, as 
multiple copies of cDNA clones were obtained from the cDNA library. When Group 5 
and Group 21 were studied in a panel of 11 recombinant allergens of S. medanensis in 82 
atopic subjects responding to both S. medanensis and B. tropicalis, Sui m 5.01, Sui m 5.02 
and Sui m 21 were found to be the first (28%), third (19%) and fourth (16%) most 
prevalent allergens, respectively. Sui m 5.01, Sui m 5.02 and Sui m 21 together 
contributed 46% of the total sera IgEs of 11 allergens. These data implied the importance 
of Group 5 and Group 21 allergens in S. medanensis. Thus, Group 5 and Group 21 
allergens were important in both predominant and less commonly occurring dust mite 
species.  
It seems that Group 5 homologous genes are common in dust mite. When EST 
database from six mite species were analyzed, Group 5 homologous sequences kept 
popping out. However, no Group 5 homologous sequences from other organisms have 
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been reported. Analysis of 15 Group 5 homologous sequences from eight mite species 
revealed that these sequences were able to be grouped in two major clusters. Sequences 
closer to Blo t 5 and Der p 5 were named Group 5, while sequences closer to Der p 21, a 
Group 5 homologous allergen, were named Group 21. Phylogenetic tree generated from 
these 15 sequences clearly showed that Group 5 and Group 21 evolved separately in the 
species. Hence, gene duplication was most likely taking place before speciation.   
 In order to compare Group 5 and Group 21 allergens from different species, 11 
Group 5 and Group 21 from A. ovatus, B. tropicalis, D. farinae, D. pteronyssinus, 
Lepidoglyphus destructor, G. domesticus and S. medanensis were evaluated in 118 mite  
positive sera from local atopic subjects using semi-quantitative immunoarray assays. 
Among these sera, 97 were positive to B. tropicalis, 74 to D. farinae, 80 to D. 
pteronyssinus, 58 to Aleuroglyphus ovatus, 82 to S. medanensis, 63 to L. destructor and 
82 to G. domesticus. Most D. farinae (68/74) and D. pteronyssinus (73/80) positive sera 
were also positive to B. tropicalis.  Interestingly, all these tested Group 5 and Group 21 
allergens were allergenic. In addition, 41 percent of sera were positive to Blo t 5, followed 
by Ale o 5 (27% positive) and Blo t 21 (25% positive). The rest of Group 5 and Group 21 
allergens showed low frequencies of IgE-binding (8%-19%) in these sera. This result 
implies that Blo t 5 is the most important allergen in this panel and reflects the 
predominant sensitization to B. tropicalis in the local population. 
In order to get a deeper insight into Group 5 and Group 21 allergens, Blo t 5, the 
most important allergen in Group 5 and Group 21 panel, was further studied to identify 
the IgE-binding regions of this molecule. Site-directed mutagenesis and systematic 
overlapping peptide approaches were applied to obtain more information on the epitopes. 
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Results from both strategies showed that IgE-binding epitopes were scattered throughout 
the entire molecule, including N-terminal, Center and C-terminal of the protein.  Majority 
of patients responded to multiple epitopes of Blo t 5 and different patients reacted to 
different epitopes. Site-directed mutagenesis method located the possible predominant 
epitopes at N40-E44, N61, Q81, E91 and T124, as more than 50% of sera tested had 
reduced IgE-binding activities to substitutions of these residues. On the other hand, 
systematic overlapping method spotted a predominant IgE-binding region at the position 
98-105 (DLNILERF) of the molecule, as 5 out of 10 sera responded to this epitope. This 
IgE-binding region was found to be conserved throughout all Group 5 and Group 21 
proteins that have been identified thus far. It can be speculated that reaction to this epitope 
might induce cross-reaction among different Group 5 and Group 21 allergens.   
In summary, this thesis has identified and characterized novel Group 5 
homologous allergens from predominant dust mites, B. tropicalis and D. farinae, and non-
commonly occurring mite S. medanensis. All these allergens have been found to be 
important in mite species, no matter whether they are predominant mites or non-common 
mites. When a panel of 11 Group 5 and Group 21 allergens in six mite species were 
compared in local mite positive sera, Blo t 5 was found to be the most important allergen 
among them. In addition, IgE antibody-interaction regions of Blo t 5 were narrowed down 
on the molecule. These results provide useful information for diagnosis, management and 
immunotherapy of Group 5 and Group 21 allergy. 
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8.2     Future direction 
 
Allergic immune reactions require a pre-sensitization of the host and re-exposure 
of the similar antigens. The reactions are complex and influenced by genetic susceptibility 
and allergen exposure. In Singapore, there are four major races in the society, i.e. Chinese, 
Malay, Indian and Eurasian. It would be very interesting to study allergic immune 
responses in subjects of a particular race, so as to understand the influences of genetic 
background on the allergic immune reactions. Group 5 and Group 21 allergens 
characterized in this thesis can be used as representative allergens for these studies. The 
immune response profiles from different races can be compared to one another to get 
better insight into Group 5 and Group 21 allergy. 
In this thesis, Group 5 and Group 21 induced allergic immune responses have been 
studied in atopic Singaporean individuals. Atopic Singaporean individuals are sensitized 
to B. tropicalis and/or D. farinae because of the predominance of B. tropicalis and D. 
farinae in the local environment. Since Blo t 5 is a major allergen in B. tropicalis, it is not 
surprising to find the predominance of Blo t 5 in a panel of 11 Group 5 and Group 21 
allergens from seven dust mite species. However, in temperate areas such as Switzerland, 
the United Kingdoms and China, D. pteronyssinus and/or D. farinae are the predominant 
mite species. Further studies on allergic immune responses of Group 5 and Group 21 with 
respect to the populations from these temperate areas will be required to achieve a more 
comprehensive understanding on the mite allergy. 
Specific allergen immunotherapy (SIT) represents the only curative treatment of 
inhalant and insect venom allergies, and it has been used for almost 100 years for 
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desensitizing. However, extensive use of allergen specific immunotherapy is limited due 
to problems related to safety of vaccines, adjuvants, treatment schedules and side effects. 
In order to produce safer vaccines for immunotherapy, several strategies have been 
applied to reduce the allergenicity while maintaining the immunogenicity of the vaccines. 
These strategies include site-directed mutagenesis to remove IgE epitopes of the 
molecule, non-IgE-binding fragments of the entire molecule, unfolded recombinant 
allergens, and soluble synthetic peptide. IgE-binding epitope studies in this thesis revealed 
that there are multiple IgE-binding epitopes existing on Blo t 5, including several linear 
epitopes. Atopic individuals tend to respond to multiple epitopes of Blo t 5. Thus, single 
mutant or double mutants may not necessarily be able to remove the majority of IgE-
binding activity of Blo t 5 for certain atopic individuals. Systematic overlapping peptides 
mapping of Blo t 5 revealed that Peptides 7, 8, 9, 17 and 18 do not bind to any specific 
IgE antibodies from all ten sera tested. However, Peptides 8 and 17 were able to bind 
rabbit IgG at medium levels (OD=0.8 ~1.0) and Peptide 18 at a high level (OD=2.5). 
Hence, Peptides 8, 17 and 18 could be used as potential vaccines for immunotherapy.  
Peptide vaccines have been evaluated in immunotherapy studies. Peptides of 
phospholipase A2, a major allergen of honeybee venom, were used to treat five highly 
allergic patients and successfully induced allergen-specific T-cell anergy to bee venom 
(Carlallido et al., 1993). Peptides from cat allergen Fel d 1 were examined in many 
studies. Peptide vaccine treatment changed immune responses, such as generation of 
allergen-specific T regulatory cells (Treg) and reduction in specific IgE levels. In 
addtition, peptide vaccine treatment decreased the asthmatic reaction and nasal problems 
to cat dander exposure (Oldfield et al., 2001; Alexander et al., 2005).  
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To examine the potency of Peptides 8, 17 and 18 for immunotherapy, it is 
necessary to establish a mouse model of Blo t 5 allergy. Peptides can be then introduced 
into Blo t 5 sensitized mice for desensitization. The effects of allergen-specific 
immunotherapy can be examined by testing the following parameters.  (1) Decrease in 
specific IgE levels at late stages of SIT. (2) Increase in specific IgG4 levels. (3) Increase in 
IL-10 and TGF-β levels. (4). Generation of Treg cells. (5) Decrease in allergen-induced 
proliferation of T cells. (6) Decrease in mediator release, e.g. Histamine levels. Based on 
the results from animal model, clinical trial could be started by introducing of peptide 
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Appendix I     Nucleotide and amino acid sequence of SM5-1. The signal peptide was 




1         GGCGGCCGCTCTAGAACTAGTGGATCCCCCGGGCTGCAGGAATTCGGCACGAGGCACGCG 
  
 
61        TAAAACAGACCCATTCCTCAAAAATGAAGTTCGTCCTTGCTCTCGCTGCCCTCCTGGCTG 
                                  M  K  F  V  L  A  L  A  A  L  L  A    
 
121       TGGCTTATGCTGCACCAACCCAGAACGACAAGGGATTCCGAAACGAGTTTGACCACCTTT 
          V  A  Y  A  A  P  T  Q  N  D  K  G  F  R  N  E  F  D  H  L    
 
181       TGGTGATCGAAGCCGAGCACCGATTCAAGGAGATCGAACAGGGTCTGATGAGGTTGAGCC 
          L  V  I  E  A  E  H  R  F  K  E  I  E  Q  G  L  M  R  L  S    
 
241       TCCAGGTGGAGACCCTCGAGAAGAGCAAATCGAAGGCGTTGAAGGCGGAGATTCTGCGTG 
          L  Q  V  E  T  L  E  K  S  K  S  K  A  L  K  A  E  I  L  R    
 
301       AGATCACCATCGGCGTGAACTTTGCCACCGGCGCCAAGGAGTTCTTCACCCGTGAGGCCA 
          E  I  T  I  G  V  N  F  A  T  G  A  K  E  F  F  T  R  E  A    
 
361       AGCGAACCGATCTCGATCTGGTCGAGAAGTTCAACTACGATGCCGCCGTTGTGTCCGCCG 
          K  R  T  D  L  D  L  V  E  K  F  N  Y  D  A  A  V  V  S  A    
 
421       AAATTCTCATCAAGGATCTCACCGAGCTTGCCAAGAAGGTCAACGCCATTGATGCCAACA 
          E  I  L  I  K  D  L  T  E  L  A  K  K  V  N  A  I  D  A  N    
 
481       ACAAGTAGATGATGATGAGAATGAACTAAAATTGATGAGCAAAGTTCTCTAACTTTGTTA 
          N  K    
 
541       TTCAATGAATAAAATAAAGTAAATAAATAATAATTTTCTGTAAAGAAAACAAAACTAAAA 
  
 




Appendix II   Nucleotide and amino acid sequence of SM5-2. The signal peptide was 
underlined. Start and stop codons of open reading frame were boxed. 
 
 
1         GGGCTGCAGGAATTCGGCACGAGGCTCCTTCCCACTCCCCAAAAAACCCAAACCAAAAAA 
  
 
61        TGAAGTGCCTTCTGGTTCTCGCTGCCTGCCTCGTCGCCGTCTATGCGGCTGACAAGAATG 
          M  K  C  L  L  V  L  A  A  C  L  V  A  V  Y  A  A  D  K  N    
 
121       ACTTTCGTCACGAGTTCGACTACTTGTTGATGAAGACCGCTGAGCACAACATGGAACGTG 
          D  F  R  H  E  F  D  Y  L  L  M  K  T  A  E  H  N  M  E  R    
 
181       GTGAGGCAATGCTTCTGGCTTTGACCGAGCAGATTGCTCATCTCGAACAGTCGAAGAACA 
          G  E  A  M  L  L  A  L  T  E  Q  I  A  H  L  E  Q  S  K  N    
 
241       AGGAGGAGAAGGAGAAGATTGTCCGAGAGCTCGAGACCATCATCGCTCTCATCTCTGGAT 
          K  E  E  K  E  K  I  V  R  E  L  E  T  I  I  A  L  I  S  G    
 
301       CGCACGATGTCTTGGAACGTGAACTCAAGCGTACTGACTTGGACATTCTCGAGCGTTACA 
          S  H  D  V  L  E  R  E  L  K  R  T  D  L  D  I  L  E  R  Y    
 
361       ACTTTGAGTCTGCCCTGAAGATCGGCGCCATCTTGGTTCGTGACCTCAAGGCCGCCGAGG 
          N  F  E  S  A  L  K  I  G  A  I  L  V  R  D  L  K  A  A  E    
 
421       CTAAGGTGAAGGCTATCAATGTCCACGCCTAGAAAGCCCACCTTGTCACCTCAGTGTTCT 
          A  K  V  K  A  I  N  V  H  A      
 




Appendix III  Nucleotide and amino acid sequence of SM5-3. The signal peptide was 




1         CCCCCGGGCTGCAGGAATTCGGCACGAGGATTTCAGGTCGCTGAAAATCGCACAATCCAG 
  
 
61        ATTCAAAAGAAAAATAATTTCAAAATTCTAAAATGAAGTTTGTTTTAATTCTTGCAACTT 
                                           M  K  F  V  L  I  L  A  T    
 
121       GTTTGGTTGCCGTGCTTGCCGCGGACAAGAATGACTTTCGCAACGAGTTTGACTTTCTGC 
          C  L  V  A  V  L  A  A  D  K  N  D  F  R  N  E  F  D  F  L    
 
181       TGATGCAAACCATGGAACACAACATGCACCGTGGAGAGCAGATGCTTCTGGCCCTAACCG 
          L  M  Q  T  M  E  H  N  M  H  R  G  E  Q  M  L  L  A  L  T    
 
241       AACAGATCGCCCACCTTGAAGAGTCGAAGAACAAGGAGGAGAAGGAGCACATCATTCGTG 
          E  Q  I  A  H  L  E  E  S  K  N  K  E  E  K  E  H  I  I  R    
 
301       AATTGGAAACCATCATCGCAATGATCTTCGGATCACACTCGGTTCTCGAACGTGAACTCA 
          E  L  E  T  I  I  A  M  I  F  G  S  H  S  V  L  E  R  E  L    
 
361       AGCGTACCGATTTGAACATTCTCGAGAGGTTCAACTTTGAGAGCATGCTTAAGGTTACCC 
          K  R  T  D  L  N  I  L  E  R  F  N  F  E  S  M  L  K  V  T    
 
421       AGGTTTTGGCCAAAGACCTCAAGGATGCAGAGGCTAAGGTCAAAGCAATTAAAGTCTAAA 
          Q  V  L  A  K  D  L  K  D  A  E  A  K  V  K  A  I  K  V      
 




Appendix IV cDNA and protein sequences of Alo e 5. Signal peptide was underlined, 
and the start and stop codons were boxed.  
 
 
1         GATCCTTTTGTGTTTCCTCTCNGAAGACGCCAAAGTCCCACCCAACCTCAACCATGAAGT 
                                                                M  K    
 
61        TTGCCATTCTCGCTCTTGCCTTCCTCGCTACGGCTTTGGCTGCCGATGTCCCCAAGGTCC 
          F  A  I  L  A  L  A  F  L  A  T  A  L  A  A  D  V  P  K  V    
 
121       CACCAAAGGGTGACTTCCGCAATGAATTTGACCATCTCCTAGTCGCCCAGCTGCAGGCTG 
          P  P  K  G  D  F  R  N  E  F  D  H  L  L  V  A  Q  L  Q  A    
 
181       GTATGGCACGTGGTGAGCAGCATCTACTTCGTCTGACGGCGGAGATTGCTCATCTGGAGC 
          G  M  A  R  G  E  Q  H  L  L  R  L  T  A  E  I  A  H  L  E    
 
241       AGACCAAGACAAAGGCTGAACAGGAGCGAATTGTCAATGAGATCAATGTGACGGTGGCCT 
          Q  T  K  T  K  A  E  Q  E  R  I  V  N  E  I  N  V  T  V  A    
 
301       TTATTGAGGGTGCCCAGGGTGTCATCAGCCGTGAGCTTGAACGAAAGGATCTGAACATTC 
          F  I  E  G  A  Q  G  V  I  S  R  E  L  E  R  K  D  L  N  I    
 
361       TGGAGAAGTTCAACTTTGAAGAGGTTCAGGCTATCTCGAAGATTCTGATTAAGGATCTTA 
          L  E  K  F  N  F  E  E  V  Q  A  I  S  K  I  L  I  K  D  L    
 
421       AGGAGGCGGAAGCTAAGGTGAAGGCGGTCAAGACTCACTAAACTGTGGCTGCGGTTCCCG 
          K  E  A  E  A  K  V  K  A  V  K  T  H       
 
481       GCTAAATTTATGGAAATTTTTGTATAATTTCTTTTTTTTGAATTTTAAATAAAATATCTT 
  
 
541       GATTCCCANGAAANACCGTCAAAAAAAAAAAAA 
 
 
 234
